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This thesis examines the regulation of muscle function following exercise-induced 
muscle damage (EIMD), in an attempt to determine whether regulation occurs primarily 
in the muscle (neuromuscular) or further upstream. Upstream regulation has been 
hypothesized to occur in the lower brain structures, but one may assume that the 
efferent output to the muscle should be guided by the motor and pre-motor cortex 
alongside other associated cortical areas.  
There are five chapters comprising of theoretical and experimental sections. Chapter 
one is a review of the current understanding, knowledge and controversies around 
EIMD, pain, electromyography (EMG) and electroencephalography (EEG). More 
specifically this chapter focuses on exercise-induced muscle damage (EIMD) and the 
associated clinical symptoms and neuromuscular changes. A further focus is on acute 
pain, mainly muscular pain and pain associated with movement and EIMD. Central 
nervous system pathways connecting the periphery with the brain are also discussed. 
This chapter further explores the use of EMG to measure the neuromuscular changes 
associated with EIMD. In the third section the effect of pain and movement on the 
activity of cortical alpha (α) and beta (β) frequency bands is discussed. The use and 
applications of EEG during movement and whilst experiencing acute pain, are also 
discussed. It was apparent after this review that there is a need to investigate the 
effects of the symptoms and neuromuscular changes caused by EIMD on the EMG 
activity as well as the cortical α- and β- frequency band activity.  
The second chapter is the first experimental chapter which investigates the effect of 
the symptoms of EIMD on the neuromuscular function and EMG activity during 
maximal isometric contractions (MVC) and submaximal flexion-extension movements. 
Twenty-five right-handed males were recruited for this study. They were allocated to 
either a control (n = 13) or experimental group (n = 12). In contrast to the control group, 
the experimental group participated in an EIMD induction protocol. Subsequently, both 
groups and their symptoms were closely monitored for 132 hours. After the induction of 
EIMD, the experimental group displayed symptoms of muscle pain, swelling, muscle 
shortening, increased serum creatine kinase activity, decreased force output and 
altered neuromuscular function. Muscle pain scores in the experimental group peaked 
after 36 hours with creatine kinase activity peaking after 108 hours. Twelve hours after 
EIMD was induced, EMG activity had decreased by 20% during a MVC in the 
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experimental group and decreased by a further 10% until the end of the study was 
reached 132 hours after the EIMD inducing protocol. In contrast EMG during a 
submaximal flexion-extension movement increased significantly until the end of the 
study (132 hours). In conclusion this study showed that EIMD disturbs neuromuscular 
function during maximal isometric and submaximal shortening-lengthening exercises 
but these changes are not directly related to the clinical symptoms. The dissociated 
EMG activity at submaximal and maximal movement intensity also suggests that 
central regulation influences the neural firing patterns and motor unit activity. 
The aim of the study in the third chapter was to investigate the effects of EIMD to 
determine the relationship between the peripheral symptoms, neuromuscular changes 
and delayed pain sensation during a submaximal movement of the biceps brachii on 
cortical alpha (α) activity. In contrast to the control (n = 12) group, the experimental (n 
= 16) group participated in an EIMD inducing protocol and both groups were monitored 
for 132 hours post-EIMD induction. At twelve hours neuromuscular functioning was 
already disturbed while the sensation of pain was perceived but not fully developed. 
Muscle pain scores in the experimental group peaked after 36 hours with the lowest 
torque reported at twelve hours. Alpha-1 activity increased significantly in the motor 
and somatosensory area twelve hours post-EIMD while α-2 activity increased in the 
contralateral fronto-central area. At 36 hours pain had further increased and 
neuromuscular function improved whilst α-1 and α-2 activities had decreased. We 
hypothesise that α-1 activity over the motor and somatosensory cortex of the 
experimental group displays a compensatory increase in response to the changes in 
neuromuscular function during movement, whilst an increase in α-2 activity is related to 
the suppression of pain experienced within the first twelve hours. 
The fourth chapter describes an experiment in which the response of cortical β activity 
to pain and neuromuscular changes caused by EIMD was studied. This study explored 
the manner in which cortical β activity changed during a testing protocol lasting for 144 
(pre to 132 hours post) hours. In more detail this study investigated the effect of 
neuromuscular changes and pain induced by EIMD and the recovery of the symptoms 
of EIMD on the global cortical β range activity in the experimental group (n = 16) and 
the effect of repeated submaximal movements on cortical β activity in the control group 
(n = 12).  
Muscle pain scores in the EIMD group peaked after 36 hours with the lowest muscle 
torque reported at 12 hours. Beta -1 activity was up-regulated in the frontal and parietal 
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area in the experimental group at 12 and 36 hours. This suggests an impact of EIMD 
induced neuromuscular changes on the cortical proprioceptive and motor perceptive 
networks. Beta-2 activity decreased in the control group over time suggesting a loss in 
focused attention and greater familiarization with the protocol as the study progressed, 
while it increased in the EIMD group. These data suggest a change in activity in the 
upstream regulator integrating movement perception and proprioception post-EIMD. 
Furthermore our data indicates that β-2 activity is associated with the anticipation of 
pain induced by movement.  
 
Finally chapter five synthesises the data from the previous studies to create a 
hypothetical model to explain how EIMD symptoms, neuromuscular function and 
cortical activity interact with each other in a feed-forward and feedback regulation 
mechanism. This chapter also includes suggestions for future directions of research in 
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Figure 1.1 A graphical representation of the central pain pathways from the biceps brachii via 
the spinothalamic tract to the somatosensory area.  
* Figure modified from Crossman AR and Neary D. Spinal cord In: Neuroanatomy, An illustrated colour text Churchill 
Livingstone, Pearson Professional Limited 1996:49 88 
 
Figure 1.2 The basis arrangement of the sensory GATE mechanism in the dorsal 
laminae of the grey matter of the spinal cord.  
*Adapted with permission from Crossman A R. Spinal Cord. In: Standring S, ed. Gray's Anatomy Elsevier; 2005:307-
326.)87 
 
Figure 1.3 Pain pathways in the brain, modified from Apkarian et al. 14. The areas labelled from 
the cortex to the brain stem are; pre-motor cortex (PMC), supplementary motor area (PMA), 
primary motor area (MI), primary somatosensory area (SI), posterior parietal area (PPC), 
anterior cingulate cortex (ACC), posterior cingulate cortex (PCC), prefrontal area (PF), insula 
(INS), secondary somatosensory area (SII), hippocampus (HC), basal ganglia (BG), thalamus 
(THAL), amygdala (AMY), hypothalamus (HT), periaqueductal grey (PAG), reticular formation 
(RF). The black lines indicate connections between areas which interact during the perception of 
pain. 
 
Figure 1.4 A graphical representation of the dorsal columns system carrying information about 
proprioception.  
* Figure modified from Crossman AR and Neary D. Spinal cord In: Neuroanatomy, An illustrated colour text, Churchill 
Livingstone, Pearson Professional Limited 1996:48 88 
 
Figure 1.5 Brain areas activated during voluntary limb movement, adapted from Apkarian et al. 
14. Highlighted in blue are the brain areas activated during voluntary movement which can be 
measured with EEG. Highlighted in light blue is the cerebellum which also plays a great role in 
movement regulation but cannot be measured with EEG. The white areas are also activated 
during movement but measuring the activity by means of EEG is difficult. 
 
Figure 1.6 A graphical representation of the corticospinal (pyramidal) tracts.  
* Figure modified from Crossman AR and Neary D. Spinal cord In: Neuroanatomy, An illustrated colour text Churchill 
Livingstone 1996:5188 
 
Figure 1.7 Processes of EMG signal analysis. (a) raw EMG data, (b) full wave rectified data, (c) 
smoothed data.  
Copied from ://www.noraxon.com/emg/ABC%20of%20EMG.pdf (26/08/2011) (Peter Konrad, Version.1.0, 2005) 
 
Figure 1.8 The 10-20 EEG system. 
 
Figure 1.9 A graphical display of the homunculus in the motor and somatosensory areas of the 





Figure 2.1: Timeline of measurements. The EIMD indicators include, pain, arm circumference, 
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elbow angle, creatine kinase activity  
 
Figure 2.2 
(a) The change in current pain measured with the NPS scale over seven days is shown the 
control () and experimental () group.  
 
## p < 0.01 at 84 hours post versus pre in the experimental group 
### p < 0.001 at 36 and 60 hours post versus pre in the experimental group 
 
 
(b) The change in the difference in relaxed elbow girth (cm) between the left and right arm of 
the control () and experimental () group over seven days. 
 
# p < 0.05 at 108 hours post versus pre in the experimental group 
## p < 0.01 at 36 and 60 hours post versus pre in the experimental group 
### p < 0.005 at 84 hours post versus pre in the experimental group 
 
(c) The change in the difference in elbow angle (degrees) between the left and right arm of 
the control () and experimental () group over seven days. 
 
## p < 0.01 at 12 hours post versus pre in the experimental group 
### p < 0.001 at 36, 60 and 84 hours post versus pre in the experimental group 
 
(d) The change in creatine kinase activity (U.l-1) over seven days is shown the control () 
and experimental () group. 
 
# p < 0.05 at 132 hours post versus pre in the experimental group  
## p < 0.01 at 108 hours post versus pre in the experimental group 
 
------ 
(* indicates results of the Kruskal-Wallis non-parametric test, # indicates results of the Friedman’s non 
parametric test) 
* p < 0.05 control versus experimental group. 
** p < 0.01 control versus experimental group 
*** p < 0.001 control versus experimental group 
 
Figure 2.3 
(a) The maximal force output produced on seven consecutive days is shown in the control 
() and experimental () group. 
  
# p < 0.05 at 60 hours post versus pre in the experimental group 
## p < 0.01 at 84 hours post versus pre in the experimental group 
### p < 0.005 at 12 and 36 hours post versus pre in the experimental group 
 
(b) Change of maximal EMG amplitude on four different occasions  
 
* p < 0.05 control group versus experimental group. 
# p < 0.05 at 132 hours post versus pre in the experimental group  
 
(c) Change in neuromuscular efficiency measured as a ratio of torque/EMG during the MVC 
in the control () and the experimental () group. 
 
# p < 0.05 at 12 hours post versus pre in the experimental group 
† p < 0.001 at 132 hours post versus 12 hours post in the experimental group 
‡ p < 0.01 at 132 hours post versus 36 hours post in the experimental group 
 
---- 
(* indicates results of the Kruskal-Wallis non-parametric test, # indicates results of the Friedman’s non 
parametric test) 
* p < 0.05 control group versus experimental group. 
** p < 0.01 control versus experimental group 
*** p < 0.001 control versus experimental group 
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Figure 2.4 Percentage change of EMG amplitude produced during a low force isometric 
contraction with a 1 kg wrist weight normalized to the maximal EMG amplitude measured on 
four different occasions in the control () and the experimental () group. 
(* indicates results of the Kruskal-Wallis non-parametric test, # indicates results of the Friedman’s non parametric test) 
* p < 0.05 control group versus experimental group. 
# p < 0.05 at 132 hours post versus pre in the control group 
## p < 0.01 at 12 hours post versus pre in the experimental group 
 
Figure 2.5: The EMG amplitude of the biceps brachii during a six second submaximal dynamic 
contraction normalized to the EMG amplitude during a maximal contraction measured on four 
different days in the control () and experimental () group.  
(* indicates results of the Kruskal-Wallis non-parametric test) 
* p < 0.05 control group versus experimental group. 
** p < 0.01 control group versus experimental group 





Figure 3.1 Timeline of measurements. The EIMD indicators include, pain, arm circumference, 
elbow angle, creatine kinase activity  
 
Figure 3.2 A layout of the EGI 129 channel system overlaid by the 10:20 electrode system 
(dark grey circles). Ellipses represent the following gross cortical areas: grey (Frontal), green 
(Pre-motor), orange (Supplementary Motor), blue (Motor), red (Somatosensory), yellow 
(Parietal), purple (Occipital). 
 
Figure 3.3 
(a) The change in current pain measured with the VAS scale over seven days is shown 
the control () and experimental () group.  
 
(b) The change in the difference in relaxed elbow girth (cm) between the left and right 
arm of the control () and experimental () group over seven days. 
 
(c) The change in the difference in elbow angle (degrees) between the left and right arm 
of the control () and experimental () group over seven days. 
 
(d) The change in creatine kinase activity (U.l-1) over seven days is shown the control () 
and experimental () group. 
 
(e) The maximal force output produced on seven consecutive days is shown in the control 
() and experimental () group 
(* indicates results of the Kruskal-Wallis non-parametric test, # indicates results of the Friedman’s non 
parametric test) 
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group, *** p < 0.001 
control versus experimental group, # p < 0.05 post versus pre in the experimental group, ## p < 0.01 post 
versus pre in the experimental group, ### p < 0.005 post versus pre in the experimental group,#### p < 0.001 
post versus pre in the experimental group 
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Figure 3.4 The global change (%) of α-1 activity measured with 129 electrodes over the scalp is 
shown in the control (a) and experimental (b) group. An outline of the electrodes showing 
significant differences between the two groups (c) at each time point is also shown. 
 
Figure 3.5 Nine different electrodes representative of the change (%) of α-1 activity in the 
frontal, central and parietal areas of the brain. Each of the electrodes represents a location on 
the 10:20 system.  
(* indicates results of the Kruskal-Wallis nonparametric test) 
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group 
 
Figure 3.6 The global change (%) of α-2 activity measured with 129 electrodes over the scalp is 
shown in the control (a) and experimental (b) group. An outline of the electrodes showing 
significant differences between the two groups (c) at each time point is also shown. 
 
Figure 3.7 Nine different electrodes representative of the change (%) of α-2 activity in the 
frontal, central and parietal areas of the brain. Each of the electrodes represents a location on 
the 10:20 system.  
(* indicates results of the Kruskal-Wallis nonparametric test)  
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group 
 
 
CHAPTER 4  
 
Figure 4.1: Timeline of measurements. The EIMD indicators include, pain, arm circumference, 
elbow angle, creatine kinase activity  
 
Figure 4.2 A layout of the EGI 129 channel system overlaid by the 10:20 electrode system 
(dark grey circles). Ellipses represent the following gross cortical areas: grey (Frontal), green 
(Pre-motor), orange (Supplementary Motor), blue (Motor), red (Somatosensory), yellow 




a: The change in current pain measured with the VAS scale over seven days is shown 
the control () and experimental () group.  
 
 
b: The change in the difference in relaxed elbow girth (cm) between the left and right arm 
of the control () and experimental () group over seven days. 
 
 
c: The change in the difference in elbow angle (degrees) between the left and right arm 
of the control () and experimental () group over seven days. 
 
 
d: The change in creatine kinase activity (U.l-1) over seven days is shown the control () 
and experimental () group. 
 
 
e: The maximal force output produced on seven consecutive days is shown in the control 
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f: Percentage change of EMG amplitude produced during a low force isometric 
contraction with a 1 kg wrist weight normalized to the maximal EMG amplitude 
measured on four different occasions in the control () and the experimental () group. 
(* indicates results of the Kruskal-Wallis non-parametric test, # indicates results of the Friedman’s non 
parametric test) 
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group, *** p < 0.001 
control versus experimental group, # p < 0.05 post versus pre in the experimental group, ## p < 0.01 post 
versus pre in the experimental group, ### p < 0.005 post versus pre in the experimental group,#### p < 0.001 
post versus pre in the experimental group 
 
Figure 4.4 The global change (%) of β-1 activity measured with 129 electrodes over the scalp is 
shown in the control (a) and experimental (b) group. An outline of the electrodes showing 
significant differences between the two groups (c) at each time point is also shown. 
 
Figure 4.5 Twelve different electrodes representative of the change (%) of β-1 activity in the frontal, 
central and parietal areas of the brain in the control () and experimental () group. Each graph is 
labeled with the corresponding electrode number. The horizontal dotted line represents the time of the 
EIMD- inducing protocol in the experimental group. The vertical grey line marks the time of the EIMD 
inducing protocol in the experimental subjects. 
(* indicates results of the Kruskal-Wallis nonparametric test, # indicates results of the Friedman’s non parametric test) 
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group 
# p < 0.05 at 12 and 36 hours post versus pre in the control group, ## p < 0.01 at 12 hours post versus pre in the control group 
### p < 0.001 at 36 hours post versus pre in the control group 
 
Figure 4.6 The global change (%) of β-2 activity measured with 129 electrodes over the scalp is 
shown in the control (a) and experimental (b) group. An outline of the electrodes showing 
significant differences between the two groups (c) at each time point is also shown. 
 
Figure 4.7 Twelve different electrodes representative of the change (%) of β-2 activity in the frontal, 
central and parietal areas of the brain in the control () and experimental () group. Each graph is 
labeled with the corresponding electrode number. The horizontal dotted line represents the time of the 
EIMD- inducing protocol in the experimental group. The vertical grey line marks the time of the EIMD 
inducing protocol in the experimental subjects. 
(* indicates results of the Kruskal-Wallis nonparametric test, #, †, ‡ indicate results of the Friedman’s non parametric test) 
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group, *** p < 0.001 control versus 
experimental group 
# p < 0.0512 and 36 hours post versus pre in the control group, ## p < 0.01 at 12 and 36 hours post versus pre in the control 
group. 






Figure 5.1 Schematic overview of the main findings of chapter 2 
 
Figure 5.2 Schematic overview of the main findings of chapter 3 
 
Figure 5.3 Schematic overview of the main findings of chapter 4 
 
Figure 5.4 Schematic overview of the hypothesized model. 
 
Figure 5.5 An abstract model of the communication pathways between the peripheral muscle 
and the cortical areas. Each colour represents a frequency. Blue = β-1, green = α-2, red = α-1 
and yellow = β-2.  
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CHAPTER 1   
 
 





1.1  INTRODUCTION TO THE REVIEW OF THE LITERATURE 
 
Humans, unlike other mammals have developed a muscular skeletal system specially 
adapted for bipedal upright locomotion 46 with front limbs free to be used for fine 
controlled grasping and holding tasks 307. In response to the demands of searching for 
food or fighting for survival, their musculo-skeletal systems, especially the skeletal 
muscles have adapted to accommodate a multitude of requirements. However even 
this well adapted system experiences severe stress and consequently is subjected to 
structural damage and associated acute pain. 
 
Today the skeletal system has to adapt to the demands of voluntary exercise, such as 
marathon running, endurance cycling, downhill running or weight training sessions at 
the gymnasium. These types of exercise can cause damage to the muscle, particularly 
if the person is not accustomed to the exercise mode and when the exercise is 
predominated by muscle lengthening under tension 16, 17, 113, 121, 251. 
 
This unaccustomed exercise immediately leads to structural and metabolic changes 
such as, pH changes in the tissue, intramuscular enzyme and metabolite leakage into 
the circulation system, muscle fibre tears and the initiation of inflammatory processes 
16-18. Furthermore there is an immediate loss in force output and changes in 
neuromuscular functioning 296. These structural and metabolic changes lead to a 
disturbance of the system homeostasis and need to be counteracted to reinstate 
homeostasis. Recent research has shown that pain, just like hunger, thirst and itch, is 
an emotional response to reinstate the system homeostasis 86, 241. Pain is also an 
expected response associated with exercise-induced muscle damage (EIMD). Most 
interestingly the sensation of pain associated with EIMD is delayed and only appears 
twelve hours after the exercise, with severity intensifying 24 hours after the protocol. 
Pain peaks at 48 hours and subsides within seven days after the exercise which 
caused EIMD. Clinical symptoms also decline within seven days. However, structural 
changes to the muscle fibres have been documented to last six weeks after prolonged 
exercise in events such as a marathon 169, 395. 
 
The pain that is associated with EIMD is not only delayed in its onset but is also not 
tightly associated with the other symptoms of EIMD. Interesting questions arise from 
this phenomenon. For example, how is this noxious stimulus received by the muscle 
tissue, and how is it perceived and integrated in the brain? Of special interest is to 
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determine if there is an involvement of cortical structures during the subsequent 
recovery period from EIMD and if cortical activity influences the neuromuscular 
activation patterns as well as the delayed onset of pain. 
To understand the underlying factors in greater detail a review of the literature was 
prepared and divided into three parts. The first part introduces EIMD, its symptoms, 
peripheral changes and how it might disturb the homeostasis of the system. In addition 
the sensation of pain and the pathways leading from the painful stimulus to the 
emotional and physiological integration of the sensation of pain is introduced.  
The second part describes the methodology of electromyography (EMG), including 
what it measures and how the data are recorded and analysed. This is of importance 
as EMG reflects the changes in activation of the muscle (peripheral changes) in 
response to the EIMD before measuring the EIMD associated changes in the cortical 
areas. The third and last part of this review illustrates the involvement of the cortical 
areas in movement execution and pain perception. This is followed by a discussion of 
electroencephalography (EEG) as a mode to measure the electrical activity and by 
implication the changes in the activity of the cortex.  
The goal with this review of the literature is to convince the reader that to further the 
knowledge on EIMD and its implications on the system, the field of research needs to 
be widened to include not only peripheral (clinical signs and EMG) but also central 
measures (EEG) to understand EIMD and its effects, particularly those of pain and 
neuromuscular changes better.  
1.2 EXERCISE-INDUCED MUSCLE DAMAGE AS AN EXAMPLE 
OF DISTURBING SYSTEM HOMEOSTASIS 
1.2.1 Introduction to muscle damage as a result of unaccustomed 
exercise 
Unaccustomed exercise, especially exercise during which the muscle is lengthened 
under tension, can lead to structural, metabolic and biochemical changes at a cellular 
level in the involved muscle tissue. Although this type of exercise is often referred to as 
eccentric exercise 76, 85, 124, 133, 142, the technically appropriate term is 'lengthening under 
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tension' 130, which will be used subsequently.  
 
Clinical symptoms of EIMD include swelling of the tissue, loss of strength and muscle 
function and a decrease in the resting length of the muscle. There is also increased 
activity of intramuscular enzymes, such as creatine kinase in the blood 56, 264, 267. The 
circulating enzyme activity is possibly a result of the disruption of the sarcolemma or 
change in membrane permeability caused by the EIMD inducing protocol. This would 
lead to the leaking of intracellular enzymes and proteins into the serum 80, 264. The 
activity of serum creatine kinase increases rapidly 48 hours after an EIMD protocol 153 
and usually remains elevated for five days or longer after the intervention 210, 215, 264, 266. 
 
The muscle stiffness associated with EIMD is usually felt within the first twelve hours 
and develops into soreness, which peaks between 24-72 hours after the muscle 
damage was induced 142, 267. The pain usually subsides within seven days after the 
damage inducing exercise 173, 210. Importantly it is still not known which biochemical and 
mechanical processes are associated with the delayed perception of pain following 
EIMD. For example, the symptoms associated with EIMD233, particularly the decrease 
in neuromuscular functionality measured as force output 79, usually occur within the first 
0-12 hours after the injury 80 and peak at different time points thereafter 80, 265. The 
increase in arm circumference is caused by oedema as a result of tissue fluids leaking 
from the injured muscle tissue and accumulating in the connective tissue 173. The 
oedema 172 and changes in the connective tissue 81 have been proposed as causes for 
the shortening of the muscle leading to a change in the elbow angle. Oedema in the 
damaged muscle, for example, leads to a peak in limb circumference 72 hours after the 
EIMD inducing protocol, as does the shortened muscle length associated with the 
damage 79, 265, while creatine kinase activity in the blood only peaks 72 or 96 hours after 
the EIMD inducing protocol . The exact timing seems to be dependent on the exercise 
protocol used 79, 80, 329. 
 
The symptoms of oedema and muscle shortening disappear after 5-7 days 81, 113, while 
the peak soreness usually occurs at 24-48 hours after the EIMD inducing exercise 403. 
Therefore, the asynchronous appearance and disappearance of the clinical symptoms 







1.2.2 Processes during EIMD 
 
Armstrong 17 has proposed that EIMD is an inflammatory process. He used a 4-stage 
model to describe this process. The four stages are as follows; an initial stage, an 
autogenic stage, the inflammatory stage followed by the regenerative stage. Not much 
is known about the initial stage besides that it triggers the following degenerative, 
inflammatory and regenerative processes in the muscle tissue. 
 
The autogenic stage which follows can last up to several hours and includes an 
increased concentration of calcium (Ca2+) in the damage tissue due to the disturbance 
in the release and reuptake of calcium by the sarcoplasmic reticulum. The free calcium 
leads to the activation of calpain and phospholipase leading to the breakdown of cell 
structures 27, 269. This stage merges into the inflammatory stage when phagocytic and 
other inflammatory cells enter the damaged tissue 232, 375. The regenerative phase is the 
last stage of the process and describes the phase when the first regenerative 
processes take place. The regeneration includes the revascularization of the damaged 
area, the activation of satellite cells resulting in proliferation and fusion of myoblasts 
and the maturation of the myotubes 65, 142, 159, 365. This occurs within 4-6 days after the 
initial event and after 10-14 days the tissue appears normal again 142. In cases of 
severe muscle damage, for example after an ultra marathon race, the regeneration 
process can take several weeks (10—12 weeks) 395. This type of exercise leads to 
severe muscle fibre tearing, intra and extra cellular oedema, myofibrillar lysis and focal 
mitochondrial degeneration within the tissue, even without displaying inflammatory 
processes 156, 395. 
 
Most of the above mentioned processes (break down of cell structures, oedema etc) 
are similar in EIMD and inflammatory processes 233, 264, 354, 381. But inflammatory 
processes do not entirely explain the events in the muscle tissue after the 
unaccustomed exercise, because the inflammatory response to the EIMD induced 
tissue damage does not provide sufficient strength to elicit the pain response as seen in 
EIMD 264. 
 
Besides the inflammatory response, mechanical damage to the contractile apparatus is 
often observed. This includes damage to the myofibrils and the cytoskeleton which is 
regularly analysed in biopsies taken from muscle tissue exposed to excessive exercise 
140, 142. It has been shown that the first structural changes of the cytoskeleton, including 
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rupturing of sarcomeres 140-142, damage to the cytoskeleton (desmin) and the cell 
membrane 140-142, 251 occur within the first 5-15 minutes after the onset of repetitive 
lengthening muscle actions 218. Other signs of damage include z-band streaming and 
dissolution, A-band disruption, disintegration of the intermediate filament system and 
misalignment of the myofibrils 2, 140-142. As a consequence of the damage to the 
myofibrillar structure and change in membrane permeability, the internal chemical 
balance is disturbed. This results in enzyme leakage, cellular degradation and failure of 
the excitation-contraction coupling in the muscle 17, 53, 80, 141. Intermediate filament 
damage is caused by direct tension on the tissue during exercise or indirect tension 
due to the pressure of oedema. The apparent damage to the intermediate filaments 
could be a secondary response to muscle damage and may be the initial step of 
sarcomereogenesis 140. 
 
The major symptoms of EIMD include soreness and tenderness. It has been suggested 
that these pain symptoms are triggered by intracellular fluids leaking out of the 
damaged muscle fibres and activating nociceptors. As the pain during EIMD is dull and 
not well localized, it is assumed that the nociceptive signal is mainly conducted by the 
type C unmyelinated pain fibres 268, 370.  
 
1.2.3 Measurement of muscular pain 
 
To be able to compare the pain caused by a variety of stimuli such as capsaicin 69, 70, 
hypertonic saline injection 75, 214, laser stimulation 185, 188 or muscle damage a reliable 
system to measure pain is needed. Several systems have been developed including 
subjective (pain scales) and objective (pressure probe) 210 pain measures. Over the 
years the visual analogue scale (VAS), a subjective pain measure, has proven to be 
valid 146, 277, reliable and repeatable 40, 122, 277, even when compared to more objective 
pain measurements  
 
The VAS, which is a widely used scale to measure pain, is a type of a ratio-interval 
scale 297. It consists of a line or scale, with each end of the line/scale labelled with 
statements appropriate for describing the extreme values of the sensation: one end is 
often labelled “no pain” and the other end is often labelled “worst possible pain.” The 
subjects rate the perceived pain by placing a marker or simply tick the line in relation to 
the two extremes. The VAS has been shown to be useful for separating measures of 
pain intensity and unpleasantness 40, 108. 
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In conclusion, EIMD with its symptoms of tissue damage, enzyme leakage, tissue 
healing and pain has been shown to be a good model for acute pain and its effects on 
the peripheral as well as central structures. Of particular interest in the context of this 
thesis are the delayed pain response and the association between neuromuscular 
changes and electrical activity in the muscle (EMG) and brain (EEG). 
 
Therefore the next two parts of this review will elucidate the use and background of 
EMG and EEG in measuring the effects of EIMD. In particular the review will focus on 
pain associated with EIMD and the electrical activity in the peripheral nerves and 
muscles as well as affected brain structures. 
 
 
1.3 PAIN: THE PERCEPTUAL RESPONSE TO DISRUPTION OF 
HOMEOSTASIS 
 
1.3.1 Introduction to pain 
 
Pain is a sensation experienced by all mammals and consists of a nociceptive signal 
accompanied by an emotion or feeling. The nociceptive signal is a physiological 
activation of niceptive receptors and their afferent nerves (physiological sensation of 
pain is discussed in greater detail from page eight onwards). The emotional component 
of pain exists largely to produce a behavioural response associated with the avoidance 
of the pain inflicting stimulus 244, 392, 402. To fully understand pain one cannot separate 
the nociceptive signal from the emotional response 86. Similar to thirst, hunger, 
temperature and itch, pain is an emotional motivation to restore homeostasis which has 
been disturbed by the sensation causing the stimulus 86, 241. 
 
1.3.2 Definition and teleology of pain 
 
The International Association for the Study of Pain defines pain as: ”Pain is an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage” 1. 
 
The sensation of pain heightens awareness of a problem such as an inflammatory 
process or injury. The sensation of pain may also protect the involved area from further 
injury and aid in the process of healing by eliciting an emotional response and causing 
Chapter 1 
 9 
an avoidance reaction 56, 86. 
 
1.3.3 Classification of pain 
 
According to the time frame of inflammation, tissue damage and healing process, the 
sensation of pain can be divided into three subdivisions; transient, acute and chronic 
pain 61, 242. Transient pain is of very short duration such as a needle prick or stubbing a 
toe and usually does not require medical attention. Acute pain, which is elicited by 
damage to tissue and can last anything from a few hours to a few weeks or even 
months but usually subsides before the healing of the damaged tissue is completed. 
Examples for acute pain are the pain associated with burning with hot water, exercise-
induced muscle fibre tears or a broken bone. Acute pain requires medical treatment in 
some cases and can also be related to trauma or surgical interventions 61, 242. Chronic 
pain lasts from a few months to several years and is often difficult to treat, as the tissue 
damage is either so severe that healing is impaired, or the pain is due to peripheral or 
central neuropathic pain. Examples of conditions associated with chronic pain included 
multiple sclerosis and osteoarthritis 1, 242. However in this review the focus will mainly be 
on the effects of acute muscular pain and in particular the pain associated with EIMD.  
This review as well as the following chapters will mainly focus on the effects of pain 
rather than nociception as, the experimental studies focused on the emotional/cognitive 
response to nociception which is included in the broader term pain. Therefore the spinal 
pathways will be called nociceptive pathways but as soon as the noxious stimulus 
reaches the brain I will be talking about pain as one cannot discriminate anymore 
between the noxious stimulus, the sensation and the emotional /cognitive response.  
 
1.3.4 Physiology of pain 
 
1.3.4.1 Noxious stimulus 
There are several muscular 66, 68, 69 or cutaneous 70 stimuli which are used in research 
to induce a noxious stimulus. Most studies of evoked pain use heat, laser, hypertonic 
saline or capsaicin injection to induce pain in the arm or foot area 66, 70, 103, 175. 
 
1.3.4.2 Nociceptors 
The painful stimulus caused by, for example, a muscle fibre tear due to exercise is first 
received in the nociceptors. Nociceptors are high threshold, free nerve endings which 
act as receptors for noxious stimuli (i.e.. needle prick, boiling water, muscle fibre tear, 
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skin cut) and are found in most organs of the body. They are stimulated either by a 
mechanical, chemical, thermal, electrical or other stimuli, but mostly are activated by 
chemical mediators before they can react to the noxious stimulus 182. These chemical 
mediators can be prostaglandins, proteolytic enzymes, potassium, bradykinin, 
histamine and other chemical or metabolic substances released by injured tissue 406. 
Local tissue acidity (pH change) can also lead to a depolarisation of the receptors, 
which in return leads to a hyper sensitivity to noxious stimuli. By activating the pain 
receptors these substances can enhance the transmission of the nociceptive signal to 
the spinal cord. This process is known as peripheral sensitization 409. 
1.3.4.3 Nociceptive fibres 
The nociceptive component of pain is transferred by two different types of nociceptive 
fibres; the fast conducting Aδ fibres and the slower conducting unmyelinated C fibres. 
Aδ fibres are thinly myelinated neurons conducting information at about 20 m·s-1, and 
are believed to be responsible for the acute and sharp pain felt immediately after an 
injury or tissue damage occurred 182. The Aδ fibres terminate in the dorsal horn, from 
where the second order neurons directly transmit the nociceptive signal through the 
spinothalamic tract (Figure 1.1) to the thalamus and sensory cortex 182. 
However in this review the pathway of only the slower type C fibres will be discussed as 
it has been hypothesised that they are more relevant to the pain felt while experiencing 
the symptoms associated with EIMD. This is due to the observation of EIMD causing a 
slow, longer lasting dull pain, which is associated with C fibre conduction, rather than 
the short sharp pain associated with Aδ fibre conduction 370. However it has been 
proposed that the pain felt during movement after an EIMD protocol is often sharper 
and more localised and could therefore be transmitted by the Aδ fibres 268. 
1.3.4.4 Nociceptive signal entry into the spinal cord 
Nociceptive inputs are mediated through a complex system of receptors and pathways. 
From the affected organ, the nociceptive signal is transmitted through the first order 
neuron to the unmyelinated dorsal root C fibre at a speed of 0.5-2.0 m·s-1. The first 
order neurons enter the dorsal horn and synapse in lamina I 86. The neurons usually 
terminate shortly after their point of entry into the dorsal horn and fan out over several 
segments 406 and therefore lose some of their localization specificity. The synapses in 
the dorsal horn show great malleability and therefore pain signals can be intensified or 































Figure 1.1 A graphical representation of the central pain pathways from the biceps brachii via 
the spinothalamic tract to the somatosensory area.  
* Figure modified from Crossman AR and Neary D. Spinal cord In: Neuroanatomy, An illustrated colour text Churchill 
Livingstone, Pearson Professional Limited 1996:49 88 
 
1.3.4.5 Gate control theory of pain 
In particular impulses from collateral and interneurons can inhibit the transmission of 
pain signals from the dorsal root fibres to the spinothalamic neurons by interfering at 
the first point of synapsing between the first and second order neurons in the dorsal 




Figure 1.2 shows the entry point to the nociceptive C fibre and the Aβ mechanoreceptor 
into the dorsal horn. It shows how interneurons can relay information from the 
mechanoreceptor to the pain fibre to inhibit pain transmission. This explains why, for 
example, rubbing the skin decreases a painful sensation. The rubbing stimulates the 
mechanoreceptors which then interact with the nociceptors at the dorsal horn level and 
decrease (or increase) the feeling of pain 298, 399. Furthermore, efferent neuronal 
signalling from the brain and the subsequent release of neurotransmitters can interact 
with, and impede flow of, information at this level and hence inhibit the further 














Figure 1.2 The basis arrangement of the sensory GATE mechanism in the dorsal 
laminae of the grey matter of the spinal cord.  
*Adapted with permission from Crossman A R. Spinal Cord. In: Standring S, ed. Gray's Anatomy Elsevier; 2005:307-
326.)87 
 
Information from the frontal somatosensory area, the cingulated cortex, hypothalamus 
and amygdala descends via the reticular formation and the spinal cord to the first order 
synapses in the dorsal horn (the areas of the brain will be discussed on page twelve). 
This efferent information is used by relay cells and interneurons to either inhibit or 
enhance signal transmission at the synapses in the dorsal horn 241, 406, hence the term 
GATE for these synapses as suggested by Melzack and Wall 244 in their GATE theory 
of pain. This GATE is the first point at which the transmission of a painful stimulus can 
be inhibited by signals transmitted from the brain and is therefore of interest when 
discussing the interaction of a painful stimulus and the brain later. Therefore the dorsal 
horn GATE is the first central point at which an efferent signal from the brain can inhibit 





1.3.4.6 Spinal pathway 
From the point of synapsing in the dorsal horn, the second order neurons ascend 
towards the brain 406. A number of neuronal axons terminate in the spinal cord 
(information used for reflex arc) while other axons enter the anterolateral system 
including the lateral spinothalamic tract 87 (Figure 1.1). The main pathway ascends 
through the dorsal horn of the spinal cord, crosses the midline to the opposite side of 
the spinal cord and often synapses several times before entering the brain stem at the 
reticular formation 87, 405. Some of the neurons end in the reticular formation and near 
the aqueduct in the midbrain. Further neurons project from the reticular formation, 
which mediates the central inhibition and arousal effect of pain, to the midline and 
intralaminar non-specific projection nuclei of the thalamus. From the ventral nuclei of 
the thalamus the signal is transmitted through the third order neuron to the 
somatosensory area 44, 171, 302 in the cortex.  
 
1.3.5 Perception of pain 
 
1.3.5.1 Brain areas associated with pain 
As discussed in the previous paragraph the painful stimulus reaches several brain 
areas. It has been found that pain is not evaluated and integrated in a single area of 
the brain but rather that the activation of the small unmyelinated type C pain fibres lead 
to the activation of several cortical and subcortical areas. A pain stimulus activates 
parts of the primary somatosensory area (SI), secondary somatosensory area (SII), 
anterior insular cortex and cingulate gyrus (both part of the limbic system), all on the 
side opposite to the stimulus (Figure 1.3) 14, 182, 392. The noxious stimulus is also 
received by the periaqueductal grey matter in the midbrain, inferior parietal area, 
rostral insula, the hypothalamus and thalamus as well as the ipsilateral (to the painful 
stimulus) cerebellum 14, 262, 293, 294, 362, 367, 367.  
 
Studies using magnetic resonance imaging (MRI) could show that brain areas 
associated with pain have an increase in blood flow with an increase in pain intensity 
294, 367. There are also negative correlations (i.e.. decreased blood flow) in the medial 
and parietal cingulate cortex, and medial prefrontal regions. These changes in blood 
flow were only correlated with the actual intensity of pain and not the anticipated 
intensity of pain 294. 
 
Further studies have shown that various pain activated areas are also activated in the 
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anticipation of pain 14, 136, 293. These areas include the anterior cingulate gyrus, insular 
cortex, pre frontal area, primary somatosensory area and the cerebellum 14. The same 
studies have shown that if a painful stimulus is expected in the foot, the correlated area 
on the homunculus of the primary sensory cortex will show increased activity, but at 






































Figure 1.3 Pain pathways in the brain, modified from Apkarian et al. 14. The areas labelled from 
the cortex to the brain stem are; pre-motor cortex (PMC), supplementary motor area (PMA), 
primary motor area (MI), primary somatosensory area (SI), posterior parietal area (PPC), 
anterior cingulate cortex (ACC), posterior cingulate cortex (PCC), prefrontal area (PF), insula 
(INS), secondary somatosensory area (SII), hippocampus (HC), basal ganglia (BG), thalamus 
(THAL), amygdala (AMY), hypothalamus (HT), periaqueductal grey (PAG), reticular formation 





1.3.5.2 Pain neuromatrix in the brain 
1.3.5.2.1 Medial pain system = perception and affectionate component 
The prefrontal cortices, amygdala, hypothalamus, posterior insula, motor area, 
hippocampus, cingulated cortex, thalamus and periaqueductal grey are collectively 
referred to as the medial pain system, because of their medial location and their 
activation whenever a noxious stimulus occurs 205, 392. In the medial pain system the 
neural and endocrine information related to pain are integrated 14, 15, 82, 205. Together 
these areas are associated with the affectionate component and perception of pain 205, 
290, 392. The periaqueductal grey area is known to not only be associated with the 
emotional component of pain but is also able to inhibit the sensation of pain in the 
conscious animal 14, 14, 185, 406. 
 
1.3.5.2.2 Lateral pain system = localization 
The primary and secondary somatosensory area as well as the inferior parietal areas 
are part of the lateral pain system which is associated with the localization of the painful 
stimulus 205 341, 383.  
 
However, recent research by Ohsiro et al 272 has shown that the medial and lateral pain 
system are not as discriminated from each other as previously thought . Functionality 
rather overlaps between the two systems and no complete discrimination is possible 
between the sensory-discriminative (previously thought to be lateral pain system) and 
emotional-affectionate (previously thought to be medial pain system) component of 
pain in the cortical areas. Of special importance is that the pain sensation is 
represented on a fronto-parietal network as are perception and attention processes 
(page 18) 272. 
 
1.3.5.2.3 Memory of pain 
Further parts of the limbic system, especially the insular cortex and anterior cingulate 
cortex, as well as the pre frontal cortex are not only associated with the cognitive, 
emotional and affectionate processing of pain, but also form memories, including 
previous responses to pain 14, 26, 185, 258, 361, 362, 392, 402. The posterior part of the anterior 
cingulate cortex, also associated with the feeling of unpleasantness and suffering, has 
a delayed response of 0.5 to 1.5 s 205, 290 which might indicate that it reacts to the pain 
transmitting C fibres which are activated during EIMD370, rather than the faster 
transmitting Aδ fibres. 
 
Collectively these pain related systems and networks are called the pain neuromatrix of 
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the brain 243, a highly complex network integrating the sensation of pain. 
1.3.6 Further pathways activating the pain response to reinstate 
homeostasis: Inflammatory processes and their association with the 
perception of pain 
Injured sites or inflammatory processes trigger the damaged tissue to release cytokines 
such as interleukin-1 (IL-1), interleukin-6 (IL-6) and tumour necrosis factor (TNF) into 
the blood within one to four minutes after tissue trauma occurred 239, 396. This trauma, 
can be an injury or an infection but also tissue damage caused by over training 355 or 
EIMD. The cytokines (IL-1, IL-6 and TNF) cross the blood-brain barrier and attach to 
receptors found on glial cells. Interestingly glial cells are the main producers of 
cytokines within the central nervous system 235. Cytokines also bind to receptors in the 
hypothalamus and hippocampus 89, 90, 224, 235, 355, 373, 384 and subsequently act as 
mediators to activate the pain modulating processes in the brain 58, 239, 241, 309, 371, 404.  
The activation of the pituitary dependent adrenal response provides evidence that the 
inflammatory stimuli can activate anti-inflammatory signals from the central nervous 
system 36, 384, as the peripheral inflammatory process may alter the neuronal signalling 
of the hypothalamus 384. The cytokines released from the glial cells activate the 
hypothalamic-pituitary axis which increases circulating glucocorticoids leading to the 
suppression of cytokine release in the periphery 33, 36, 224, 384.  
Therefore there seems to be a bi-directional communication between the immune 
system and the brain during an inflammatory process which functions without the 
involvement of the peripheral nervous system 235, but is dependent on the glial cells 
rather than the neurons situated in the central nervous system. The glial cells in the 
central nervous system possess a membrane potential slightly larger than that of 
central nervous system neurons. When localised changes in the extra cellular 
potassium concentration of the central nervous system occur the glial cells depolarize. 
Thus it appears that the glial cells have an amplifying effect on extra cellular field 
potentials 282. This possible amplification of the electrical field potential may be 
recorded in EEG. 
Due to the extensiveness of this topic and the emphasis on acute pain in this review, 
the immune system and glial cells will not be discussed in further detail. They are only 
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mentioned above to acknowledge the fact that there are other systems of information 
transfer besides the neuronal pathways which might be important in the information 
transmission process during peripheral inflammatory processes.  
 
1.3.7 Interaction between movement and pain 
 
Small, soft and brief movement is known to lead to a reduction in C fibre transferred 
pain 390. Therefore the next section will focus on movement and its control by the brain. 
It is of special interest where the information about pain overlaps with motor control. Le 
Pera 213 showed that motor cortex activation due to movement preparation could inhibit 
cortical pain processing as well as increase the pain threshold and decrease the pain 
rating.  
 
Since the general pathways of pain conduction have been outlined, the following 
section will discuss EIMD, a model for muscular pain. This section will emphasize that 
the symptoms consequent to EIMD will lead to a pain response. 
 
However, the experience of EIMD does not only lead to an increased sensation of pain 
but also influences proprioception 299, 300, 380 and motor control 43, 206, 300 in the affected 
limb. Proprioception is the afferent information from the periphery to the brain which is 
altered due to the altered state and disturbed homeostasis of the muscle tissue. Motor 
recruitment and motor activation on the other hand change due to the altered efferent 
response by the motor control centres in the brain, especially the cortex.  
 
 
1.4  VOLUNTARY MOTOR CONTROL: AFFERENT AND 
EFERENT FEEDBACK 
 
1.4.1 Afferent sensory pathways associated with changed 
proprioception  
 
Information about proprioception received by the muscle spindles and Golgi tendon 
organs ascend to the brain via the anterolateral system (which includes the 
spinothalamic tract involved in the transmission of pain) to the somatosensory are of 




While the cerebellum is known to integrate proprioceptive feedback 87, 123, recent 
research suggests that the cerebral cortex is also involved in the integration of 
proprioception, motor perception, posture control and the determination of force output 
315, 320, 350-353, 387. Electroencephalographic research has shown that the frontal and 
parietal-occipital areas are activated when receiving and integrating proprioceptive 





























Figure 1.4 A graphical representation of the dorsal columns system carrying information about 
proprioception.  
* Figure modified from Crossman AR and Neary D. Spinal cord In: Neuroanatomy, An illustrated colour text, Churchill 









Proprioceptive information is needed to guide motor output to adjust force output and 
neuromuscular recruitment to altered circumstances (i.e.. during EIMD). Recent 
research shows that this integration takes place in the cerebral cortex 147, 206, 249.  
 
1.4.2 Brain areas involved in voluntary motor control  
 
Figure 1.5 depicts the areas of the brain which are directly involved in the control of 
voluntary movement. This has not only been detected indirectly (by MRI) but also 
directly by the stimulation of cortical regions with transcranial magnetic stimulation 

























Figure 1.5 Brain areas activated during voluntary limb movement, adapted from Apkarian et al. 
14. Highlighted in blue are the brain areas activated during voluntary movement which can be 
measured with EEG. Highlighted in light blue is the cerebellum which also plays a great role in 
movement regulation but cannot be measured with EEG. The white areas are also activated 
during movement but measuring the activity by means of EEG is difficult. 
 
The most prominent areas of the brain which control voluntary movement include the 




sensory motor area ipsilateral to the movement (during limb movement), the 
somatosensory area contralateral to the movement, the parietal area and the posterior 
insula 92, 136, 137, 151, 270.  
 
1.4.3 Function of the motor control areas 
 
While the efferent control of the movement is guided by the primary motor cortex, the 
secondary and associated areas are not only activated by voluntary movements but 
are also interacting with each other to learn and integrate movement as well as form 
memories of motor sequences 137, 151. The supplementary motor area is assumed to be 
important for the preparation and organisation of voluntary movement 92 while the 
parietal lobe is involved in the procedural organisation of movement as well as 
proprioception and movement perception 134, 135, 137.  
 
1.4.4 Efferent motor pathways 
 
The motor pathway for voluntary movement consists of the pyramidal tract also called 
the corticospinal tract (Figure 1.6). The motor impulses originate in the giant pyramidal 
cells, the so called primary motor neurons, of the motor area in the precentral gyrus. 
The axons of the pyramidal neurons pass from the cerebral cortex to the corona 
radiata and then descend to the midbrain and the medulla oblongata117 87. In the lower 
part of medulla oblongata neuronal fibres sending information to the extremities (limbs) 
pass to the opposite side. The fibres of the corticospinal tract terminate in the anterior 
horn of the grey matter of the spinal cord and synapse with the secondary motor 
neurons. These peripheral motor nerves transmit the motor impulses from the anterior 
horn to the voluntary muscles, where the nerve innervates the muscle fibres forming 
the motor units 117 87.  
 
1.4.4.1 Efferent communication between the central nervous system and 
the periphery 
As described before efferent output from the brain to the muscle is guided by the 
precentral motor area during voluntary movement 22, 49, 83, 148, 157, 300. This notion is 
supported by the discovery of a coherent 15-30 Hz activity in the muscle, peripheral 
and central nervous system during movement 12, 13, 64, 83, measured by EEG and EMG 
13, 64. This motor-cortical coherence is assumed to be due to the firing behaviour of the 
corticospinal tract (Figure 1.6) or other spinal motor neurons 83. The time delay 
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between the first occurring EEG rhythm and the following EMG rhythm can be 
explained by the conduction velocity of the nerves 157 and is 15 ms longer for EMG 
recorded in the leg than in the arm 50, due to the longer pathway. 
Figure 1.6 A graphical representation of the corticospinal (pyramidal) tracts. 
* Figure modified from Crossman AR and Neary D. Spinal cord In: Neuroanatomy, An illustrated colour text Churchill
Livingstone 1996:5188
r 













Ventral corticospinal tract 
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Further cortico-muscular synchronization during movement has been shown, 
especially between the contralateral primary motor area and the activated muscle in 
the 15-35 Hz activity 83, 129, 157, 193, 317. A 40 Hz oscillation in the motor area contralateral 
to the moving side precedes a 40 Hz rhythm in the EMG during strong voluntary 
isometric contractions and phasic wrist movements 50. The coherence between EEG 
and EMG is strong in the 15-35 Hz 64 frequency range and is recorded during dynamic 
and isometric tasks50, 157, 193. The coherence is also positively correlated to the force 
output by the activated muscle 64, 193, 194. 
 
Therefore there seems to be a link between the 15-35 Hz frequency activity and motor 
output, however it has not been determined if this is a bottom-up afferent connection or 
a top- down efferent connection. Furthermore, it is not known whether this could be 




1.5 ELECTROMYOGRAPHY:  
 MEASURING ELECTRICAL ACTIVITY IN THE MUSCLE 
 
1.5.1 Introduction to Electromyography  
 
Surface electromyography (EMG) is the electrical activity which is measured in a 
muscle by electrodes placed on the skin overlaying the muscle of interest 37. An EMG 
signal represents a global measure of the active motor units within the muscle, and 
does not have the precision to measure the signal of individual motor units 37. As the 
recorded signal is comprised of the neural recruitment of the motor units as well as the 
firing rate of the active motor unit, it can be stated that the EMG reflects on the 
properties of the peripheral as well as the central components of the neuromuscular 
system and that the two cannot be separated from each other 127. EMG can also 
measure the amplitude of the signal 9, 223 as well as its power frequency spectrum 223, 
229. The power spectrum is the frequency distribution of the signal which is influenced 
by the muscle fibre type which is recruited 223. The EMG signal can be disturbed by 
several factors, since the electrical activity is created within the muscle, but the EMG 
signal is measured on the surface (skin). For example, the subcutaneous fat layer 263, 
the electrode position 125, 128, 165, 187, 189, 246 and muscle fibre characteristics and length 
118, 127, 127, 187, 252, 253 have a large effect on the accuracy of surface EMG readings 125 
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and therefore need to be considered in an experimental design. The next section will 
discuss the methodology of EMG measurement, followed by applied aspects of EMG 
measurements, particularly when applied to EIMD. 
 
1.5.2 Methods of recording and electrode placement 
 
Studies on maximal and submaximal, as well as raw and normalised data have not 
shown conclusively which method is the most appropriate for EMG data analysis after 
an EIMD protocol 95, 133, 339, 385, 413. EMG activity in the elbow flexors (biceps brachii and 
brachialis), for example, may be influenced by the type of contraction and the required 
force level and both of these factors are also important for the normalisation of the 
data. However, the most common way of displaying the EMG data is to normalise the 
submaximal recordings to the EMG amplitude during a maximal isometric recording 95, 
339, 385, 398. But with careful electrode placement 187, 200, well controlled contractions and 
normalisation of the data, interpretable measurements of surface EMG amplitude can 
be obtained from the biceps brachii. It has also been shown that correct and 
repeatable electrode placement is very important for EIMD studies on the biceps 
brachii. Different locations of electrode placement can lead to varying results as a 
consequence of uneven muscle fibre damage, reduced neural drive due to pain or 
central fatigue and changes in muscle geometry like fibre length and orientation. All 
these factors can influence the EMG recording at different recording sites on the 
biceps brachii 287. 
 
1.5.3 Methods of analysing the EMG signal 
 
The first step when analysing EMG data is to filter the raw data (Figure 1.7a) using 
high and low pass filters. Filtering the signal is necessary to remove artefacts, 
especially muscular artefacts and non–physiological artefacts such as interference 
from electromagnetic sources. The data are then rectified using root mean squared 
analysis, which calculates the squares of the raw signal followed by 'weighted' 
averaging over a suitable time window (Figure 1.7a,b) 245. The aim of this process is 
twofold; (i) to ensure that opposing amplitudes do not cancel each other out and (ii to 
smooth the data (Figure 1.7c). The surface EMG signal represents the summation of 






























Figure 1.7 Processes of EMG signal analysis. (a) raw EMG data, (b) full wave rectified data, (c) 
smoothed data.  
Copied from ://www.noraxon.com/emg/ABC%20of%20EMG.pdf (26/08/2011) (Peter Konrad, Version.1.0, 2005) 
 
 
1.5.4 EMG and force relationship 
Many researchers during the 1950 to 1970's have shown that the relationship between 
EMG and force produced by the muscle is linear 38, 39, 364. Since 1970 it has been 
shown that this linear relationship only exists in muscles such as the soleus or 
adductor pollicis and not for muscles such as the biceps brachii and brachialis 78. The 
biceps brachii and brachialis muscles follow two linear responses with two different 
slopes intercepting when the force output reaches about 35% of the maximal voluntary 








be due to the mixed muscle fibre composition of the biceps brachii and brachialis 
muscle 179. It was suggested that at the change over point (approximately 35% of 
MVC), recruitment changes from a higher number of slow twitch type I fibres to more 
fast twitch type II fibres 39, 222. A type II fibre can generate more force than a type I fibre 
222. Therefore when more type II fibres are recruited the resultant force increases. 
 
 
1.5.5 Pain as an inhibitory factor for EMG 
 
Certain research designs mimic the effects of acute pain by injecting hypertonic saline 
or capsaicin into the muscle 120, 154. These methods have shown that under resting 
conditions, the acute pain caused by hypertonic saline does not cause any EMG 
hyperactivity in the tibialis anterior and gastrocnemius muscles119. However the torque 
output and EMG amplitude during a maximal voluntary contraction is reduced 154. 
Similar results were found when hypertonic saline was injected into the biceps brachii 
muscle followed by elbow extension and flexion exercises 120. The pain induced by the 
hypertonic saline decreased EMG activity in the biceps brachii during the movement 
~23%. This inhibitory effect of muscular pain on EMG activity is greatest during 
maximal contraction. 
 
1.5.6 EMG responses to EIMD 
 
Exercise protocols which require that the muscle is repeatedly lengthened under 
tension have been used to induce muscle damage and associated pain and 
neuromuscular changes 21, 287. In EIMD muscle tenderness occurs 1-2 days after the 
exercise protocol, pain occurs during muscle contraction 1-4 days after the induction of 
EIMD and the force output during a MVC decreases by about 38% directly after the 
EIMD protocol and remains low for several days 296. The EMG amplitude of the 
affected muscles also decreases during the maximal isometric contraction after EIMD 
95, 201, 332. Although Day et al. 96 did not show a decrease in EMG amplitude during a 
MVC after an EIMD protocol, mean frequency power and MVC decreased on day two 
and three. The unchanged EMG amplitude may have been due to a small subject 
numbers (n = 8) coupled with large standard deviations in the EMG data and their data 
should be interpreted with caution. 
 
The decrease in average EMG amplitude during the MVC in the study by Day et al. 
may have been caused by the damage inflicted on the muscle by the EIMD protocol 
Chapter 1 
 26 
leading to a decrease in functional capacity. This skeletal muscle damage could have 
influenced the motor unit activation 220, 296. 
 
As previously discussed, muscle activation rates can only be changed by either 
recruiting more motor units or by increasing their firing rates. Decreased muscle 
activity after EIMD has been attributed to several factors. These include damage of the 
myofibrillar structure such as disruption of the contractile machinery, inexcitability of 
the muscle or changes in the release and reuptake of calcium and the ability of 
troponin C to bind to the calcium within the cells to activate the actin-myosin binding 18, 
251. 
 
The muscle damage as a consequence of the exercise could also lead to changes in 
the excitation-contraction coupling rates and this in return would lead to a disturbance 
in the contractile properties of the individual muscle fibres 54. Furthermore, it has been 
proposed that most of the damage is selective to the type II muscle fibres 142. The 
changes in EMG amplitude and frequency over time show that the functional capacity 
of the muscle decreases after an exercise protocol dominated by muscle lengthening 
under tension 95, 385. At low levels of force, without isometric preactivation, mean spike 
amplitude is higher when the muscle lengthens under tension, than when the muscle 
shortens. This might indicate a selective activation of type II motor units 220. Type II 
fibres are more prone to fatigue and therefore also to damage by the lengthening 
action 142. EMG studies have also shown that the median frequency of muscle activity 
decreases after EIMD exercise protocols 133. This is a sign that more damage occurs in 
the type II than in the type I fibres 133, 219. The shift to lower median frequencies can be 
detected for up to seven days after an EIMD protocol 133.This suggests that during a 
maximal voluntary contraction, after an exercise protocol designed to induce muscle 
damage, the entire muscle fibre population would not be available for activation and 
that some fibres which are activated might not be capable of full activation. Inhibition of 
muscle activity could be situated in another part of the activation pathway. This could 
be upstream, at spinal or cortical level, where, for example, there would be a decrease 
in overall motor unit recruitment or neural firing rates 39, 132. A change in firing rates 
would be due to a change in either central activation or at the level of the motor nerve 
or the neuromuscular junction 39, 95, 132, 240 and EIMD could have an influence at any of 
these levels. 
 
It has been shown that the EMG amplitude during submaximal static and dynamic 
contractions increases in participants who have been exposed to an exercise protocol 
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designed to induce muscle damage 21, 43, 95, 339, 385, 398. Exercise involving lengthening 
muscle actions resulted in a larger than proportional increase in elbow flexor EMG for a 
given level of force at low levels of activation 339. Studies also found that the increases 
in EMG amplitude are more pronounced in lower force ranges (submaximal 
contractions at 0-40% of MVC) in most muscle groups including the biceps brachii 21, 95. 
The increases in EMG amplitude are also more pronounced in isometric and 
shortening (90-60°) contractions compared to lengthening (90-120°) actions 21, 385. 
It has been shown that EMG can be decreased during the maximal contraction and 
during controlled lengthening actions for up to a week after EIMD 43. However, most 
EMG studies following an EIMD protocol have only been conducted up to 24 339, 385 or 
48 hours 21, 398 after the EIMD inducing exercise protocol. A study by Prasartwuth et al. 
296 showed that the decrease in maximal voluntary force and the associated EMG were 
dissociated from the changes in elbow angle, soreness levels and force production. 
They reported that EMG activity during the submaximal contraction of the elbow flexors 
increased significantly compared to control values at two and 24 hours after the EIMD 
protocol, but did not show any further differences 48 hours later. They suggest that 
motor units might have become damaged during the EIMD protocol and therefore 
produced less force even with sarcolemmal activation being preserved. Cytochemical 
studies have shown myofibrillar damage occurs following EIMD therefore the 
contractile (myofibrillar damage) but not the excitatory properties (sarcolemmal 
activation) of the muscle could be disturbed 140. 
Muscle fibre repair starts within the first 72 hours after the EIMD protocol however 
some damage is still seen 132 hours later 140, 142. This could explain both the increase 
in EMG activity during submaximal exercise, as the neural activation rates as well as 
the firing rates of the non-damaged muscles have to be higher to produce the same 
force output, compared to before the EIMD protocol. During the maximal voluntary 
contraction after an EIMD protocol the EMG activation remains lower, because some 
fibres are damaged and therefore fewer intact muscle fibres are available for activation 
296. 
As previously discussed the damage caused by lengthening under tension movements 
mainly affects the type II fibres, with the greatest effect shown during the first three 
days after the EIMD protocol 140-142. Therefore the increased EMG activity during the 
submaximal dynamic contraction could be caused by increased firing patterns of the 
type I fibres, as they are trying to generate more force to sustain the dynamic 
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contraction. A higher firing rate of type I fibres would lead to an increase in submaximal 
EMG amplitude 414. While type I fibres fatigue at a slower rate than type II fibres, they 
are also not able to produce as much force as the type II fibres do at the same firing 
rates 222. Therefore they need to fire more rapidly or more fibres need to be recruited to 
attain the same force output leading to an increase in EMG amplitude during a 
submaximal contraction. But as the overall fibre population is still damaged and unable 
to fire to full capacity, EMG amplitude during a maximal contraction would therefore 
decrease. 
 
Another explanation for the increase in submaximal EMG is that after the damage 
inducing exercise protocol the firing of the motor units becomes more synchronised 414 
as has been shown in the biceps brachii after an EIMD protocol 95. This leads to an 
increase in EMG amplitude and an increase in power in the lower frequency domain. 
EMG amplitude increases during submaximal exercise while experiencing the 
symptoms of EIMD 110, 133, 385. The increased EMG during low force contractions (< 40% 
of MVC) could be explained by motor unit synchronisation and also by motor unit 
coherence, as motor unit coherence was 34% greater in the biceps brachii, 24 hours 
after EIMD was induced 95. This led the author to conclude “that the series of events 
leading to muscle damage after an EIMD protocol alter the correlated behaviour of the 
motor units in the biceps brachii “95. 
 
Therefore one could assume that there is an upstream control mechanism which 
regulates the motor unit recruitment and firing rates following EIMD. 
 
1.5.7 Upstream drive of EMG 
 
Upstream drive is defined as the central activation of the muscular system. It can be 
measured at the motor nerve level by nerve activation 295, 296, 377 or can be directly 
induced on the motor cortex by transcranial magnetic stimulation (TMS) 147, 170, 216, 296, 
372, 377, 378. Fatigue leads to a decrease in voluntary activation of the biceps brachii 
during MVC, as measured by nerve stimulation and transcranial magnetic stimulation 
of the motor cortex 372, 377. Todd et al. 377 have shown that when the MVC torque 
decreased by 40% about a quarter of this reduction in force can be attributed to the 
failure of optimal activation. Prasartwuth et al. 296 performed a similar study but 
measured voluntary activation, rather than nerve stimulation 377 of the biceps brachii 
after an EIMD protocol. They concluded that the decrease in torque immediately after 
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the EIMD was caused by a reduced voluntary activation either at the spinal or motor 
cortex level. The authors also suggested that the decrease in force output was due to 
decreased voluntary activation but was not caused by the soreness felt due to the 
EIMD protocol 296. Another study on EIMD and voluntary activation found that elbow 
angle recovered eight days after an EIMD protocol in contrast to MVC and voluntary 
activation 295 which were still reduced at this stage. They also concluded that EIMD did 
not only lead to peripheral factors limiting activation but also lead to central changes, 
from the spinal cord up to the brainstem and the motor cortex. It has also been shown 
that for eight days following an EIMD protocol, the median frequency power of the 
surface EMG signal during 50% and 80% MVC contraction is of lower spectral power 
than before the EIMD protocol 133. This phenomenon as mentioned before, suggests 
either a recruitment shift towards type I muscle fibres, or a lower drive by the upstream 
regulator. 
 
Spectral analysis, also called time-frequency analysis (used to calculate frequency 
power values) was done on EMG data recorded during finger contractions at 50% 
MVC. In the spectral analysis, three frequency peaks were discovered; 10, 20 and 40 
Hz 240. The authors suggest that the frequency peaks are too large to be created by 
single motor units and must therefore be due to synchronised firing of several motor 
units and could therefore be created by central oscillators (to be discussed in more 
detail in the next section). These central oscillators are neuronal bundles firing in a 
synchronised pattern, and are most likely needed for inter-neuronal communication, 
between different areas in the brain as well as for communication between the brain 
and the periphery 22, 29, 162, 240. McAuley et al. 240 also mention that the three frequency 
peaks are also represented in the EEG frequency spectrum as α, β and gamma (γ) 
activity bands 240. This will also be explained in more detail in the next section. 
 
In summary this section has shown that there are peripheral changes including 
changes in muscle activation and muscle fibre recruitment patterns following EIMD. It 
has also been suggested that these changes could be guided by an upstream 








1.6 ELECTROENCEPHALOGRAPHY:  
MEASURING ELECTRICAL ACTIVITY IN THE BRAIN 
 
1.6.1 Introduction to electroencephalography  
 
Electroencephalography is the measure of spontaneous electrical activity of the brain, 
similar to electromyography in the muscle. EEG measures brain activity as neural 
oscillation or as wavelike sinusoidal changes in voltage amplitude and can detect 
changes which appear within seconds to milliseconds.  
 
There are o methods of analysing brain activity like functional magnetic resonance 
imaging (fMRI) and positron emission tomography (PET) scans 92, 150, 275, 346, 367, 400, 415. 
MRI, as well as PET scans, are more accurate in localising an active brain area, 
especially in deeper lying structures but are not as useful in movement trials as the 
subjects need to remain motionless over the recording period. While fMRI is an indirect 
measure of brain activity, as it only measures blood flow, EEG is a direct measurement 
of the electrophysiological signalling at anyone point in time. Limited limb movement is 
possible during EEG recording which makes it the better option for movement and 
exercise studies and it also has a greater time resolution than fMRI or PET scans. 
Therefore fMRI and EEG are regularly used in combination to study changes in the 
activity of the brain 42, 91, 92, 306, 346, 415. However to obtain data during movement with a 
greater time resolution and direct association with cortical functionality; EEG is the 
more preferred measure.  
 
1.6.2 Neural Oscillations: EEG signal generators 
 
Neural oscillations are rhythmic or repetitive neural activities in the central nervous 
system. Neural tissue can generate oscillatory activity in many ways, driven either by 
mechanisms localized within individual neurons or by feedback interactions among 
populations of neurons 51, 97, 335. As mentioned previously the oscillations are similar to 
the electrical activity in the muscle measured by EMG. The oscillations can appear 
either as: 
 
(i) sub-threshold rhythms of membrane potentials rising and falling, which cannot be 
measured by EEG, or 
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(ii) increases and decreases in action potential activity, reflective of changes in the 
postsynaptic (i.e.. dendritic) membrane potentials 3, 211, 260. As a result they produce a 
rhythmic activation of synapses in the target neurons leading to the propagation of 
action potentials along the target neurons 211. 
 
When action potentials occur consecutively within the same neuron they are called 
spikes or bursts 97, 98, 211. Neurons can generate multiple action potentials in sequence 
forming so-called spike trains 202. These spike trains are the basis for neural coding 
and information transfer in the brain 51, 97, 98, 177, 368. Spike trains can form all kind of 
patterns, such as rhythmic spiking and bursting as well as irregular spike patterns. 
Different types of neuronal coding schemes have been proposed, such as rate coding 
(frequency of action potentials), temporal coding (dependent on interval length 
between action potentials), independent- spike coding and correlation coding 163, 177. All 
the coding schemes contribute to the oscillatory activity. Apart for single neurons that 
can generate oscillatory spike trains, oscillations can be created by the combined 
electrical activity of multiple individuals or groups of neurons 51, 97, 335. These large-scale 
oscillations arise to synchronize the activity of multiple neurons or neuronal assemblies 
in different brain areas 357. Apart from the intrinsic properties of neurons, network 
properties are also important for oscillatory activity 227, 273. Neurons are connected 
locally, forming small clusters that are called neural assemblies or neural populations 
60, 163. Some of these network structures promote oscillatory activity at specific 
frequencies. This is determined by the type of neurons, i.e.. excitatory or inhibitory 
neurons, as well as time delays and neuronal coupling. Neural synchronization is the 
process by which the activities of two or more neurons or neural assemblies tend to 
oscillate with a repeating sequence of relative phase angles 273, 345.  
 
Experimentally these oscillations can be measured by fluctuation in the local field 
potential or by means of EEG and magneto-encephalography (MEG) 97, 129, 163, as 
synchronized oscillations of large numbers of neurons can give rise to macroscopic 
oscillatory electric fields, which can be observed in the EEG. This synchronized firing 
of large neuronal assemblies is believed to be driven by a pacemaker most probably 
situated in the thalamus 51, 374. It has been proposed that these coherent oscillations 
are important for interactions and communication between close and distant neuronal 
populations 8, 178, 225, 335, 345. 
 
This synchronized activity of large numbers of neurons and neural assemblies results 
in electromagnetic fields that can be measured on the surface of the scalp with EEG. 
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Using these techniques, synchronized neural activities have been observed throughout 
the central nervous system and during various tasks 98, 363. Neural synchronization can 
be modulated by different events, tasks, states and behaviours such as attention, 
movement and cognition 98, 314, 363, and is thought to play a role in neuronal 
communication 144, 211, 319, 357 and motor coordination 12. A change in neural 
synchronization can be observed by measuring the increases and decreases in activity 
(amplitude2 or power of the signal) in the different oscillatory frequencies. Increased 
amplitude2 means greater synchronised firing of the neurons at any one time. Lower 
amplitude2 implies that neuronal firing is desynchronized. “Event-related 
desynchronization (ERD) and event-related synchronization (ERS) is the change of 
signal's power (amplitude2) occurring in a given band, relative to a reference interval” 
111, 282. 
 
Oscillatory EEG is a result of firing of localized neuronal population and coherent 
global activation of neuronal population is seen as wave-like EEG signals. These 
wavelike signals originate not only in the cortex but also areas deeper in the brain 8. 
The difference between oscillations and waves can be seen in the EEG as follows: In 
oscillations the alternation between two states is important, while the regularity and the 
extreme values are less important, while a wave is a single variation of a parameter 
between two extremes 8. 
 
Different brain structures, for example, the thalamus and the cortex, can form 
connections or feedback loops which support synchronized oscillatory activity 51, 196. 
Oscillations recorded from multiple cortical areas become synchronized and form a 
large-scale network, where dynamics and functional connectivity can be studied by 
spectral analysis. This coherent behaviour of brain areas can be responsible for 
dynamic links of large-scale brain activity which is required for the integration of 
distributed information 357, 368. 
 
1.6.3 Interpretation and understanding EEG 
 
Due to different firing rates of the neurons the EEG signal is comprised of a range of 
different frequencies. The frequencies have been segmented into groups with different 
wavelength properties. As a result there are different frequency peaks in the EEG 
spectrum (e.g. delta (δ), theta (θ), α, β and γ 260. This will be discussed in more detail in 
the next section (see Table 1.1, page 39). 
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Usually the frequencies of brain activity, measured by time-frequency (spectral) 
analysis on the EEG, are negatively correlated to their amplitudes (i.e.. the lower the 
frequency the higher its amplitude). This is due to the amplitude being proportional to 
the number of synchronously active neural elements 115. Slowly oscillating cell 
assemblies comprise a larger number of neurons than fast oscillating cell assemblies 
347, 348. Therefore with an increasing number of interconnecting neurons and an 
increasing number of synchronously active neurons the amplitude of a recorded signal 
increases and the frequency decreases 226. 
1.6.3.1 How to measure EEG 
Electroencephalography was recorded for the first time in the late 1920’s by Berger 30 
with a simple galvanometer and a one channel recording. Since then the equipment 
has been developed extensively and now the most common used EEG system is the 
10:20 system 24, 260. Twenty-three electrodes are set on a cap which covers the scalp 
and measures the EEG amplitude at pre determined locations (Figure 1.8). 
Figure 1.8 A schematic of the 10-20 EEG system 
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The data are digitised and recorded on a personal computer in real time with the 
applicable software. Newer systems have an increased number of electrodes (up to 
256 or more) to get a higher resolution of the EEG signal over the scalp 32, 176, 230. 
There are also needle electrodes which can be inserted into the brain to measure EEG 
149, 257, 291. This methodology might be used to study, for example, seizure or epilepsy 
patients 260, 288, or to determine individual neuron activity in animal studies 149, 257, 314. 
This procedure is invasive and is not suitable for mechanistic type studies on healthy 
people. Therefore as this methodology was not used in this thesis it will not be 
discussed in further detail here. 
 
1.6.3.2 Artefacts 
Since the voltage signals produced by the brain are of low amplitude the signals are 
very susceptible to be corrupted by stronger electrical activity with higher signal 
amplitudes. Artefacts can be created by internal (subject specific) or external 
(technical) sources. 
 
1.6.3.2.1 Internal (subject related) artefacts 
The subject related artefacts are caused by muscular activity like eye blinking, jaw 
movements, tensed shoulder muscles or the heart beat 183, 286, 416. Therefore artefacts 
need to be avoided during testing and data needs to be inspected during signal 
analysis to reduce the effect of artefacts on the data. There are several processes to 
minimize the effect of internal artefacts on the recorded data 109, 158, 288, 308. 
 
While recording: 
• Focus eyes on one point or close eyes  
 
• Use eye blink channels on the EEG setup to monitor eye movement 
 
• Record EMG and/or ECG simultaneously to monitor effect of muscle 




• Use of eye blink channel recordings to remove or dampen eye blink and 





• Use of amplitude thresholds to reject data epochs which contain eye blinks or 
other muscular artefacts 
 
• Manual removal of epochs in which data cannot be corrected 
 
1.6.3.2.2 External (technical) artefacts 
There are also external or technical artefacts which can influence EEG recordings. 
These include interference by the electrical mains as well as the impedance of the 
recording electrodes 260.  
 
To record EEG as accurately as possible a standard protocol has to be followed. The 
impedance of the electrodes needs to be kept as low as possible to record accurate 
signals (or data needs to be recorded with high impedance amplifiers) and data needs 
to be filtered to remove any non physiological artefacts. These artefacts include those 
produced by the electrical mains 260, 288. 
 
While recording: 
• Subject to be prepared accurately (i.e.. with hair washed and wet) 
 
• Electrodes to be supplied with enough conduction gel or salt solution to last for 
the entire testing period 
 
• Use of correct size EEG net  
 
• Electrodes adjusted and set on head correctly 
 
• Impedance of electrodes set correctly and tested 
 
During analysis: 
• Filter data, especially apply a 50 Hz notch filter to remove effect of the electrical 
mains 
 
• Use of a built in bad channel replacement function or use an appropriate 





1.6.3.3 EEG components 
The measurements of an electrode on the surface of the scalp (EEG) represent an 
average of the oscillations in the region of the brain located beneath the electrode 3, 52, 
199, 234, 260. An EEG signal can be broken down into three components: 1) amplitude or 
magnitude, 2) frequency or oscillations per second and 3) phase or lag in time 260. 
Therefore the recorded EEG data presents with different activity patterns of which 
different components are emphasized depending on the method of analysis. 
 
1.6.4 Activity patterns 
 
1.6.4.1 Spontaneous activity 
Spontaneous activity is defined as brain activity in the absence of an explicit task, such 
as sensory input or motor output, and is therefore usually considered to be noise by 
those evaluating EEG recordings. However, spontaneous activity is considered to play 
a crucial role during brain development, such as neurogenesis, synaptogenesis and 
cortical plasticity 155. Spontaneous activity may be informative regarding the current 
mental state of the person (e.g. wakefulness, alertness) 28, 138, 212 and is therefore often 
used in sleep research 28, 138, 212, 260. Certain types of oscillatory activity, based on 
certain frequency ranges, can be part of spontaneous activity 28, 139, 212. The term 
ongoing brain activity is used in electroencephalography for the signal components 
which are not associated with the processing of a stimulus or the occurrence of specific 
events; such as movement or attention to a task or stimulus. Therefore they form part 
of the evoked potentials/evoked fields, event-related potentials, or induced activity but 
are rather related to the underlying basic functionality of the brain which is not stimulus 
related 28.  
 
Most neuroscience studies have focused on the brain’s response to a task or stimulus. 
However, the brain is very active even in the absence of explicit input or output. 
Research on spontaneous fluctuations of oscillatory activity has shown that especially 
in the β frequency range a correlation between EEG and fMRI activity seems to exist 
212. Research on spontaneous activity led to the hypothesis that specific brain regions 
constitute a network supporting a default mode of brain functioning. These areas are 
especially active while the brain is in a resting mode but activity is attenuated when 





1.6.4.1.1 Evoked activity 
The EEG recordings can change in signal strength and amplitude correlated to certain 
events. These time-locked changes in the activity of neuronal populations are generally 
called event-related potentials or evoked potentials 282. These events can be motor or 
somatosensory evoked; they can be associated with movement, pain, temperature, 
visual or auditory tasks 23, 106, 379. It is hypothesised that they are of cortical as well as 
subcortical origin 304. These event related potentials (ERPs) are phase and time locked 
to an event and frequency independent.  
 
The ERPs can only be extracted from the ongoing electroencephalographic recording 
by averaging large numbers of trials 106, 282. As a consequence, those signal 
components that are the same in each single measurement are conserved and all 
other signals are averaged out. Evoked activity is often considered to be independent 
from ongoing spontaneous and induced brain activity although this is an ongoing 
debate 237. Examples for ERPs are the Bereitschaftspotential178, 302 or the P300 174, 180, 
304. 
 
1.6.4.1.2 Induced activity 
Induced activity refers to changes in ongoing brain activity brought on by processing of 
stimuli or event preparation (i.e.. medicated versus non-medicated or painful versus 
non-painful 322). A well-studied type of induced activity is the change in amplitude in 
oscillatory activity. For example, the γ activity amplitude increases during increased 
mental activity such as during object representation 35, implying that a higher number 
of neurons are firing 35, 225. Induced responses may have different phase angles across 
measurements and would cancel out during averaging, therefore they can only be 
obtained using time-frequency analysis 260. 
 
The changes in the amplitude of the different frequency components are compared 
(i.e.. γ activity increasing during mental activity) 282. It is a useful tool to compare 
changes in EEG frequency activity over longer periods or when comparing the 
reactions to different situations which are not necessarily events but longer lasting 
stimuli (i.e.. meditation, medication, pain etc 67, 69, 93, 175, 207, 255). If the values are 
normalised to a baseline reading they are referred to as being relative and if they are 
used without a baseline they are called absolute values. The data are segmented into 
epochs which are then averaged. As mentioned before, the epoch length decides the 




Induced activity generally reflects the activity of numerous neurons and amplitude 
changes in oscillatory activity and is believed to arise from the synchronization of 
neural activity, e.g. synchronization of spike trains or membrane potential fluctuations 
of individual neurons 163, 227, 314, 325, 328, 345, 363.  
 
1.6.4.1.3 Event related synchronization and desynchronization 
Event related phenomena are frequency specific changes of the ongoing 
electroencephalographic activity. They consist either of decreases or of increases in 
signal amplitude in a given frequency band 259, 282, 282, 420, referenced to a baseline 
before the stimulus occurred 282. This is called event related synchronization (increase 
of the number of neurons firing at the same time) and event related desynchronization 
(decrease in oscillatory activity related to internally or externally paced events) 259, 282.  
 
An event related desynchronization can be interpreted as an electrophysiological 
correlate of activated cortical areas involved in processing of sensory or cognitive 
information or production of motor behaviour 281, while an event related synchronization 
is most commonly associated with the neuronal networks being in an idle state 279. 
However recent research shows, that the activity in certain frequency bands increases 
with attention and cognition 274.  
 
Event-related synchronization/desynchronization is usually topographically localised, 
phasic in its behaviour and as mentioned before, frequency specific 10, 151, 217, 359. It can 
further be assumed that event related, as well as induced activity, or power changes 
represent the responses of cortical neurons due to changes in afferent activity (an 
event). To measure spontaneous induced activity, or “state” induced changes, a study 
of longer lasting (e.g. three minutes) spectral field powers is more advisable rather 
than measuring transient event-related activities in the EEG 28, 73. 
 
1.6.4.1.4 Summary of activity 
While evoked activity is phase locked induced activity is not phase locked. Evoked 
potentials are a good measure for stimuli with repetitive onsets (i.e.. evoked pain or 
movement) but induced activity has been shown to be superior at detecting the effect 
of a physiological state (i.e.. state of pain or EIMD)84.  
 
1.6.4.2 Prominent frequency bands within the EEG recording 
As mentioned above an EEG signal is an average of neuronal oscillations with 
frequencies between 0.1 Hz and 100 Hz. The frequencies are grouped into frequency 
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ranges: delta (δ) (0.1 -3.5 Hz), theta (θ) (4.0- 7.5 Hz), alpha (α)-1 (8.0-10.0 Hz), alpha 
(α)-2 (11.0-13.0 Hz), beta (β)-1 (13.5-19.5 Hz), beta (β )-2 (20.0-35.0 Hz), the rolandic 
mu rhythm (μ) (10 Hz) gamma (γ) (>35 Hz) 30, 260, 325 (see also Table 1.1). 
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Large scale cortical integration 325 
Attention 195 
Sleep 168, 254











of the cortex 254 
Observed during sleeping, waking and 
drowsiness 260 
Increased during meditation 207 
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Global 
distribution 260 Cortex with 
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maker 59, 260
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Usually blocked by α- and β- waves 
during movement 10, 32, 283, 368 












Associated with sensory and motor 
activity 48, 316, 318











cortex 55, 225, 260
Cortex 388, 389
Memory and cognitive processes 166, 225 
Neural synchronization or phase lock of 
firing activities 225, for example visual, 
sound, linguistic, attention, working 
memory, object recognition 35, 145, 254, 337 
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1.6.4.3 Fast Fourier transform  
To obtain the frequency content of the EEG activity the frequency power spectrum is 
calculated by applying mathematical calculations and assumptions called a Fast 
Fourier Transform (FFT). This is similar to the processing done with an EMG signal to 
gain a frequency power spectrum. In the FFT the EEG wave is displayed in the 
different frequency components of which the original EEG wave consists. The data are 
converted from a wavelike display of voltage changes over time to a display of grand 
overall voltage power (amplitude2) at any given frequency and time point 6, 75, 126, 254, 288. 
Therefore the frequency spectrum can have several peaks at different frequencies. In 
the frequency power spectrum there is always a trade off between the time and 
frequency resolution. The larger the data epoch length the better the frequency 
resolution will be and vice versa 288. Therefore, when the data are processed, a 
decision has to be made whether it is more important to have a better frequency or 
time resolution of the recorded data.  
 
Depending on the frequency the signal can be distributed widely over the entire scalp 
area (α) or be very localised (μ rhythm) 278, 283. To keep the time and frequency effect 
one can also do wavelet analysis, which shows changes in the frequency spectrum 
without losing the time effect 75, 126, 312. 
 
The EEG changes associated with voluntary movement start in the mesial fronto-
ventral area and move towards the pre-motor area 151, 217. However, they are mostly 
seen in the motor area anterior to the central gyrus, and in the primary somatosensory 
area on the side contralateral to the performed movement 151, 217, where the limb 
movements are usually represented on the motor homunculus (see Figure 1.9, page 
42) 248. 
 
Of special interest in the field of movement and pain research are the activities of α 
and β frequencies. Both α and β frequencies are known to be influenced by 
somatosensory and motor changes. Therefore the last part of this review will focus on 
the effects of pain and movement on these two activity bands. 
 
1.6.4.4 Alpha activity 
1.6.4.4.1 Introduction to alpha activity 
Alpha was the first frequency band to be discovered by Berger in 1929 30. The α band 
has a frequency of between 8-14 Hz, which is not always clearly defined in the upper 
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limit (some researcher say 7-12 Hz other 8-14 Hz) 102, 274, 306, 358. The α- band gets 
divided into the lower (α- 1) (8-10 Hz) and upper α (α- 2) (11-13 Hz) band 102, 306 due to 
the different responsiveness of the higher and lower α-activity to events and task. 
 
Alpha shows large inter and intra individual differences, as some people display the α 
frequency bands prominently, whereas others hardly display them at all 3, 102, 104 and 
therefore the responses can be grouped into high and low α responders 3. The waves 
can also display a high day to day variation within each person 3. This makes the 
comparing of recorded data between subjects difficult as often the standard deviations 
for recorded α frequency bands are relatively large. 
 
1.6.4.4.2 Alpha-1 and -2 activity 
Generally there is a decrease in α activity in response to a task, especially if the task is 
related to movement, memory or learning 196, 420. Alpha activity is known to decrease 
with the preparation and onset of motor or cognitive tasks as well as when the 
sensation of pain is experienced 67-70. Alpha-1 reacts to processes related to attention 
to a task while α-2 reacts selectively to sensory-semantic memory processes 
especially related to long term memory systems 196, 327.  
 
1.6.4.4.3 Physiological meaning of alpha 
Berger was the first person to detect that certain events, such as eye opening can 
attenuate the ongoing α rhythm (the so called eyes open and closed paradigm), also 
called α blocking or desynchronization 30, 31. Since then α desynchronization, has been 
associated with visual, motor and sensory evoked events 261, 270, 274.  
 
Alpha activity is at its maximal in the occipital region (back of the head, the visual 
cortex), in the left lateral temporal cortical regions, the parietal area and the 
hippocampus and is blocked for a short time interval with the opening of the eyes and 
the accompanying influx of light 260, 408. However, the α frequency activity can spread 
as far forward as the central areas (Cz) and even the superior frontal electrodes (F3, 
F4 and Fz) 20, 419. The so called spontaneous α frequency, a smaller amplitude α wave, 
which does not respond to the eyes open and closed paradigm, is seen more globally 
especially in the prefrontal cortical region as well as the thalamus 28, 131.  
 
It has been hypothesised that the α frequency band is of cortical origin 59, 260, 261. 
However, it has also been suggested that there is a thalamic pacemaker and that 
corticocortical and thalamocortical modulatory systems and feedback loops play a part 
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in the generation of the α frequency 196, 260. Therefore the exact location of the origin of 
the α frequency and the underlying neuronal mechanism is not well determined.  
 
1.6.4.4.4 The effects of movement on the alpha band 
Pre-movement 
It has been shown that α activity is associated with movement planning 10, 278and 
decreases before the onset of movement (event related desynchronization) over the 
central, posterior-parietal and occipital areas 10, 57, 101, 102, 280, 401. 
 
During movement: Representation of alpha activity in electrodes overlying the 
motor and somatosensory homunculus 
Movement itself is known to lead to a decrease of motor evoked α activity in the 
contralateral central and parietal areas. These areas are associated with motor control, 
learning and memory 196, 327, 420. Changes in α activity, which are related to limb 
movements, are recorded in electrodes placed topographically over the homunculus 
representation on the precentral motor area, i.e. a shoulder movement is represented 
superior to a finger movement on the somatosensory and motor areas (Figure1.9) 151, 






















Figure 1.9 A graphical display of the homunculus in the motor and somatosensory areas of the 




Elite athletes even show increased synchronization in the 8-12 Hz oscillations, and 
therefore increased α-1 and -2 activity compared to non-athletes during movements 100, 
102, 104. Alpha-1 and -2 activity has been linked to a relaxed focus or mental activity 160, 
421 and it is believed that an increased α activity during exercise increases focus and 
attention and therefore sporting performance 374.  
 
Post-movement 
Alpha activity is enhanced again after a movement has ended 334. The increase in α 
activity could be related to the intensity or fatiguing potential of the exercise involved 
and is especially pronounced in the frontal areas of the brain. 
 
1.6.4.4.5 Effect of pain on the alpha activity 
Pain leads to a decrease in activity in the α frequency band. However the decrease in 
activity is seen at different brain locations depending on the type of pain stimulus. 
While cutaneous pain, for example, stimulates activity in the contralateral prefrontal 
and ipsilateral pre-motor area, muscular pain does not 367. 
 
Painful stimuli induced by either heat, capsaicin or hypertonic saline lead to decreases 
in α-1 activity in the frontal and temporal areas as well as the parietal and occipital 
areas of the scalp, contralateral to the side on which the stimulus was induced 66, 69, 70, 
175. Alpha-1 also decreases in the central and parietal areas with an injection which 
does not lead to the long term sensation of pain (injection of isotonic saline). 
 
Changes in α-2 activity are less noticeable and only occur in the central and parietal 
area 66, 67, 69, 175 during movement, while the painful stimulus is experienced. This is 
followed by an increase in α-2 activity in the parietal area after the painful stimulus 
ends 66, 67, 69. Following heat induced pain, the α-2 activity increases globally, except in 
the most anterior electrodes (Fp) after the end of the stimulus 67.  
 
Muscular pain as induced by EIMD also causes changes in α-1 and -2 activity in the 
cortex. Alpha-1 and -2 activity decrease in the posterior parietal and occipital region 
when muscular pain is evoked in the brachioradialis68, 74 and are negatively correlated 
to intensity of pain.  
 
Interestingly it has been shown that meditation increases the global activity of α-2 




1.6.4.4.6 Combined effect of movement and pain on the alpha activity, as a 
model for EIMD 
The combined effect that movement and acute pain, as seen in EIMD, have on the 
electroencephalographic activity is different to that of movement and pain individually. 
In a study with laser induced pain the feeling of pain and unpleasantness was reduced 
when the subjects had to move a finger at the same time as the pain was induced in 
the arm 103. The decrease in the feeling of unpleasantness occurred together with a 
smaller than usual decrease in α activity. In the case of α-2 (10-12 Hz) there was an 
increase in α-2 activity before the painful stimulus. The changes were maximal in the 
fronto-central midline area103. 
 
1.6.4.4.7 Recent developments 
Until recently it was believed that increased α activity was related to decreased 
neuronal processing or an “idle state” of the brain. Therefore when neuronal 
assemblies display coherent activity and the α frequency band shows increased 
activity, it was assumed that the underlying cortical neuronal populations are less 
active in information processing 279.  
 
Studies have shown that only about 15% of all cortical neurons are inhibitory instead of 
excitatory neurons 45, 260. However, as inhibition is a crucial part of controlling neural 
networks, Klimesch et al. 198 suggested a top-down control 198, 326, 393 where an increase 
in α activity in cortical areas causes an inhibition of retrieval of information in the same 
areas. Thus uninhibited areas are able to process relevant information more efficiently 
197, 326, 393, due to the “idling” of inessential neural pathways. However, in contrast to the 
findings of Klimesch et al., recent research by Palva and Palva has shown that α 
activity increases with attention and cognitive processes 274. Synchrony across the 
frequency ranges of α, β and γ might be needed during working memory tasks, 
perception and consciousness to select and maintain neural pathways 198, 274. 
 
Von Stein et al. found in animal studies that synchronous interactions between frontal 
and parietal cortical areas lead to an increase in α-2 activity and the interactions 
appear to act as a top-down regulator 393. Palva and Palva 274 and Halgren et al. 161 
proposed that this fronto-parietal α synchrony is associated with focused attention, 
working memory, conscious perception, cognition and action. Chen et al. 72 suggested 





1.6.4.5 Rolandic mu rhythm 
The rolandic μ rhythm is, as the name implies measured by electrodes covering the 
rolandic area (motor cortex). Its distribution is confined to the motor and 
somatosensory area during rest 11, 317, and is associated with attention and execution 
32, 283, especially of movements 10, 321. The rolandic μ rhythm can be attenuated by 
active, passive or even reflexive movement 283. The decreased activity is usually seen 
bilaterally over the motor cortex 11, 283, but is more pronounced on the side contralateral 
to the moving limb 282. It is most commonly a 10 Hz frequency and is one of the several 
different α rhythms mentioned in Table 1.1.  
1.6.4.6 Beta activity 
1.6.4.6.1 Introduction to beta activity 
The β activity has a frequency between 13 and 35 Hz 13, 64, 83 and like the α frequency 
band has often been divided into β-1 (13-24.5 Hz) and β-2 (25-35 Hz) 25, 26, 68, 70, 175. 
The lower β range activity overlaps with the α-2 activity and therefore similar 
functionality can be assigned at times. The amplitude of the β frequency seldom 
exceeds 30 μV 260, 282. It is mostly recorded in the frontal, central and parietal areas 68,
175, 310, 334, but has also been shown to exist as a globally distributed frequency 70 and is 
associated with arousal 116, attentiveness 13 and motor and sensory function 116, 208, 284,
305.  
1.6.4.6.2 Physiological function of beta 
The β activity in different areas has been linked to different underlying physiological 
functions, as it is unlikely that any given frequency subserves a single cognitive 
function in the brain 116. Frontal β activity is common but has no proven relationship 
with any physiological function. The slow central 20 Hz β activity which can be 
attenuated by movement is believed to be an amplification of the rolandic μ rhythm 260,
306. The posterior β rhythm, for similar reasons, is assumed to be an amplification of the
posterior α frequency band 260, 306.
It has been established that the β activity is a dominant basis for information flow in the 
somatosensory area 208, 417 . This suggests that β activity is important to “maintain the 
status quo” in the motor and somatosensory area 12, 22, 116. Beta activity is important for 
the interaction of afferent proprioceptive and neuromuscular information with the 
existing motor plan and execution of a new movement 292, 369. 
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Overall there is only limited knowledge on β oscillations which appear in a sustained 
state during high arousal and attentiveness 13, 116 and during somatosensory 
processing 116. 
 
1.6.4.6.3 The effects of movement on the beta band 
The motor and somatosensory cortex of monkeys displays an intermittent oscillatory 
activity at 25-35 Hz when animals are performing motor tasks 257. This is especially 
pronounced when the animal has to focus its attention such as during fine control 
movements and during demanding somatosensory processes. Similar activity is seen 
in the pre-motor, motor and somatosensory area of humans 151 and it is suggested that 
the synchronous activity of cortical areas in the β frequency aids in attention and motor 
and somatosensory information integration and execution 104, 119, 145, 217, 247, 249, 257, 270. 
 
There are two types of β oscillations related to movement, which have been described 
in humans. The first well known β oscillation is longer lasting and simultaneous with 
motor tasks, during activation of motor cortex networks 151, 358, 359. The β activity 
decrease is usually more pronounced in the area contralateral to the movement but 
also appears in the ipsilateral brain area 359. 
 
Several studies have shown that the motor cortex and peripheral motor units fire in β 
activity coherence during steady state contractions 64, 83, 199. These coherent oscillations 
in the β activity during a steady state muscle contraction or a dynamic movement are 
observed in the motor and pre-motor cortex, the basal ganglia, supplementary motor 
area, thalamus and even subthalamic structures and the cerebellum as well as the 
peripheral motor units 22, 49, 199, 316. These areas are involved in movement generation 
and execution. As β activity is increased during strong isometric contractions it seems 
that the correlation between force output and synchronised firing of cortical neurons 
and motor units decreases during the transition from an isometric contraction to 
movement 316. 
 
The second type of β oscillation is made up of short lasting bursts of activity after the 
termination of a movement or somatosensory stimulation. In this case the β oscillation 
is increased due to an increased firing synchrony of the oscillating neurons, especially 
in the central electrodes 334, 358, 359. This rebound of β activity after movement can be 
large (24-245%) in some subjects 358. It was assumed to be an inhibitory activity, which 
increased to stop processes such as motor output or might just return the brain to its 
idling state 63, 279, 284.  
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1.6.4.6.4 Recent beta activity research 
Recent research proposes that the rebound might be linked to the closure of cortical 
processes needed when processing movement sequences 119. The authors suggested 
that the β activity is more closely related to the execution of a continuous movement 
than is α activity 119. An alternative explanation is that the increased synchrony is 
reflecting on somatosensory processing after a movement as somatosensory feedback 
is needed for this β rebound to occur 63, 305. 
 
1.6.4.6.5 Beta activity and peripheral feedback and proprioception 
More recent studies suggest that increased β activity is not only important for the 
maintenance of steady state contractions but is needed for the efficient processing of 
peripheral feedback required to maintain the status quo and constant recalibration of 
the motor and somatosensory system 22, 49, 152, 199, 208, especially to maintain low force 
contractions 12, 13, 22, 62, 64, 300, 339, 398. As a result of these associations with the motor and 
somatosensory system, β activity is not only represented in the central, frontal and 
temporal areas but is also strongly represented in the parietal area 104, 249, which 
together with the pre-motor area is associated with movement perception, 
proprioception, motor planning and learning 5, 208, 249, 386. 
 
1.6.4.6.6 The effect of pain on the beta band 
The findings on the reactivity of the β band to pain are not conclusive. Studies 
conducted with the injection of hypertonic saline into the brachioradialis have shown no 
effect on β frequency 66. Furthermore, an auditory input also had no effect on the β 
frequency during the same study 66. Tonic heat pain in the arm leads to an increase in 
β-1 activity in the frontal and ipsilateral temporal scalp region, but no or minimal 
changes in β-2 activity were observed68, 74, 175. 
 
However, other studies have shown that β-2 activity increases over the entire area of 
the head with induced muscle pain 69, 70 and β-1 increases in the frontal and ipsilateral 
temporal areas to the painful stimulus 68, 74, 175. In patients with neurogenic pain the β 
activity is increased even during resting measurements 322. Therefore there is no 







1.7 SUMMARY AND HYPOTHESIS: POSSIBLE EFFECTS OF 
EIMD ON THE BRAIN MEASURED BY EEG 
 
Exercise-induced muscle damage is a well studied phenomenon in exercise physiology 
in which the peripheral changes have been well described over the last 30 years. 
These studies show that EIMD disturbs body homeostasis as it leads to increases in 
serum creatine kinase activity, and muscular swelling as well as a decrease in muscle 
length. 
 
Interestingly another measure of this disturbed homeostasis is the decrease in force 
output and EMG activity, both of which are influenced by neuromuscular function. Pain, 
which is known to be an emotional response to a disturbed homeostasis, only 
increases twelve hours after the damage was induced and peaks 48 hours after the 
damage occurred. From an evolutionary perspective it can be argued that acute pain is 
a protective mechanism aligned to survival. The mechanism of the delayed pain and 
explanations for its purpose are not so clear.  
 
It has also been hypothesised that the changes in EMG activity associated with EIMD 
might be regulated by an upstream, central control mechanism which may be located 
as high up as the brain stem, thalamus and even cortical regions. Leading on from this, 
two fundamental questions arise. The first question is to determine the effects of EIMD 
on the periphery, especially the neuromuscular function while the muscle tissue is 
recovering from the induced damage. The second question is to determine where there 
are central effects or even a central regulating mechanism which contributes to 
reinstate homeostasis after it was disturbed by EIMD. 
 
One of the methodologies which can be used to study central regulation is EEG as it 
measures the electrical activity on the scalp which is associated with the physiological 
states on the brain, mainly the cortex. Measuring induced cortical activity has been 
particularly useful in detecting cortical changes due to changes in various physiological 
states.  
 
In recent years advances have been made with EEG methodology in explaining the 
cortical control of movement as well as cortical integration of pain. Of special interest in 
the area of movement and pain research are the activities of the α- and β frequency 
bands, as both are known to be related to motor and somatosensory activity of the 
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cortex. Movement and pain individually lead to decreased activities of central α-1 and α 
-2, but the combination of a pain state and movement, as often seen during EIMD, 
leads to an increased α activity over the central areas of the cortex. Beta activity on the 
other hand is associated with somatosensory feedback and integration and might 
therefore play an important role in the neurophysiologic feedback about neuromuscular 
adaptations, which occur as a result of EIMD.  
 
Therefore the aim of this thesis is to investigate the effect of the symptoms of EIMD on 
neuromuscular changes and cortical activity in the α and β frequency bands during 
steady-state and low force contractions.  
 
 
1.8 STUDY OBJECTIVES 
 
1) To determine the effect of a protocol designed to induce symptoms of EIMD, on 
EMG activity during maximal and submaximal biceps movement tasks for 132 hours 
following the damage inducing protocol. 
 
2) To measure the effect of EIMD and the associated neuromuscular changes and 
delayed pain on cortical α activity within the first 132 hours following the damage 
inducing protocol. 
 
3) To measure the effect of EIMD and the associated neuromuscular changes and 
delayed pain on cortical β activity within the first 132 hours following the damage 
inducing protocol. 















1) Exercise-induced muscle damage and its associated pain and neuromuscular 
changes lead to changes in EMG activity measured during maximal and 
submaximal isometric actions as well as during a low force flexion extension biceps 
action lasting for 132 hours after exposure to the damage inducing protocol. 
 
2) Cortical α- activity increases in the motor and somatosensory area while 
experiencing the symptoms of EIMD. 
 
3) Cortical β activity in an experimental group experiencing the symptoms of EIMD for 
132 hours will be significantly different to cortical β activity in a control group. 
These hypotheses will be discussed in more detail in the subsequent experimental 
chapters.  
The study objectives are addressed in three experimental sections (chapter 2, 3 and 
4). Each experimental section has been written as a self-contained unit with its own 
introduction, methods, results and discussion; however the data was conducted as one 
study. While there may be some overlap and repetition, particularly in the methods, this 
compartmentalized approach was deemed more appropriate for interpreting and 
analysing these data than having a single methods section. The final chapter (chapter 







DISSOCIATION IN CHANGES IN EMG ACTIVATION 
DURING MAXIMAL ISOMETRIC AND SUBMAXIMAL LOW 
FORCE DYNAMIC CONTRACTIONS WHILE 







Exercise-induced muscle damage is a well described phenomenon which often occurs after 
exercise during which the muscle is lengthened under tension. The symptoms of EIMD 
include a lowered pain threshold in the affected area, a decreased range of motion of the 
affected joint, increased circumference of the affected area due to swelling and increased 
serum creatine kinase activity. The clinical symptoms usually appear twelve hours after the 
exercise, peak at 48 hours and subside about seven days later 18. In addition to these 
symptoms there is also impaired performance during the recovery from muscle damage, 
especially during low force shortening and lengthening actions of the biceps brachii 385. 
Several studies have shown that EMG activity during a submaximal isometric contraction 
increases with EIMD 95, 339, 385, 398. Similarly, increased EMG activity also occurs during 
isokinetic elbow flexion under constant load 385 with the greatest increase in EMG activity 
occurring during muscle shortening (90-60°) compared to isometric or lengthening action 
(90-120°). The changes in the submaximal EMG can be ascribed to changes in motor unit or 
muscle fibre recruitment, changes in neuromuscular firing rates or increased synchronization 
of the firing units 331. Muscle fibre recruitment changes are possibly a result of the type II 
muscle fibres being more prone to damage causing a recruitment shift towards type I fibres 
141, 143. Therefore to achieve the same submaximal force output when the muscle is 
damaged, compared to before the damage, more type I fibres are recruited increasing EMG 
activity.  
  
While EMG activity during submaximal exercise increases after EIMD, the activity during 
maximal exercise is reduced 201. This could either be due to changes in recruitment patterns 
as a result of damage to the muscle fibres or as a compensatory mechanism designed to 
protect the muscle fibres from further damage which might occur during maximal exercise 
220, 296.  
  
The time course of the changes and recovery of the neuromuscular function during 
submaximal and maximal exercise is not as clearly defined as the manifestation of the 
clinical symptoms described earlier. It has been shown that maximal EMG and 
neuromuscular function can be altered during a maximal contraction for up to seven to ten 
days after an EIMD exercise 43, 105, while the symptoms of EIMD subsided seven days after 
the protocol 105. However most EMG studies following EIMD have been conducted up to 24 
hours 339, 385 or 48 hours 398 after the exercise protocol, therefore the time course of changes 
have not been well described.  
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 Therefore, the aim of this study was to determine how the symptoms of EIMD influence the 
neuromuscular recruitment patterns, measured by the means of EMG, during maximal and 
submaximal isometric and submaximal flexion–extension contractions over a 132 hours 
period after the muscle damage was induced. 
 
Therefore we hypothesize that exercise-induced muscle damage and its associated pain and 
neuromuscular changes lead to changes in EMG activity measured during maximal and 
submaximal isometric actions as well as during a low force flexion extension biceps action 





Thirty-two right-handed male participants, aged 21-40 years, were recruited for this study. 
This sample size was based on similar research previously conducted and published in this 
department 210. Handedness was determined by the Edinburgh handedness inventory 
(Appendix 1) 271. Participants were recruited in groups of six and allocated to the control or 
experimental group matched for age, height, weight, body fat and skinfold thickness 
measured at the biceps and triceps as the thickness of the fat layer can influence the EMG 
signal 263. None of the participants had any chronic or acute upper body pain or injuries 
(Appendix 2 and 3) and did not do any upper body training, which included lengthening the 
muscle under tension, within the twelve weeks before the study (Appendix 4) . They were 
informed about the study design, familiarized with the equipment and signed the consent 
form before starting the study (Appendix 5). The study was approved by the Human Ethics 
Committee of the Faculty of Health Science, University of Cape Town (Appendix 6), while 
the principles outlined by the Declaration of Helsinki were adopted in this study 410.  
 
2.2.1 Study design 
 
Before the start of the study all participants were familiarized with the different testing 
protocols. Data collection occurred over seven consecutive days (Figure 2.1). To minimize 
the effect of circadian rhythm on any of the outcome measures, all testing was scheduled at 
the same time of the day (within 60 minutes), except for the measurements at twelve hours.  
 
Twelve hours before the exercise protocol, stature, body mass, body fat percentage 112 and 




taken and elbow muscle function, pain scores, biceps girth and resting elbow angle were 
measured for comparative reasons. During the different muscle function tests (MVC, 
isometric low force contraction test and active flexion and extension movement test) 
electromyography activity was captured of the musculus (M.) biceps brachii, M. triceps 
brachii and M. trapezius. Except for EMG measurements (at -12, 12, 36 and 132 hours) all 










Figure 2.1 Timeline of measurements. The EIMD indicators include, pain, arm circumference, elbow 
angle, serum creatine kinase activity  
 
2.2.2 Exercise protocol 
 
The experimental group participated in an exercise intervention twelve hours after baseline 
testing. As the aim of the study was to induce muscle soreness, a previously described 
exercise protocol, which has been shown to induce EIMD 210,was adopted in this study. In 
brief, participants were asked to resist the lengthening movement of the left biceps (5 sets of 
25 movements; see more details in ‘muscle function tests’ section). The resistance to these 
movements was set on a Biodex dynamometer at 80% of each subject’s maximum isometric 
contraction torque 210.  
 
2.2.3 Muscle function tests 
 
The MVC for the left elbow flexion was determined by a Biodex dynamometer (Biodex pro 3, 
New York, USA). To assess MVC, participants sat on the Biodex chair with their upper body 
and left upper arm securely strapped to the machine while the left forearm rested freely on 
the arm rest. In this position, participants were able to freely flex and extend their elbow over 
a range of approximately 120°, without hyper-extending the elbow. The rotation axis of the 
dynamometer was aligned with the lateral epicondyle of the humerus, while the forearm was 
fixed into a fully supinated position. This ensured that the flexion-extension movement was 
carried out in the transversal axis and sagittal plane. Participants were asked to perform 
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three five second isometric elbow contractions at maximal effort, with a fixed dynamometer 
arm angle of 45°. This set-up results in an elbow angle at about 60°, which is within the 
optimal length tension curve range 71, 330, while also allowing for optimal EMG activity 221. The 
three measurements were interspaced with 60 second recovery periods, while the last two 
measurements were used to determine an average MVC. 
 
In addition to the MVC, an isometric low force contraction test and active low force flexion 
and extension movement test were performed. Within the isometric low force contraction test 
participants were placed on a normal chair and asked to relax their upper arm. The left arm 
was relaxed and hanging by their side, while the right arm was resting on the participants 
lap. For the submaximal EMG measurements participants were asked to move at an 
average angular velocity of 30°·s-1 for three seconds with a 1kg wrist weight, with a fully 
supinated forearm placed at 90° and the fist closed. This measurement was also repeated 
three times interspaced with ten second intervals. Active flexion and extension movements 
of the elbow from to 90° and back to 180° were performed in the sagittal plane, while the 
upper and lower arm were kept as described in the MVC method. Participants were asked to 
perform three flexion (3 seconds) - extension (3 seconds) movements which were controlled 
by an auditory signal, while EMG data were captured continuously.  
 
2.2.4 Electromyographic measurements  
 
Electromyographic data were collected during muscle function tests at -12, 12, 36 and 132 
hours. For measurements two circular surface electrodes (Blue Sensor, Medicotest, 
Denmark) were placed on the muscle belly of the M. biceps brachii, the M. triceps brachii of 
the left arm and the M. trapezius with a reference electrode being placed on the clavicle 
bone. Data were captured at a rate of 2000 Hz (Telemyo 900, Noraxon USA, Inc., Arizona, 
USA). To ensure accurate EMG readings, the skin where the electrodes were placed, was 
shaved and vigorously rubbed with ethanol 4. To prevent skin irritations during the 
continuous measurements sandpaper was not used to abrade the skin. To ensure electrode 
placement remained the same on the four testing days over a period of seven days a 
permanent marker was used to circle the electrodes on the first day of EMG testing 43, 303. 
EMG measurements of the M. triceps brachii and M trapezius were monitored closely to 
corroborate that participants did not use compensation techniques to produce more force 
during the exercises. To minimize the possible effect of skinfold thickness on the EMG 




2.2.5 Electromyographic data analysis 
EMG data were analyzed with the Noraxon Myoresearch software (Version 2.11, Arizona, 
USA). The recorded data were filtered (50 Hz notch) to remove signal interference from 
external electrical sources (Myoresearch 2.11). Thereafter the data were filtered using a 15-
500 Hz band pass filter and smoothed using root mean squared analysis which was 
calculated for a 50 ms window. Within the MVC measurement, the average EMG was 
calculated by averaging the 2, 3 and 4th second and excluding the data from the 1 and 5th 
second. In contrast to EMG data from MVC, expressed absolutely, the EMG data from the 
isometric low force and flexion and extension measurements were normalized to the peak 
EMG amplitude during the maximal isometric contraction. 
Neuromuscular efficiency was calculated as torque produced during MVC/ divided by peak 
EMG during MVC340.  
To make the graphs of EMG activity more easily understandable the isometric data are 
displayed as percentage changes of the isometric data normalized to the EMG during MVC 
339. The flexion–extension data are displayed as normalized EMG (submaximal EMG
normalized to EMG during MVC).
2.2.6 Other measurements 
Blood samples, biceps girth, resting elbow angle and a pain score (VAS) (Appendix 7) were 
also measured and completed on a daily basis. Blood samples (5 ml) were taken from the 
right antecubital vein every testing day before the muscle function test. Samples were stored 
(-20°C) and later analyzed (Beckman DU-62, Beckman Instruments, Fullerton, California, 
USA) for the determination of serum creatine kinase (CK) activity as described previously 210. 
The girth of the left biceps was measured with a tape measure midway between the 
acromion and radiale bony landmarks, which was marked with a permanent marker for 
repeatability purposes 210. Resting elbow angles, and by implication the resting length of the 
biceps muscle were measured with a goniometer 210. Current pain perception was measured 
on a daily basis before the muscle function test with the use of a 10 cm visual analogue 
scale (VAS) 366. 
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2.2.7 Statistical analysis  
 
Statistical analysis was performed using STATISTICA 8.0 data analysis software (StatSoft, 
Inc. Tulsa, OK, USA). An independent t-test was used to compared the descriptive data 
between experimental and control group. As some of the data sets in this study had an 
unequal variance, determined using Levene’s test of homogeneity of variance, we decided to 
use non parametric statistical tests. A Kruskal-Wallis test (H) compared the differences 
between the control and experimental group on each of the testing days. A Friedman’s test 
(X2) was used to compare changes within each group over the repeated testing days. A 






2.3.1 Characteristics of subjects  
 
Two subjects did not finish their entire trials. Due to incomplete EMG data sets and 
equipment failure another five subjects were excluded from further analysis. The general 
characteristics of the remaining 25 subjects are shown in Table 2.1. No significant 
differences were found between the experimental and control group in age, weight, height or 
skin fold measurements.  
 
Table 2.1: Descriptive data for the control (n = 13) and experimental groups (n = 12). Data are 
expressed as mean ± SD. 
 
Variable Control Responders 
Age (years) 24 ± 5 23 ± 5 
Body mass (kg) 74.4 ± 12.8 73.4 ± 12.9 
Stature (cm) 173.9 ± 6.1 178.5 ± 8.3 
Body fat (%) 16.0 ± 5.4 12.9 ± 6.1 
Skinfolds (mm) 83 ± 50 66 ± 41 
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2.3.2 Muscle soreness  
 
The difference in pain in the left arm in the experimental and control group measured by the 
means of the VAS scale is shown in Figure 2.2a. Peak pain in the experimental group was 
observed at 36 hours after the exercise protocol (X2 = 43.03, p < 0.0001) (Figure 2.2a). A 
difference in pain between the two groups can be observed at 12 (H = 9.13, p = 0.0025), 36 
(H = 14.67, p = 0.0001), 60 (H = 12.93, p = 0.0003), 84 (H = 10.13, p = 0.0015) and 108 (H = 
10.13, p = 0.0015) hours after the exercise protocol. Significant changes in pain were also 
found over time in the experimental group compared to the baseline value at 36, 60 and 84 
hours (X2 = 43.03, p < 0.01).  
 
2.3.3 Arm circumference  
 
There was a significant increase in the difference in girth between the exercised and rested 
arm in the experimental group compared to the control group which lasted for the duration of 
the experiment 12 (H = 5.16, p = 0.0231), 36 (H = 6.99, p = 0.0082), 60 (H = 8.01, p = 
0.0046), 84 (H = 7.79, p = 0.0053), 108 (H = 4.66, p = 0.031), 132 (H = 5.1, p = 0.0239) 
hours (Figure 2.2b). Significant changes in arm circumference were also found over time in 
the experimental group compared to the baseline value at 36, 60, 84 and 108 hours (X2 = 
32.29, p < 0.01). The difference between the left and right biceps girth of the control group 
did not change throughout the experiment. 
 
2.3.4 Resting elbow joint angle (muscle length)  
 
There was a significant decrease in elbow joint angle in the experimental group compared to 
pre-exercise values at 12, 36, 60 and 84 hours (X2 = 34.70, p < 0.0001) (Figure 2.2c). The 
difference in joint angle increased in the experimental group compared to the control group 
at 12 (H = 5.34, p = 0.0208), 36 (H = 7.16, p = 0.0075), 60 (H = 7.01, p = 0.0081), 84 (H = 
11.02, p = 0.0009) and 108 (H = 6.16, p = 0.0131) hours after the exercise protocol. No 
changes in the resting elbow joint angle over time were observed in the control group.  
 
2.3.5 Serum creatine kinase activity  
The serum creatine kinase activity increased significantly after the baseline measurement in 
the experimental group compared to the control group and peaked at 84 (H = 7.69, p = 
0.0056), 108 (H = 8.84, p = 0.003) and 132 (H = 9.47, p = 0.0021) hours after the EIMD 
protocol. Increases over time were seen 108 and 132 hours after the induction of EIMD in 
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the experimental group (X2 = 22.17, p < 0.0011) (Figure 2.2d). The serum creatine kinase 






























2.3.6 Muscle function  
Muscle function as measured by MVC (Figure 2.3a) decreased significantly in the 
experimental group compared to the control group on all but one visit to the laboratory after 
the exercise protocol (p < 0.05). The largest decrease in maximal force output was observed 
within the first twelve hours after the EIMD protocol in the experimental group (H = 14.50, p 
Figure 2.2 
(a) The change in current pain measured 
with the VAS scale over seven days is 
shown the control () and experimental 
() group.  
 
## p < 0.01 at 84 hours post versus pre in the 
experimental group 
### p < 0.001 at 36 and 60 hours post versus pre in 
the experimental group 
 
(b) The change in the difference in 
relaxed elbow girth (cm) between the left 
and right arm of the control () and 
experimental () group over seven days. 
 
# p < 0.05 at 108 hours post versus pre in the 
experimental group 
## p < 0.01 at 36 and 60 hours post versus pre in 
the experimental group 
### p < 0.005 at 84 hours post versus pre in the 
experimental group 
 
(c) The change in the difference in elbow 
angle (degrees) between the left and right 
arm of the control () and experimental 
() group over seven days. 
 
## p < 0.01 at 12 hours post versus pre in the 
experimental group 
### p < 0.001 at 36, 60 and 84 hours post versus 
pre in the experimental group 
 
(d) The change in creatine kinase activity 
(U.l-1) over seven days is shown the 
control () and experimental () group. 
 
# p < 0.05 at 132 hours post versus pre in the 
experimental group  
## p < 0.01 at 108 hours post versus pre in the 
experimental group 
------ 
(* indicates results of the Kruskal-Wallis non-
parametric test, # indicates results of the Friedman’s 
non parametric test) 
 
* p < 0.05 control versus experimental group. 
** p < 0.01 control versus experimental group 





= 0.0001). The force output in the experimental group did not recover completely for the 
duration of the trial at 36 (H = 10.30, p = 0.0013), 60 (H = 7.70, p = 0.0055), 84 (H = 6.82, p 
= 0.009) and 132 (H = 6.26, p = 0.0123) hours. The control group did not show any changes 
throughout the experiment. 
  
A difference was also observed in the force output of the experimental group compared to 
the baseline measurement at 12, 36, 60 and 84 hours (X2 = 38.41, p < 0.0001). There were 

























2.3.7 EMG activity  
2.3.7.1 EMG activity during maximal force output 
The electromyographic activity during a maximal force output is displayed as raw data in µV 
(Figure 2.3b). There was a significant decrease in EMG activity in the experimental group at 
Figure 2.3 
(a) The maximal force output produced on 
seven consecutive days is shown in the 
control () and experimental () group. 
  
# p < 0.05 at 60 hours post versus pre in the 
experimental group 
## p < 0.01 at 84 hours post versus pre in the 
experimental group 
### p < 0.005 at 12 and 36 hours post versus pre in 
the experimental group 
 
(b) Change of maximal EMG amplitude on 
four different occasions  
 
* p < 0.05 control group versus experimental group. 
# p < 0.05 at 132 hours post versus pre in the 
experimental group  
 
(c) Change in neuromuscular efficiency 
measured as a ratio of torque/EMG during 
the MVC in the control () and the 
experimental () group. 
 
# p < 0.05 at 12 hours post versus pre in the 
experimental group 
† p < 0.001 at 132 hours post versus 12 hours post 
in the experimental group 
‡ p < 0.01 at 132 hours post versus 36 hours post in 
the experimental group 
 
---- 
(* indicates results of the Kruskal-Wallis non-
parametric test, # indicates results of the Friedman’s 
non parametric test) 
* p < 0.05 control group versus experimental group. 
** p < 0.01 control versus experimental group 






132 hours following the EIMD protocol (X2 = 8.40, p < 0.05). The control group did not show 
any changes over time.  
There was also a significant difference between the control and experimental group at 132 
hours (H = 5.22, p < 0.0223) and a nearly significant difference at 36 hours (H = 3.83, p < 
0.0502) after the EIMD protocol. 
2.3.7.2 Neuromuscular efficiency measured as torque/EMG during the MVC  
The neuromuscular efficiency during the maximal isometric contraction is displayed as the 
ratio torque/EMG. There was a significant decrease in this ratio at twelve hours compared to 
the pre-exercise value in the experimental group (X2 = 21.70, p = 0.05). There was a 
significant increase in neuromuscular function at 132 hours compared to 12 hours (X2 = 
21.70, p = 0.001) and at 132 hours compared to 36 hours (X2 = 21.70, p = 0.01). No 
changes were observed in the control group (Figure 2.3c).  
2.3.7.3 EMG activity during an isometric low force contraction 
The electromyographic activity during a submaximal isometric low force contraction is shown 
in Figure 2.4. The data are displayed normalized to the EMG during the maximal force 
output and as a percentage change compared to before the EIMD protocol. There was a 
significant increase in the experimental group at twelve hours (X2 = 10.9, p < 0.0123) after 
the EIMD protocol. There was also a difference between the groups at twelve hours (H = 
6.54, p < 0.0106). The control group showed a significant difference to the baseline values at 
132 hours (X2 = 9.24, p = 0.03). 
Figure 2.4 Percentage change of EMG amplitude produced during a low force isometric contraction 
with a 1kg wrist weight normalized to the maximal EMG amplitude measured on four different 
occasions in the control () and the experimental () group. 
---- 
(* indicates results of the Kruskal-Wallis non-parametric test, # indicates results of the Friedman’s non parametric test) 
* p < 0.05 control group versus experimental group.
# p < 0.05 at 132 hours post versus pre in the control group, ## p < 0.01 at 12 hours post versus pre in the experimental group
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2.3.7.4 EMG activity during a submaximal force output  
EMG data measured during the submaximal flexion-extension movements are shown in 
Figure 2.5. The lightly grey shaded area represents the flexion while the dark grey shaded 
area represents the extension. The data are represented as a percentage of the EMG 
recorded during maximal force contractions. No differences were observed on the first day of 
testing (Figure 2.5a). 
 
Twelve hours after the exercise protocol (Figure 2.5b) the muscle activity during the 
submaximal movement was significantly higher in the experimental compared to the control 
group during the last two seconds of the flexion as well as the first two seconds of the 
extension movement (s2: H = 9.61, p = 0.0019; s3: H = 11.01, p = 0.0009; s4: H = 8.00, p = 
0.0047; s5: H = 4.05, p = 0.0442). The largest difference in muscle activation between the 
two groups occurred in the last or third second of the flexion movement (H = 11.01, p = 
0.0009), where the experimental group had a higher EMG activity than the control group. 
At 36 hours after the exercise protocol the muscle activity was still significantly increased in 
the experimental group during the entire flexion movement and the first second of the 
extension movement (s1: H = 4.73, p = 0.0296; s2: H = 7.4, p = 0.0065; s3: H = 8.62, p = 
0.0063; s4: H = 8.00, p = 0.0047) (Figure 2.5c).  
 
At 132 hours after the exercise protocol the muscle activity in the experimental and control 
group differed during the last two seconds of the flexion movement (s2: H = 4.74, p < 
0.0295, s3: H = 4.27 p < 0.0387) (Figure 2.5d).  
  
The increase in EMG activity was most visible twelve hours after the exercise protocol 
(Figure 2.5b), but could still be measured 36 and 132 hours after EIMD (Figure 2.5c and d). 
At twelve hours a marked increase occurred in the flexion, but also in the first two seconds of 
the extension movement (Figure 2.5b). At 36 and 132 hours the increases in EMG activity 





Figure 2.5: The EMG amplitude of the biceps brachii during a six second submaximal dynamic 
contraction normalized to the EMG amplitude during a maximal contraction measured on four different 
days in the control () and experimental () group.  
---- 
(* indicates results of the Kruskal-Wallis non-parametric test) 
* p < 0.05 control group versus experimental group, ** p < 0.01 control group versus experimental group 









The first finding of this study was that the EIMD exercise protocol resulted in similar 
physiological responses reflecting muscle damage in the experimental group as has been 
reported previously in studies in this and other laboratories 80, 210, 236, 264, 267. 
  
In particular the symptoms of EIMD (soreness, swelling, muscle shortening and creatine 
kinase activity) changed in the typical way for the duration of the experiment (Figure 2.2a-d). 
Also, muscle function measured as force output was impaired immediately after the EIMD 
protocol 296, 331 and gradually recovered but was still significantly different to the control group 
at 132 hours (Figure 2.3a). Maximal EMG activity and neuromuscular efficiency showed 
persistent signs of down regulation over the course of 132 hours. A significant decrease to 
pre-exercise values was seen at twelve hours in neuromuscular efficiency (Figure 2.3c) 
while the EMG during a MVC only showed a significant decrease to pre-exercise values and 
between groups 132 hours after the exercise protocol (Figure 2.3b).  
 
Previous studies by Turner et al. 385 and Semmler et al. 339 have shown that an EIMD 
inducing protocol is followed by changes in the electromyographic activity in the 24 hours 
following the protocol. Both studies show that the EMG activity increases and force steadily 
decreases in the biceps brachii during submaximal isometric and flexion-extension 
contractions after an EIMD protocol, therefore showing alterations in neuromuscular 
recruitment within the first 24 hours. We could not find other published studies which 
measured neuromuscular function during maximal and submaximal contractions of the 
biceps for 132 hours after EIMD and therefore believe that this provides novel insight into 
neuromuscular recruitment while experiencing EIMD.  
 
Our data shows that force output was decreased in the EIMD group until the end of the study 
at 132 hours (Figure 2.3a). The EMG during the maximal contraction was decreased at 132 
hours, while neuromuscular efficiency was decreased at 12 and 36 hours suggesting that 
there was a down regulation of contractile function (explained in further detail in the following 
paragraphs) (Figure 2.3b and c).  
 
Muscle function could be disturbed due to several factors. Based on the clinical symptoms it 
may be assumed that the EIMD protocol would have caused damage of the myofibrillar 
structure, including disruption of the contractile machinery, inexcitability of the muscle or 
changes in the release of Ca2+ and the sensitivity of cells to it 251, 403. The damage could also 
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have caused changes in the excitation-contraction coupling rates, which in turn, would lead 
to a disturbance in the contractile properties of the individual muscle fibres 54. EIMD 
protocols are known to damage type II, especially type IIB muscle fibres in preference to 
type I fibres 133, 219. In contrast to type I fibres, type II fibres generate more force but are not 
as resistant to fatigue 222. They also tend to tear when lengthened under tension 141. 
Therefore, the type I fibres need to increase their firing frequency, or more fibres need to be 
recruited to attain the same force output reached before 39, 132. 
 
This increased firing would lead to an increased EMG activity during submaximal 
contractions while the EMG during the MVC would be decreased due to the damaged overall 
fibre population. Therefore the entire muscle fibre population would not be available for 
activation during a MVC, while experiencing EIMD, and some fibres which are activated 
might not be capable of full contraction. The recovery of the muscle from EIMD usually takes 
a week or even longer 79, 80 and can therefore explain the decreased force output and EMG 
activity for 132 hours following the study. The maximal EMG/force ratio shows the 
dissociation of the recovery rates in MVC force output and the maximal EMG recorded at the 
same time. By 132 hours after the EIMD protocol the force output has started recovering 
while the maximal EMG recorded at the same is significantly decreased compared to  pre 
measurements. This observation could be explained by adaptations in neuromuscular 
function including a down regulation of muscular activity during maximal voluntary 
lengthening actions 397.  
 
Studies with motor nerve and transcranial stimulation have also shown that the expected 
decline in force output during a maximal isometric contraction while experiencing fatigue can 
be reduced. Transcranial magnetic stimulation increases the voluntary force output by about 
25%, therefore it was suggested that there is an upstream down regulator during fatigue 
(termed central fatigue) 377. We suggest that the same down regulation could occur for 132 
hours after the EIMD protocol (Figure 2.3b). The results need to be interpreted with caution 
because the repeated daily measuring of the MVC could have lead to a repeated fatiguing or 
re-damaging of the already damaged muscle in the experimental group.  
The opposite activation pattern to the maximal EMG can be seen in the low force isometric 
and flexion-extension contractions (Figures 2.4 and 2.5a-d). The low force isometric and 
flexion-extension data show similar significant changes when displayed as raw data, 
normalized to the EMG during MVC and when percentage normalized. During both the low 
force isometric and flexion-extension contraction there was an increase in EMG activity in 




The increases in EMG amplitude during the submaximal contractions could be explained by 
several mechanisms. For example, there could be increased recruitment of motor units 
especially larger motor units 94, 132, 391, increased firing rates of the already active motor units, 
increased discharge variability and increased synchrony in the firing of motor units 95, 331, 414. 
Any of the changes in muscle activation, measured as EMG activity, could manifest as a 
change in neural firing rates or in overall motor unit recruitment 39, 132. A change in firing rates 
would be due to a change in either central activation or at the level of the motor nerve or the 
neuromuscular junction 240, 349 and EIMD could have an influence at any of these levels.  
 
A change in firing rate and recruitment patterns can lead to an increase in rectified EMG 
amplitude and average EMG during submaximal contractions as well as a decrease in the 
mean power frequency 96, 356. As EMG amplitude increases during submaximal exercise to 
fatigue, the same is true for submaximal exercise while experiencing the symptoms of EIMD. 
Therefore an interpretation of these data is that non-damaged muscle fibres start firing with 
more synchrony to produce the same force output which the undamaged muscle fibre 
population produced before the EIMD protocol. Due to the firing synchrony the submaximal 
EMG signal increases. It has been shown before that especially during low force 
contractions after an EIMD protocol, motor unit synchrony and the motor unit discharge rate 
increases 414.  
 
Excitation-contraction coupling failure could also lead to an increase in EMG activity during 
the submaximal contraction. Due to the action potentials not being able to stimulate the 
release of adequate amounts of Ca2+ from the sarcoplasmic reticulum, a loss in force output 
is experienced 209, 289. This is especially apparent at a shorter muscle length, when more 
Ca2+ release is needed to achieve the same force output as seen at longer muscle length 276, 
289. 
 
Therefore we hypothesize that an adaptive response of the central nervous system could be 
to up regulate the firing frequency at a shorter muscle length to achieve the same force 
output as seen at longer length. This study supports this hypothesis by the fact that the 
submaximal EMG in the experimental group shows significant increases in the later stage of 
the flexion (last 2-3 seconds of flexion) and early stage of extension (first 1-2 seconds of 
extension action). This hypothesis is in line with the suggested centrally mediated neural 
adaptation as described by Starbuck and Eston 360.  
 
If one assumes that changes in especially the submaximal EMG are at least partially due to 
changes in neural firing rates, motor unit synchrony or recruitment changes then there must 
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be an upstream regulator which receives the afferent input (e.g. pain, disturbed functionality, 
changed proprioception, swelling etc) caused by EIMD and provides efferent output which 
regulates the muscle activation. This upstream regulator could probably be situated in the 
lower brain structures, but one can assume that especially the efferent output to the muscle 
could be guided by the motor cortex 83. However this hypothesis needs to be confirmed in 
future research studies.  
2.4.1 Conclusion 
In conclusion this study shows that EIMD disturbs neuromuscular function during maximal 
isometric and submaximal shortening-lengthening exercises but these changes seem to not 
be directly related to the clinical symptoms. These changes suggest that central regulation 
influences the neural firing patterns and motor unit activity. 
The next study examines the effect of EIMD and the associated neuromuscular changes and 
delayed pain on cortical α activity. 
 
CHAPTER 3  
 
THE RESPONSE OF CORTICAL ALPHA ACTIVITY TO 
PAIN AND NEUROMUSCULAR CHANGES CAUSED BY 








Exercise-induced muscle damage is a phenomenon which occurs after unaccustomed 
exercise, especially exercise where the muscles are lengthened under tension. Symptoms 
include structural damage to the muscle 141, development of pain and changes in 
neuromuscular function including electromyography activity (EMG) 339 and force production 
339, as described in the previous chapter. 
 
Interestingly, whilst there is a decrease in EMG activity during a maximal voluntary 
contraction, submaximal EMG is increased within the first twelve hours after an EIMD 
protocol. This is of interest since the sensation of pain is only perceived 12- 24 hours after 
an EIMD protocol (chapter 2). Collectively these data suggest that the changes observed in 
the neuromuscular function after EIMD are driven by an upstream regulator situated in the 
brain, which is guided by peripheral bottom-up input (i.e. noxious stimulus, inflammation, 
intramuscular enzyme leakage and tissue damage) 339. 
 
It has been shown previously (fMRI and PET) that a noxious stimulus activates several 
areas of the brain, the primary somatosensory cortex (SI), secondary somatosensory cortex 
(SII), pre-motor cortex and the cingulate gyrus (limbic system) contralateral to the stimulus14 
392. These areas integrate the information arising from the periphery to create an emotional, 
behavioural and motor response, depending on the circumstances 241, 392. 
 
As fMRI does not allow for movement during the measurement or precise time resolution of 
the data 323, electroencephalography (EEG) is a preferred method to measure brain activity 
during movement 374. EEG is measured on the scalp with multiple low-amplitude sensitive 
electrodes and measures electrical activity produced by the neuronal firing in cortical and 
subcortical areas of the brain 260, 374. An outcome of the EEG measurement is spectral power 
in different frequencies, also known as frequency band activity. The 8-13 Hz band which 
represents the α activity, is known to be influenced by pain 68, 69, movement 358, attention 327 
and arousal 67. 
 
The most common response of α activity to a painful, cognitive or motor stimulus is a 
decrease in activity at the onset of the stimulus, followed by an increase in activity once the 
stimulus has lasted for several minutes 68, 358 or ended 10, 69. However recent research has 
shown that α activity can also increase during focused attention and cognitive processes 274. 
Von Stein et al. showed that the increase in α activity especially α-2 activity was due to 
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interactions between the frontal and parietal areas and that the increase in activity appears 
to be acting as a top-down regulator 393. A similar top-down regulatory process has been 
suggested by Chen and Herrmann 74 to control the sensation of pain. The notion of the top-
down suppression of pain is further supported by studies showing that meditation increases 
the global α-activity whilst decreasing the subjective sensation of pain 186, 207.  
 
EIMD provides an interesting model for investigating the effect of structural damage and 
acute pain on α-activity, particularly in the first twelve hours after EIMD when neuromuscular 
changes occur with minor symptoms of pain (chapter 2). Therefore the aim of this study was 
to investigate the effects of EIMD and determine whether there is a relationship between the 
peripheral symptoms, the neuromuscular changes and delayed pain sensation and cortical 
α-1 and α-2 activity.  
 
We hypothesize that a compensatory increase in α-1 activity will be displayed over the motor 
and somatosensory cortex of the experimental group compared to the control group in 
response to changes in neuromuscular function. We further hypothesize that an increase in 
α-2 activity is associated with the suppression of the sensation of pain experienced within 





Thirty-seven right-handed male participants, aged 21-40 years, were recruited for this study. 
Handedness was determined by the Edinburgh handedness inventory (Appendix 1) 271. 
Participants matched for age, height, weight, body fat and skinfold thickness, were allocated 
to the experimental or control group. All participants had to be free of any upper body injuries 
and were not participating in any upper body training during the last twelve weeks before the 
study. This included the engagement in exercises involving specific muscle lengthening 
under tension movements. 
 
Prior to being informed about the study design and familiarization with the equipment, 
participants had to sign an informed consent form (Appendix 5) and complete a Physical 
Activity Readiness Questionnaire (Par-Q) (Appendix 2) 7. They were also asked to complete 
questionnaires about their injury and training history (Appendix 3 and 4). Participants were 
informed about the study design, familiarized with the equipment and signed the consent 
form before starting the study. The study was approved by the Human Ethics Committee of 
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the Faculty of Health Science, University of Cape Town (Appendix 6). The principles outlined 
by the Declaration of Helsinki for the use of Humans were adopted in this study 410. 
 
3.1.1 Study design 
 
Before the start of the study all participants were familiarized with the testing equipment and 
different test protocols. Figure 3.1 is a time line depicting the order of tests performed over 
the seven day testing period. To minimize the effect of circadian rhythm on any of the 
outcome measures, all tests were scheduled at the same time of the day (within 60 minutes). 









Figure 3.1 Timeline of measurements. The EIMD indicators include, pain, arm circumference, elbow 
angle, creatine kinase activity  
 
Twelve hours before the start of exercise protocol (see also Figure 3.1), stature, body mass, 
body fat percentage and skinfolds of each participant was measured. In addition resting 
elbow angle, elbow muscle function (measured by MVC), biceps girth and pain scores were 
measured. A blood sample was taken to determine serum creatine kinase activity. 
 
Electroencephalographically activity was measured during a self-initiated self paced flexion-
extension movement. In contrast to all the above mentioned measurements that were 
conducted at -12, 12, 36, 60, 84, 108 and 132 hours EEG measurement were only captured 
at -12, 12, 36 and 132 hours (Figure 3.1). These measurements were time consuming for 
the participants and there was concern about poor compliance if they were required to be 
tested more frequently.  
 
3.1.2 Exercise protocol 
 
Twelve hours after baseline testing, the subjects in the experimental group completed an 




were asked to resist the lengthening movement of the left biceps (5 sets of 25 movements; 
see also ‘muscle function tests’ section for set up of the Biodex (Biodex pro 3, New York, 
USA)). The resistance to these movements was set on a Biodex dynamometer at 80% of 
each subject’s maximum isometric contraction torque, as this has been shown to induce 
EIMD. The control group did not perform this exercise protocol. The set up of the Biodex 
dynamometer is explained in detail in the methodology section of chapter 2, page 55. 
 
3.1.3 Muscle function tests 
 
The muscle function tests consisted of a MVC measurement and a self-paced submaximal 
flexion-extension movement. The experimental and the control group performed these 
muscle function tests. 
 
The MVC was measured using a Biodex dynamometer while performing elbow flexion of the 
left arm. For this, the participant sat in the chair of the Biodex dynamometer with their upper 
body and left upper arm securely strapped to the dynamometer, while the left forearm was 
only able to move in the sagittal plane (flexion-extension), In this position, participants were 
able to freely flex and extend their elbow over a range of approximately 120°, without hyper-
extending the elbow. The rotation axis of the dynamometer was aligned with the lateral 
epicondyle of the humerus, while the forearm was fixed into a fully supinated position. This 
ensured that the flexion-extension movement was carried out in the transversal axis and 
sagittal plane. Participants were asked to perform three five second MVC’s interspaced by 
60 second recovery periods, as previously described in chapter 2, page 55. 
 
The flexion-extension movement was not performed on the Biodex, but rather the 
participants were seated on a standard armless-chair. The participants’ left arm was relaxed 
and hanging by their side, while the right arm was resting on the participants lap. For the 
submaximal self-paced flexion-extension movements all participants wore a 1kg wrist strap 
and movements were performed in the sagittal plane between elbow angles of 180° and 90°. 
During the movements subjects were ask to look at a fixed point at the wall to reduce the 
interference of eye movements on the EEG measurement (see also EEG evaluation). In 
addition, the upper body and upper arm were positioned as described in the MVC set-up for 
standardization purposes. Participants were asked to perform 75 repetitions, which were 
interspaced by 5-10 second recovery periods with slightly longer rest periods (during which 




3.1.4 Electroencephalographic study procedure 
The EEG data were obtained in a darkened, sound-attenuated, temperature controlled room 
to minimize the effect of confounding factors. Participants were instructed how to perform the 
self paced flexion-extension movements. EEG activity was measured during the 75 
submaximal, fast self paced flexion- extension movements. In addition, subjects were asked 
to keep their eyes open and focused on a fixed spot on the wall during the submaximal self 
paced movements.  
3.1.5 Electroencephalographic recording 
Figure 3.2 A layout of the EGI 129 channel system overlaid by the 10:20 electrode system (dark grey 
circles). Ellipses represent the following gross cortical areas: grey (Frontal), green (Pre-motor), 
orange (Supplementary Motor), blue (Motor), red (Somatosensory), yellow (Parietal), purple 
(Occipital). 
An Electrical Geodesic ™ dense-array system (EGI) EEG net with 128 recording sites plus a 
vertex reference electrode (electrode 129) (Electrical Geodesics, Inc, Oregon, USA) 32, 
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which measures the electrical activity on the surface of the scalp, was fitted onto each 
participant (see Figure 3.2 for an electrode layout). The impedance of all electrodes was 
maintained below 50 kΩ as suggested by the manufacture of the EGI system and different 
technical references 32, 190, 256 due to the high input resistance of the EEG amplifier. Specially 
designed amplifiers processed the high impedance signal. EEG was recorded using a 0.1–
50 Hz bandpass filter (3 dB attenuation) 256. The signals were sampled at 250 Hz 32, 256. All 
recordings were initially referenced to the central reference electrode (Cz/129) 32, 256. The 
EEG system was connected to an experimental workstation (Net Station software, Apple Inc 
desktop) 32. 
 
3.1.6 Electroencephalographic data analysis 
 
Data were collected continuously during the pre-movement, movement and rest phase and 
therefore represent the common state of the brain during a biceps brachii movement 
protocol rather than only a movement induced change.  
 
The EEG data were analyzed offline with the Net Station Waveform Tools (a component of 
Net Station software version 4.2.3, (Electrical Geodesics, Inc, Oregon, USA)). The data-
analysis path recommended in the Net Station Waveform Tools Technical Manual 
(http://www.egi.com/ accessed January 2008) was followed. The raw EEG data were 50 Hz 
notch filtered as well as 1-40 Hz band pass filtered. Following this the data for each trial 
were segmented into three second epochs 374.  
 
The EEG was re-referenced against an average reference 32, 34, 190, which made data 
recorded in the reference electrode (Cz/129) available for analysis. The EEG recording was 
monitored for movement, eye movement, blink artefacts, and noise by an amplitude 
threshold criterion. Epochs were excluded if the eye blink threshold exceeded 140 μV and 
the eye movement threshold exceeded 55 μV 167. Ocular artefacts were also detected by a 
slope threshold, if the slope of a channel increased more than 14 μV·ms-1 that channel was 
discarded within that epoch 418. The amplitude of a given channel was excluded in that 
epoch if it exceeded 150 μV, and in such a case replaced by an estimate calculated of the 
values of the surrounding channels. This was performed by computer algorithms built into 
the Net Station software version 4.2.3, (Electrical Geodesics, Inc, Oregon, USA) 256.  
 
After the automated artefact rejection algorithm all epochs were also visually inspected 
offline and the recordings in which artefacts could not be removed were manually discarded 
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before further data analysis took place. 
 
While shorter epochs might reveal the relationship between, for example, spectral estimates 
or time-locked events, our intent was to characterize background brain states (induced 
activity) rather than specific components of event related processing 382. Subjects who had 
less than 40 usable, artefact-free epochs per trial day were excluded from further analysis. A 
Fast Fourier Transform (FFT) with a Welchen window was performed to obtain the spectral 
information of an epoch of each subject. Hereafter the data were exported to Microsoft 
Excel© and each subject’s data were averaged before further analysis. 
 
The different frequency bands used in this study were as follows: α-1 (7.81–9.77 Hz) and α-2 
(10.74–12.7 Hz). Thereafter the relative power (activity) for each frequency on each day was 
calculated with the following formula: ((Power (12h or 36h or 132h) - Power (-12h)) / Power 
(-12h))*100. The different relative power values for each subject on the different testing days 
were used to calculate the statistical differences between the two different groups on the four 
different testing days. 
 
Matlab 6.5 (The Mathworks Inc., Massachusetts, USA) and EEGlab v 5.02 (SCCN, 
University of California, San Diego, USA) were used to create topographical maps of the 
relative power on each day in each frequency. 
 
Recorded data are represented based on the 10:20 system. All electrodes are grouped 
according to electrode on the 10:20 system which represents the same area. For example 
the 10:20 electrode Fz is represented by electrodes 5, 6, 11 and 12 in the Net Station 
system (Figure 3.2). 
 
3.1.7 Other measurements 
 
Blood samples, biceps girth, resting elbow angle and a pain score were measured daily as 
previously described in chapter 2. For the blood sample 5 ml of blood were drawn from the 
right antecubital vein. These samples were stored (-20° C) and later analyzed to determine 
the serum creatine kinase (CK) activity in the blood (Beckman DU-62, Beckman Instruments, 
Fullerton, California, USA) as described previously 210. The girth of the left biceps was 
measured with a tape measure midway between the acromion and radial bony landmarks, 
that was marked with a permanent marker for repeatability purposes 210. Resting elbow 




Variable Control Experimental 
Age (years) 23 ± 4 23 ± 3 
Body mass (kg) 71.1 ± 8.8 72.7 ± 11.3 
Stature (cm) 171.7 ± 6.8 177.4± 8.0 
Body fat (%) 15.9 ± 4.9 13.4 ± 5.4 
Skinfolds (mm) 
Handedness (%) 
79 ± 37 
73 ± 20 
69 ± 38 
79 ± 19 
 
 
goniometer 210. Current pain perception was measured on a daily basis before the muscle 
function test with the use of a 10 cm visual analogue scale (VAS) 366. 
 
3.1.8 Statistical analysis 
 
An independent t-test was used to compare the descriptive data between experimental and 
control group, using STATISTICA 8.0 data analysis software (StatSoft, Inc. Tulsa, OK, USA).  
As some of the data sets in this study had an unequal variance, determined using Levene’s 
test of homogeneity of variance, it was decided to use non parametric statistical tests instead 
of the parametric ANOVA test. A Kruskal-Wallis test (H) compared the differences between 
the control and experimental group on each of the testing days in each electrode separately. 
A Friedman’s test (X2) was used to compare changes within each group over the repeated 
testing days in each electrode separately. A Dunn’s test was used for post-hoc analysis. 





3.2.1 Characteristics of subjects 
 
One participant did not finish the entire trial and was excluded from the study. Seven other 
participants were also excluded because they did not have sufficient EEG data epochs for 
further analysis. The remaining twenty eight participants were divided into two groups similar 
in weight, height, age, skinfold thickness and handedness (Table 3.1).  
 
Table 3.1: Descriptive data for the control (n = 12) and experimental groups (n = 16). Data are 













3.2.2 Muscle soreness 
 
The difference in pain in the left arm in the experimental and control group measured by the 
VAS scale is shown in Figure 3.3a. Peak pain in the experimental group occurred 36 hours 
after the EIMD inducing protocol (X2 = 53.66, p = 0.0001). A difference in pain between the 
two groups occurred at 12 (H = 7.48, p = 0.0062), 36 (H = 14.32, p = 0.0002), 60 (H = 10.21, 
p = 0.0014), 84 (H = 8.03, p = 0.0046) and 108 hours (H = 8.37, p = 0.0038). Significant 
changes in pain occurred in the experimental group compared to the baseline value at 12, 
36, 60 84 and 108 hours (X2 = 53.66, p = 0.0001) (Figure 3.3a). 
 
3.2.3 Arm circumference 
 
During the experiment there was a significant increase in the difference in girth between the 
exercised and rested arm in the experimental group compared to the control group at 36 (H 
= 7.23, p = 0.0072), 60 (H = 6.97, p = 0.0093), 84 (H = 5.36, p = 0.0207) and 108 hours (H = 
5.04, p = 0.0248). Significant changes in arm circumference were also found over time in the 
experimental group compared to the baseline value at 36, 60 and 84 hours (X2 = 27.04, p = 
0.01). The difference between the left and right biceps girth of the control group did not 
change throughout the experiment. The difference between the left and right biceps girth of 
the control group did not change throughout the experiment (Figure 3.3b). 
 
3.2.4 Resting elbow joint angle (muscle length) 
 
The difference in resting joint angle between the left and right arms in the control and the 
experimental group are shown in Figure 3.3c. There was a significant decrease in elbow joint 
angle in the experimental group until 84 hours after the EIMD inducing protocol (X2 = 42.46, 
p = 0.001). The difference in joint angle decreased in the experimental group compared to 
the control group from 12 hours and reached its minimum 36 hours (H = 7.34, p = 0.0067) 
after the EIMD inducing protocol. It remained decreased until 108 hours (H = 6.71, p = 
0.0096) after the EIMD protocol. No changes in the resting elbow joint angle over time were 
observed in the control group (Figure 3.3c). 
 
3.2.5 Serum creatine kinase activity 
 
The serum creatine kinase activity in the experimental group increased at 36 hours (H = 
3.90, p = 0.0484) in the experimental group and reached its highest values compared to the 
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control group at 84 (H = 3.99, p = 0.0456), 108 (H = 4.87, p = 0.0274) and 132 hours (H = 
5.27, p = 0.0217) after the EIMD protocol. Creatine kinase activity in the experimental group 
was only significantly increased compared to baseline at 108 and 132 hours (X2 = 20.27, p = 
0.0025). The serum creatine kinase activity in the control group did not change during the 



































(a) The change in current pain measured 
with by VAS over seven days is shown the 
control () and experimental () group.  
 
 
(b) The change in the difference in 
relaxed elbow girth (cm) between the left 
and right arm of the control () and 
experimental () group over seven days. 
 
 
(c) The change in the difference in elbow 
angle (degrees) between the left and right 
arm of the control () and experimental 
() group over seven days. 
 
 
(d) The change in creatine kinase activity 
(U.l-1) over seven days is shown the 
control () and experimental () group. 
 
 
(e) The maximal force output produced on 
seven consecutive days is shown in the 
control () and experimental () group.  
 
(* indicates results of the Kruskal-Wallis nonparametric test, # indicates results of the Friedman’s non parametric test)  
Data are presented as averages with standard deviations. 
 
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group, *** p < 0.001 control versus  
experimental group. 
# p < 0.05 post versus pre in the experimental group, ## p < 0.01 post versus pre in the experimental group, ### p < 0.005 post 




3.2.6 Muscle function 
Muscle function, as measured by MVC (Figure 3.3e), decreased significantly in the 
experimental group compared to the control group on all but one visit (108 hours) to the 
laboratory after the EIMD inducing protocol (p < 0.05). The largest decrease in maximal 
force output was observed within the first twelve hours after the EIMD protocol in the 
experimental group (H = 14.14, p = 0.0002) while there were no changes in the control group 
throughout the experiment. The force output in the experimental group remained different to 
that of the control group until the end of the trial (H = 5.61, p = 0.0179) (Figure 3.3 e). 
A difference was also observed in the force output of the experimental group over time at 12, 
36, 60 and 84 hours compared to the baseline measurement (X2 = 48.3, p = 0.001). There 
were no changes in the control group over time. 
3.2.7 Alpha-1 
Figure 3.4 and 3.5 show significant differences in α-1 activity between the control and 
experimental group at 12 and 36 hours after the exercise protocol. The greatest number of 
electrodes showing significant increases are seen 12 hours after the exercise protocol 
although changes remain at 36 hours especially in the electrodes overlying the motor and 
somatosensory areas (C3, Cz, and C4).  
3.2.7.1 Twelve hours 
At twelve hours after the EIMD protocol there was a widespread increase in α-1 activity over 
the motor and somatosensory area in the experimental group compared to the control group. 
This is seen especially at electrodes representing the areas surrounding C3, Cz and C4. To 
simplify the understanding of the results, electrodes have been placed into subgroups and 
labelled with the title of the closest electrode represented on the 10:20 system.  
Fz and F4 
Electrodes 6 (H = 4.97, p = 0.0259) and 113 (H = 4.56, p = 0.0327) placed on the frontal 



















Figure 3.4 The global change (%) of α-1 activity measured with 129 electrodes over the scalp is 
shown in the control (a) and experimental (b) group. An outline of the electrodes showing significant 
differences between the two groups (c) at each time point is also shown. 
 
T3 
A significant differences was found in electrode 47 (H = 4.56, p = 0.0327) which is located 
between C3 and T3. 
 
C3 
In the ipsilateral central area surrounding electrode C3 significant differences were seen in 
electrodes, 31 (H = 4.97, p = 0.0259), 32 (H = 6.29, p = 0.0122), 36 (H = 4.17, p = 0.0411), 
37 (H = 4.17, p = 0.0411), 38 (H = 8.02, p = 0.0046), 42 (H = 4.97, p = 0.0259), 43 (H = 7.76, 
p = 0.0053) and 48 (H = 5.61, p = 0.0179) where α-1 activity increases were significant in the 
experimental versus the control group. 
 
Cz 
Significant changes between the two groups were also seen over the vertex of the head in 
electrodes representing Cz. These electrodes are 7 (H = 6.28, p = 0.0122), 81 (H = 7.76, p = 
0.0053) and 129 (H = 8.28, p = 0.004). 
 
C4 
Significant differences occurred in the central area contralateral to the moving arm in 
electrodes 99 (H = 5.61, p = 0.0179), 104 (H = 8.28, p = 0.004), 105 (H = 5.61, p = 0.0179), 
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106 (H = 7.00, p = 0.0081) and 111 (H = 7.00, p = 0.0081). 
 
P3 and Pz 
There were significant differences in electrode 53 (H = 3.99, p = 0.0459), representing P3 
and also electrode 55 (H = 8.28, p = 0.004) representing Pz. 
 
T4 
Further down in the temporal areas there was a significant difference between groups 
(electrode 103; H = 7.77, p = 0.0053). 
 
 
Figure 3.5 Nine different electrodes representative of the change (%) of α-1 activity in the frontal, 
central and parietal areas of the brain. Each of the electrodes represents a location on the 10:20 
system.  
---- 
(* indicates results of the Kruskal-Wallis nonparametric test) 







3.2.7.2 Thirty-six hours 
Thirty-six hours after the EIMD inducing protocol differences were still observed between the 
experimental and control group, especially in the electrodes overlying the medial motor area.  
 
Cz 
The largest differences were recorded in the three electrodes surrounding the vertex area, 




Differences occurred between the experimental and the control group at electrodes 32 (H = 
5.83, p = 0.0158) and 38 (H = 4.76, p = 0.0291) in the motor area ipsilateral to the 
movement (between C3 and Cz). 
 
C4 
Differences occurred between the groups in electrode 99 (H = 6.76, p = 0.0093). 
 
3.2.7.3 One hundred and thirty-two hours 
No differences were observed in α-1 activity between the two groups at 132 hours. 
 
3.2.8 Alpha-2  
 
Figures 3.6 and 3.7 show that there are significant differences in the α-2 activity between the 
control and experimental group at 12 and 36 hours after the induction of EIMD.  
 
3.2.8.1 Twelve hours 
At twelve hours after the EIMD protocol the differences between control and experimental 
group were seen on the contralateral frontal side of the cortex as well as on the ipsilateral 
side along the F3, C3 and P3 axis. 
 
F3 
In the ipsilateral frontal area only one electrode was significantly different, electrode 29 (H = 
4.56, p = 0.0327). 
 
Fz 




12 (H = 3.99, p = 0.0459) were significantly different between the two groups. 
 
F4 
In the contralateral frontal area electrodes 112 (H = 6.28, p = 0.0122), 113 (H = 7.25, p = 
0.0071), 118 (H = 9.97, p = 0.0016), 119 (H = 4.76, p = 0.0291) and 124 (H = 5.61, p = 
0.0179) there were significant differences between the groups while in the ipsilateral frontal 

















Figure 3.6 The global change (%) of α-2 activity measured with 129 electrodes over the scalp is 
shown in the control (a) and experimental (b) group. An outline of the electrodes showing significant 




Differences between groups occurred in the ipsilateral central area at electrode 42 (H = 6.52, 
p = 0.0107), 43 (H = 4.97, p = 0.0259) and 48 (H = 6.52, p = 0.0107). 
 
Cz 
In the medial central area at electrodes 107 (H = 6.52, p = 0.0107) and 129 (H = 4.76, p = 
0.0291) there were differences between the groups.  
 
C4 
In the contralateral central area surrounding C4 there were differences between groups at 
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The difference between groups occurred in the parietal area at 52 (H = 7.50, p = 0.0062) and 
60 (H = 4.17, p = 0.0411). 
 
Pz 
Of the electrodes representing Pz only electrode 55 (H = 5.61, p = 0.0179) showed 
significant differences between the groups. 
 
Figure 3.7 Nine different electrodes representative of the change (%) of α-2 activity in the frontal, 
central and parietal areas of the brain. Each of the electrodes represents a location on the 10:20 
system. 
----  
(* indicates results of the Kruskal-Wallis nonparametric test) 
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group 
 
 
3.2.8.2 Thirty-six hours 
At 36 hours after the exercise protocol significant changes between the experimental and 
Chapter 3 
87 
control group were localized and only found in the electrodes contralateral to the movement. 
C4  
Significant differences between groups occurred in electrode 88 (H = 4.17, p = 0.0411), 105 
(H = 6.52, p = 0.0107) and 111 (H = 4.97, p = 0.0259). 
P4 
There were significant differences between groups in electrode 87 (H = 6.28, p = 0.0122). 
3.2.8.3 One hundred and thirty-two hours 
No differences were observed in the α-2 activity between the two groups at 132 hours. 
3.3 DISCUSSION 
The first finding of this study was that the EIMD protocol resulted in similar physiological 
responses (Figure 3.3) reflecting muscle damage in the experimental group as previously 
reported in chapter 2 (page 59). 
In particular the symptoms of EIMD (swelling, muscle shortening and CK activity) changed in 
the typical way for the duration of the experiment (Figure 3.3a-d). Also, muscle function 
(force output) was impaired immediately after the EIMD protocol 339 and gradually recovered, 
but did not return to baseline by 132 hours (Figure 3.3e). Pain on the other hand 
progressively increased, peaking around 36 to 60 hours and was decreasing at 132 hours. 
The following sections will discuss α-1 and α-2 activity separately, as the two bands have 
shown to be active in different cortical areas. It is acknowledged that deducing functional and 
anatomical associations from EEG data is challenging, but the clustering of significant 
differences in certain areas does support the association with areas and functionality. 
3.3.1 Alpha 1 
The participants with symptoms of EIMD experienced an increase in cortical α-1 activity 
(Figure 3.4 and 3.5) while performing a series of brisk biceps brachii contractions. The 
increase in the experimental group was most noticeable at twelve hours after EIMD induction 
(Figure 3.4b) and activity had decreased, although it was still significantly different between 
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the two groups, by 36 hours post (Figure 3.4b and c). The difference in activity between the 
groups was most pronounced in electrodes overlying the motor and somatosensory cortex 
(Figure 3.4c). 
Heightened α-1 activity in the somatosensory and motor cortex has previously been 
associated with movement planning 10, as well as increased consciousness and perception 
274. Altered perception is suggested to lead to the increased α-1 activity as a response to 
changed peripheral bottom-up feedback. Feedback about changes in peripheral 
neuromuscular function (greater movement unsteadiness, increased submaximal EMG 
activity and decreased force output 339) is integrated and processed by the central nervous 
system, including the cortical areas. 
 
 The increase in α-1 activity could also be a result of precise movement planning and 
execution in the motor and somatosensory cortex to compensate (feed-forward) for the loss 
in neuromuscular function whilst experiencing the symptoms of EIMD.  
 
As previously shown in chapter 2 submaximal EMG activity increases within the first 12 to 36 
hours after the induction of EIMD, while maximal EMG and force output decrease. It has 
been suggested that the increased submaximal EMG activity is due to increased neural drive 
initiated by the central nervous system 240, 339. Thus our current findings of increased cortical 
α-1 activity in electrodes overlying the motor and somatosensory area together with the 
previous findings of increased submaximal and decreased maximal EMG activity at 12 and 
36 hours post-EIMD, support our hypothesis that the motor and somatosensory cortex act as 
a compensatory upstream regulator of motor control while experiencing EIMD.  
 
While it cannot be clearly stated what causes the increases in α-1 activity over the motor and 
somatosensory area in the EIMD group it is suggested that increased cortical α-1 activity 
might be necessary to counteract the loss of movement steadiness and force output whilst 
experiencing EIMD. Due to the recording of α-1 activity in this proximal location this leads to 
the assumption that this may be a cortical top- down regulator of peripheral function. 
Therefore the increased α-1 activity could be part of an upstream regulatory mechanism of 
motor perception, activation and neuromuscular function.  
 
3.3.2 Alpha 2 
 
Whilst α-1 activity increased in the motor and somatosensory areas, α-2 activity increased in 




Alpha-2 activity peaked at twelve hours (Figure 3.6 and 3.7), when neuromuscular function 
was already disturbed although the main sensation of pain was yet to develop. At 36 hours 
post-EIMD induction α-2 activity remained elevated in the contralateral centro-parietal area. 
Pain peaked at 36 hours whilst α-2 activity decreased again towards pre-EIMD values.  
 
It has previously been shown that α-2 activity increases due to interactions between the 
frontal and parietal cortical areas. Palva and Palva 274 and Halgren et al. 161 proposed that 
this fronto-parietal α synchrony is associated with focused attention, working memory, 
conscious perception, cognition and action. As this is assumed to be the most proximal level 
of control, this fronto-parietal α synchrony is known to act as a top-down regulator for 
subcortical and peripheral information integration processes 393. 
 
Klimesch et al. 198 have further suggested that increased α-2 activity in cortical areas causes 
an inhibition of information retrieval from the involved areas. Hence the authors suggested 
the increase in α activity to be an inhibitory top-down control mechanism of information 
integration processes. A similar cortical top-down regulator has been suggested for pain 74, 
stating that the painful signal is perceived and incorporated at different frequency levels and 
areas of the cortex, with the somatosensory and the frontal cortex playing an important part.  
 
Further research by Kakigi and Lagopoulos 186, 207 showed that meditation increased α-2 
activity whilst simultaneously decreasing the sensation of pain. Following this trend Babiloni 
et al. 19 showed that α-2 activity decreases in the contralateral hemisphere with the induction 
of a combined stimulus of pain and movement 19. In addition the perception of pain, 
especially limb pain, has been further localized to the dorsolateral prefrontal, the primary 
somatosensory, motor and supplementary motor cortex 228.  
 
The above findings support the existence of a relationship between increased α-2 activity in 
the contralateral pre-motor, motor and somatosensory cortex and the subsequent inhibited 
perception of pain twelve hours post-EIMD induction 114, 228, 274, 393. Therefore an increased α-
2 activity in our cohort might be responsible for the dissociation between the sensation of 
pain and the changes in neuromuscular function caused by EIMD. This is of clinical 
importance as pain during the first twelve hours after the induction of EIMD does not reflect 
on the amount of damage caused. 
 
Therefore we propose that an increased contralateral fronto-central α-2 activity acts as a 
cortical top-down regulator of the perception of pain twelve hours post-EIMD induction and 
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therefore leads to the delayed–onset pain response associated with EIMD. There was a 
visible increase in α-2 activity in the control group at 132 hours (Figure 3.6b), but this was 
not significant. We suggest that these changes are a consequence of a learning or 
familiarization phenomenon, although we have no descriptive data to confirm this. As a 
result of repetitive testing sessions control participants probably had a lower attentiveness 
and increased movement automation 420. An increase in α-1 and -2 is associated with this 
lower attentiveness 327. 
 
3.3.3 Limitations and future research  
 
This study explored the relationship between the neuromuscular changes and pain induced 
by an EIMD protocol and associated changes in cortical α-1 and α-2 activity. However our 
study investigated changes in induced α activity, rather than event related α activity and 
therefore includes, pre movement, movement and post movement recordings. The aim was 
to investigate the influence of pain and changed neuromuscular function on α activity during 
a movement task. Also our data were not baseline corrected but rather compared to pre-
EIMD protocol values to identify differences in activity between the groups post- versus pre-
EIMD induction. Therefore it is acknowledged that other factors such as changes in pain 
pathways or inflammatory processes could have lead to the dissociated response of 
neuromuscular changes and the delayed pain response, but the interest of this study was 
how EIMD and its associated symptoms affected the α-1 and α-2 activity measured over the 
cortical areas. Further research is needed to integrate not only the pain and neuromuscular 
response with the EEG recordings but also possible inflammatory changes and adaptations 
in the pain pathways. Future studies should consider correlations between EMG and EEG, 




Therefore it is proposed that the increase in α-1 activity, twelve hours after the EIMD 
protocol, may be part of a neurocognitive top-down regulator of neuromuscular function 186, 
198, 300, 326, and that α-2 activity may be a cortical top-down regulator that suppresses the 
sensation of pain during the first twelve hours of experiencing EIMD 186, 198, 326.  
 
 
CHAPTER 4  
 
 
THE RESPONSE OF CORTICAL BETA ACTIVITY TO 
PAIN AND NEUROMUSCULAR CHANGES CAUSED 






As has been shown in the previous chapters EIMD leads to a decrease in force and 
EMG output during a MVC, and an increase in EMG activation during submaximal 
contractions with these changes lasting up to 132 hours post-EIMD induction 300, 301, 339,
385. The change in neuromuscular function, immediately after EIMD induction, is
caused by a reduction of voluntary activation either at the level of the spinal cord or
motor cortex 296, 300. These changes occur independently of the soreness caused by
EIMD 300.
During voluntary movement, efferent output from the brain to the muscle is guided by 
the motor cortex 22, 49, 83, 148, 157, 300. One of the frequencies in the brain associated with 
voluntary movement is the 15–35 Hz band 13, 64, 83. This frequency, known as β activity, 
is usually pronounced in the motor and somatosensory areas of the cortex and has 
been linked to motor performance 104, 119, 145, 217, 247, 249, 270 due to the measurement of 
synchronized 15–30 Hz activity in the muscle, peripheral and central nervous system 
12, 13, 64, 83 during isometric and dynamic muscle contractions. Due to the large 
frequency range covered by the β activity, the band has been divided into two sub 
bands, the β-1 activity at 15–20 Hz and the β-2 activity at 21–35 Hz, which display 
different responses to external stimuli 68-70, 73, 250.  
Studies have shown that the motor cortex and motor units fire in coherence at a 
frequency between 15–30 Hz (i.e. in the β-1 and -2 activity range) during a steady 
state contraction 64, 83, 199. These coherent oscillations are observed in the motor, 
somatosensory and pre-motor cortex during a steady state muscle contraction 22, 49, 199. 
Beta activity is usually decreased before and during movement action 285 and 
increases after the movement has ended or as an isometric contraction is maintained 
over several seconds 63, 83, 119, 191, 280, 285. 
However, recent studies suggest that increased β-1 and -2 activity is not only important 
for the maintenance of steady state contractions but is also required for the efficient 
processing of peripheral feedback required to maintain the status quo by means of 
constant recalibration of the motor and somatosensory system 22, 49, 152, 199, 208, 
especially while maintaining low force contractions 12, 13, 22, 62, 64, 300, 339, 398. Further it has 
been shown that the coherence between the EEG and EMG activity in the 15–30 Hz 
range is positively correlated to force output 64, 193, 194. 
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During EIMD this peripheral feedback might be disturbed, as it has been shown that 
EIMD, as well as muscular pain in the biceps brachii, lead to a loss of proprioception, 
motor perception as well as neuromuscular function and motor recruitment 301, which in 
turn could lead to a compensatory increase in β activity in the associated cortical areas 
5, 13, 208, 249, 386.  
 
Movement perception, proprioception, motor planning and learning 5, 208, 249, 386 are 
associated with the pre-motor, supplementary motor and parietal area of the brain, all 
of which display strong β-1 and -2 activity during movement 104, 249. 
 
EIMD not only causes changes in neuromuscular function and proprioception but also 
induces muscular pain. It has been shown previously that tonic muscle pain, which is 
comparable to EIMD induced pain, leads to an inhibition of motor evoked potentials in 
the contralateral motor cortex and therefore leads to a reduction in cortical and spinal 
motor neuron excitability 214. It has been found that tonic heat pain in the arm leads to 
an increase in β-1 activity in the frontal and ipsilateral temporal region 68, 74, 175, while β-
2 activity increases globally with non-exercise-induced muscle pain 69, 70. However, 
other studies have not shown conclusive evidence that pain has an impact on β-1 or β-
2 activity at all 66.  
 
To clarify the inconsistencies in these studies we aim to investigate the relationship 
between the symptoms of EIMD and cortical β-1 and -2 activity during a submaximal 
movement for up to 132 hours following an exercise protocol design to cause EIMD. Of 
special interest is not only the effect of the neuromuscular changes, but also the effect 
of the sensation of pain on the β-1 activity and β-2 activity. We hypothesise that β-1 
and -2 activity in electrodes overlying the frontal and parietal area will be increased 
during EIMD to compensate for loss of neuromuscular function and to integrate the 





Thirty-seven right-handed male participants, aged 21-40 years, were recruited for this 
study. Handedness was determined by the Edinburgh handedness inventory 
(Appendix 1) 271. Participants matched for age, height, weight, body fat and skinfold 




be free of any upper body injuries and were not participating in any upper body training 
during the last twelve weeks before the study. This included the engagement in 
exercises involving specific muscle lengthening under tension movements. 
 
Prior to being informed about the study design, participants had to sign an informed 
consent form and complete a Physical Activity Readiness Questionnaire (Par-Q) 
(Appendix 2) 7. They were also asked to complete questionnaires about their injury 
(Appendix 3) and training history (Appendix 4). Participants were informed about the 
study design, familiarized with the equipment and signed the consent form before 
starting the study (Appendix 5). The study was approved by the Human Ethics 
Committee of the Faculty of Health Science, University of Cape Town (Appendix 6). 
The principles outlined by the Declaration of Helsinki for the use of Humans were 
adopted in this study 410. 
 
4.2.1 Study design 
 
Before the start of the study all participants were familiarized with the testing 
equipment and different test protocols. Figure 4.1 is a time line depicting the order of 
tests performed over the seven day testing period. To minimize the effect of circadian 
rhythm on any of the outcome measures, all tests were scheduled at the same time of 
the day (within 60 minutes). This however was not possible for the measurement at 












Figure 4.1: Timeline of measurements. The EIMD indicators include, pain, arm circumference, 
elbow angle, serum creatine kinase activity  
 
Twelve hours before the start of exercise protocol (see also Figure 4.1), stature, body 
mass, body fat percentage and skinfolds of each participant was measured. In addition 
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resting elbow angle, elbow muscle function (MVC), biceps girth and pain scores were 
measured. A blood sample was taken to determine creatine kinase activity. 
 
EEG activity was measured during a self-initiated self-paced flexion-extension 
movement. In contrast to all the above mentioned measurements that were conducted 
at -12, 12, 36, 60, 84, 108 and 132 hours EEG measurement were only captured at -
12, 12, 36 and 132 hours (Figure 4.1). These measurements were time consuming for 
the participants and there was concern about poor compliance if they were required to 
be tested more frequently.  
 
4.2.2 Exercise protocol 
 
Twelve hours after baseline testing, the subjects in the experimental group completed 
an EIMD inducing protocol. In brief, participants were asked to resist the lengthening 
movement of the left biceps (5 sets of 25 movements; see also ‘muscle function tests’ 
section for set up of the Biodex (Biodex pro 3, New York, USA)). The resistance to 
these movements was set on a Biodex dynamometer at 80% of each subject’s 
maximum isometric contraction torque, as this has been shown to induce EIMD in the 
previous two chapters. The control group did not perform this exercise protocol.  
 
4.2.3 Muscle function tests 
 
The muscle function tests consisted of a MVC measurement and a self-paced 
submaximal flexion-extension movement. The experimental and the control group 
performed these muscle function tests. 
 
The MVC was measured using a Biodex dynamometer while performing elbow flexion 
of the left arm. For this, the participant sat in the chair of the Biodex dynamometer with 
their upper body and left upper arm securely strapped to the dynamometer, while the 
left forearm was only able to move in the sagittal plane (flexion-extension). In this 
position, participants were able to freely flex and extend their elbow over a range of 
approximately 120°, without hyper-extending the elbow. The rotation axis of the 
dynamometer was aligned with the lateral epicondyle of the humerus, while the 
forearm was fixed into a fully supinated position. This ensured that the flexion-
extension movement was carried out in the transversal axis and sagittal plane. 
Participants were asked to perform three 5 second MVC’s interspaced by 60 second 
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recovery periods, as previously described in chapter 2. 
 
The submaximal flexion-extension movements were not performed on the Biodex, but 
rather the participants were seated on a standard armless-chair. The left arm was 
relaxed and hanging by their side, while the right arm was resting on the participants 
lap. For the submaximal self-paced flexion- extension movements all participants wore 
a 1kg wrist strap and movements were performed in the sagittal plane between elbow 
angles of 180° and 90°. In addition, the upper body and upper arm were positioned as 
described in the MVC set-up for standardization purposes. Participants were asked to 
perform 75 repetitions, which were interspaced by 5–10 second recovery periods with 
slightly longer rest periods after each 25 repetitions (during which EEG data were not 
recorded). 
 
4.2.4 Electroencephalographic study procedure 
 
The EEG data were obtained in a darkened, sound-attenuated, temperature controlled 
room to minimize the effect of confounding factors. Participants were instructed how to 
perform the self-paced flexion and extension movements. EEG activity was measured 
during the 75 submaximal, fast self-paced flexion and extension movements. In 
addition, subjects were asked to keep their eyes open and focused on a fixed spot on 
the wall during the submaximal self-paced movements.  
 
4.2.5 Electroencephalographic recording 
 
An EEG net with 128 recording sites plus a vertex reference electrode (electrode 129) 
Electrical Geodesic ™ system (Electrical Geodesics, Inc, Oregon, USA) 32, which 
measures the electrical activity on the surface of the scalp, was fitted onto each 
participant (see Figure 4.2 for an electrode layout). The impedance of all electrodes 
was maintained below 50 kΩ as suggested by the manufacture of the EGI system and 
different technical references 32, 190, 256 due to the high input resistance of the EEG 
amplifier. Specially designed amplifiers processed the high impedance signal. EEG 
was recorded using a 0.1–50 Hz bandpass filter (3 dB attenuation) 256. The signals 
were sampled at 250 Hz 32, 256. All recordings were initially referenced to the central 
reference electrode (Cz/129) 32, 256. The EEG system was connected to an 


























Figure 4.2 A layout of the EGI 129 channel system overlaid by the 10:20 electrode system 
(dark grey circles). Ellipses represent the following gross cortical areas: grey (Frontal), green 
(Pre-motor), orange (Supplementary Motor), blue (Motor), red (Somatosensory), yellow 
(Parietal), purple (Occipital). 
 
4.2.6 Electroencephalographic data analysis 
 
The raw EEG data were 50 Hz notch filtered as well as 1-40 Hz band pass filtered. 
Following this the data for each trial were segmented into three second epochs 374. 
Data were collected continuously during the pre-movement, movement and rest phase 
and therefore represent the common state of the brain during a biceps brachii 
movement protocol rather than a movement induced change. 
 
The EEG was re-referenced against an average reference 32, 34, 190, which made data 
recorded in the reference electrode (Cz/129) available for analysis. The EEG recording 
was monitored for movement, eye movement, blink artefacts, and noise by an 




exceeded 140 μV and the eye movement threshold exceeded 55 μV. Ocular artefacts 
were also detected by a slope threshold, if the slope of a channel increased more than 
14 μV.ms-1 the channel was discarded within that epoch 418. The amplitude of a given 
channel was excluded in that epoch if it exceeded 150 μV, and in such a case replaced 
by an estimate calculated of the values of the surrounding channels. This was 
performed by computer algorithms built into the Net Station software version 4.2.3, 
(Electrical Geodesics, Inc, Oregon, USA) 256.  
After the automated artefact rejection algorithm all epochs were also visually inspected 
offline and the recordings in which artefacts could not be removed were manually 
discarded before further data analysis took place. 
While shorter epochs might reveal the relationship between, for example, spectral 
estimates or time-locked events, our intent was to characterize background brain 
states (induced activity) rather than specific components of event related processing 
382. Subjects who had less than 40 usable, artefact-free epochs per trial day were
excluded from further analysis. A FFT with a Welchen window was performed to obtain
the spectral information of an epoch of each subject. Hereafter the data were exported
to Microsoft Excel© and each subject’s data were averaged before further analysis.
The different frequency bands used in this study were as follows: β-1 (13.67–18.55 Hz) 
and β-2 (19.35–35.16 Hz). Thereafter the relative power (activity) for each frequency 
on each day was calculated with the following formula: ((Power (12h or 36h or 132h) - 
Power (-12h)) / Power (-12h))*100. The different relative power values for each subject 
on the different testing days were used to calculate the statistical differences between 
the two different groups on the four different testing days. 
Matlab 6.5 (The Mathworks Inc., Massachusetts, USA) and EEGlab v 5.02 (SCCN, 
University of California, San Diego, USA) were used to create topographical maps of 
the relative power on each day in each frequency. 
Recorded data are represented based on the 10:20 system. All electrodes are grouped 
according to electrode on the 10:20 system which represents the same area. For 
example the 10:20 electrode Fz is represented by electrodes 5, 6, 11 and 12 in the 
Netstation system (Figure 4.2). 
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4.2.7 Other measurements 
Blood samples, biceps girth, resting elbow angle and a pain score were measured 
daily as previously described in chapter 2. For the blood sample 5 ml of blood were 
drawn from the right antecubital vein. These samples were stored (-20° C) and later 
analyzed to determine the serum creatine kinase (CK) activity in the blood (Beckman 
DU-62, Beckman Instruments, Fullerton, California, USA) as described previously 210. 
The girth of the left biceps was measured with a tape measure midway between the 
acromion and radial bony landmarks, that was marked with a permanent marker for 
repeatability purposes 210. Resting elbow angles, and by implication the resting length 
of the biceps muscle were measured with a goniometer 210. Current pain perception 
was measured on a daily basis before the muscle function test with the use of a 10 cm 
visual analogue scale (VAS) 366. 
 
4.2.8 Statistical analysis 
 
An independent t-test was used to compare the descriptive data between experimental 
and control group, using STATISTICA 8.0 data analysis software (StatSoft, Inc. Tulsa, 
OK, USA). As some of the data sets in this study had an unequal variance, determined 
using Levene’s test of homogeneity of variance, it was decided to use non parametric 
statistical tests instead of the parametric ANOVA test. A Kruskal-Wallis test (H) 
compared the differences between the control and experimental group on each of the 
testing days in each electrode separately. A Friedman’s test (X2) was used to compare 
changes within each group over the repeated testing days in each electrode 
separately. A Dunn’s test was used for post-hoc analysis. Statistical significance was 





4.3.1 Characteristics of subjects 
 
One participant did not finish the trial and was excluded from the study. Seven other 
participants were also excluded because they did not have sufficient EEG data epochs 
for further analysis. The remaining twenty eight participants were divided into two 




Table 4.1: Descriptive data for the control (n = 12) and experimental groups (n = 16). Data are 
expressed as mean ± SD. 
4.3.2 Muscle soreness 
The difference in pain in the left arm in the experimental and control group measured 
by the VAS scale is shown in Figure 4.3a. Peak pain in the experimental group 
occurred 36 hours after the EIMD inducing protocol (X2 = 53.66, p = 0.0001). A 
difference in pain between the two groups occurred at 12 (H = 7.48, p = 0.0062), 36 (H 
= 14.32, p = 0.0002), 60 (H = 10.21, p = 0.0014), 84 (H = 8.03, p = 0.0046) and 108 
hours (H = 8.37, p = 0.0038). Significant changes in pain occurred in the experimental 
group compared to the baseline value at 12, 36, 60 84 and 108 hours (X2 = 53.66, p = 
0.0001) (Figure 4.3a). 
4.3.3 Arm circumference 
During the experiment there was a significant increase in the difference in girth 
between the exercised and rested arm in the experimental group compared to the 
control group at 36 (H = 7.23, p = 0.0072), 60 (H = 6.97, p = 0.0093), 84 (H = 5.36, p = 
0.0207) and 108 hours (H = 5.04, p = 0.0248). Significant changes in arm 
circumference were also found over time in the experimental group compared to the 
baseline value at 36, 60 and 84 hours (X2 = 27.04, p = 0.01). The difference between 
the left and right biceps girth of the control group did not change throughout the 
experiment (Figure 4.3b). 
Variable Control Experimental 
Age (years) 23 ± 4 23 ± 3 
Body mass (kg) 71.1 ± 8.8 72.7 ± 11.3 
Stature (cm) 171.7 ± 6.8 177.4± 8.0 
Body fat (% 15.9 ± 4.9 13.4 ± 5.4 
Skinfolds (mm) 79 ± 37 69 ± 38 











































a: The change in current pain 
measured with the VAS scale over 
sevendays is shown the control () 




b: The change in the difference in 
relaxed elbow girth (cm) between the 
left and right arm of the control () 





c: The change in the difference in 
elbow angle (degrees) between the 
left and right arm of the control () 





d: The change in creatine kinase 
activity (U.l-1) over seven days is 
shown the control () and 




e: The maximal force output 
produced on seven consecutive days 
is shown in the control () and 
experimental () group.  
 
 
f: Percentage change of EMG 
amplitude produced during a low 
force isometric contraction with a 1 
kg wrist weight normalized to the 
maximal EMG amplitude measured 
on four different occasions in the 




(* indicates results of the Kruskal-Wallis 
nonparametric test, # indicates results of the 
Friedman’s non parametric test)  
 
Data are presented as averages with standard 
deviations. 
 
 * p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group, *** p < 0.001 control 
versus experimental group, # p < 0.05 post versus pre in the experimental group, ## p < 0.01 post versus pre in the 





4.3.4 Resting elbow joint angle (muscle length) 
 
The difference in resting joint angle between the left and right arms in the control and 
the experimental group are shown in Figure 4.3c. There was a significant decrease in 
elbow joint angle in the experimental group until 84 hours after the EIMD inducing 
protocol (X2 = 42.46, p = 0.001). The difference in joint angle decreased in the 
experimental group compared to the control group from 12 hours and reached its 
minimum 36 hours (H = 7.34, p = 0.0067) after the exercise protocol. It remained 
decreased until 108 hours (H = 6.71, p = 0.0096) after the exercise protocol. No 
changes in the resting elbow joint angle over time were observed in the control group 
(Figure 4.3c). 
 
4.3.5 Serum creatine kinase activity 
 
The serum creatine kinase activity in the experimental group increased at 36 hours (H 
= 3.90, p = 0.0484) and reached its highest values compared to the control group at 84 
(H = 3.99, p = 0.0456), 108 (H = 4.87, p = 0.0274) and 132 hours (H = 5.27, p = 
0.0217) after the EIMD inducing protocol. Creatine kinase activity in the experimental 
group was only significantly increased compared to baseline at 108 and 132 hours (X2 
= 20.27, p = 0.0025). The serum creatine kinase activity in the control group did not 
change during the experiment (Figure 4.3d). 
 
4.3.6 Muscle function 
 
Muscle function, as measured by MVC (Figure 4.3e), decreased significantly in the 
experimental group compared to the control group on all but one visit (108 hours) to 
the laboratory after the EIMD inducing protocol (p < 0.05). The largest decrease in 
maximal force output was observed within the first twelve hours after the EIMD 
protocol in the experimental group (H = 14.14, p = 0.0002) while there were no 
changes in the control group throughout the experiment. The force output in the 
experimental group remained different to that of the control group on all days but one 
day until the end of the trial (132 hours; H = 5.61, p = 0.0179) (Figure 4.3e). 
 
A difference was also observed in the force output of the experimental group over time 
at 12, 36, 60 and 84 hours compared to the baseline measurement (X2 = 48.3, p = 
0.0001). There were no changes in the control group over time. 
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4.3.7 EMG activity 
 
The electromyographic activity during a submaximal isometric low force contraction is 
shown in Figure 4.3f. The data are displayed as normalized to the EMG during the 
maximal force output and as a percentage change compared to twelve hours pre-EIMD 
protocol. There was a tendency towards a significant difference between the groups at 
twelve hours (H = 3.81, p < 0.051).  
 
4.3.8 EEG results 
4.3.8.1 Beta-1 
Beta-1 activity was different between the experimental and control group in the frontal, 
central and parietal area at twelve hours post EIMD. The central differences are 
represented stronger on the ipsilateral compared to the contralateral side. These 
differences can still be seen 36 hours after the EIMD inducing protocol but were not as 
widespread and mainly focused in the contralateral frontal, ipsilateral central and 
contralateral parietal areas. Differences persisted 132 hours post-EIMD induction in the 
contralateral frontal and the parietal areas (Figures 4.4 and 4.5). To simplify the 
understanding of the results, electrodes have been placed into subgroups and labelled 
















Figure 4.4 The global change (%) of β-1 activity measured with 129 electrodes over the scalp is 
shown in the control (a) and experimental (b) group. An outline of the electrodes showing 




4.3.8.1.1 Twelve hours 
At twelve hours post-EIMD induction the differences between the control and 
experimental group were widespread over the frontal, ispilateral central and parietal 
areas (Figure 4.4 and 4.5) of the cortex. In particular the changes recorded in the 
frontal electrodes were widespread and recorded over the supplementary and pre-
motor areas.  
 
Fz 
Differences between groups were very pronounced in the electrodes surrounding the 
Fz area. The electrodes showing significant differences caused by an increase in 
activity in the experimental group were electrodes 4 (H = 5.39, p = 0.0203), 5 (H = 
6.52, p = 0.0107), 6 (H = 7.25, p = 0.0071), 11 (H = 5.61, p = 0.0179), 12 (H = 4.56, p = 
0.0327) and 13 (H = 4.36, p = 0.0367), all directly surrounding the Fz area and 
therefore representing electrical activity changes above the supplementary motor area. 
 
F4 
Differences between groups are also seen in the in the contralateral frontal area in 
electrodes 113 (H = 8.02, p = 0.0046), 118 (H = 4.76, p = 0.0291), 119 (H = 7.76, p = 




Differences in the ipsilateral central area occurred in electrodes 38 (H = 4.56, p = 
0.0327), 42 (H = 6.05, p = 0.0139), 43 (H = 4.76, p = 0.0291) and 48 (H = 3.99, p = 
0.0459). These electrodes overlay the motor and somatosensory areas and differences 
between groups are caused by a decrease in activity in the control group rather than 
an increase in activity in the experimental group.  
 
Cz 
The electrodes covering the vertex of the head, such as electrodes 7 (H = 6.05, p = 
0.0139), 81 (H = 5.61, p = 0.0179), 107 (H = 7.00, p = 0.0081) and 129 (H = 4.76, p = 
0.0291) also showed significant differences between the groups at twelve hours after 






Figure 4.5 Twelve different electrodes representative of the change (%) of β-1 activity in the 
frontal, central and parietal areas of the brain in the control () and experimental () group. 
Each graph is labelled with the corresponding electrode number. The vertical dotted line marks 
the time of the EIMD inducing protocol in the experimental subjects. 
---- 
(* indicates results of the Kruskal-Wallis nonparametric test, # indicates results of the Friedman’s non parametric test) 
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group 
# p < 0.05 at 12 and 36 hours post versus pre in the control group, ## p < 0.01 at 12 hours post versus pre in the control 
group,### p < 0.001 at 36 hours post versus pre in the control group 
 
P3 
Differences in activity between the groups also occurred in the ipsilateral parietal area 
seen in electrodes 52 (H = 7.76, p = 0.0053), 53 (H = 8.55, p = 0.0034), 60 (H = 6.52, p 
= 0.0107), 61 (H = 6.05, p = 0.0139) and 67 (H = 4.17, p = 0.0411).  
 
Pz 
Differences were further observed in electrodes surrounding the parietal area 
represented by Pz. Electrodes 62 (H = 4.56, p = 0.0327), 54 (H = 4.17, p = 0.0411) and 






Differences between groups also occurred in electrodes on the contralateral side to the 
movement in electrodes 87 (H = 4.76, p = 0.0291) and 79 (H = 3.99, p = 0.0459). 
O1 and O2 
There were significant differences in the occipital region at electrodes 72 (H = 4.76, p = 
0.0291), 73 (H = 5.83, p = 0.0158) representing O1 as well as 77 (H = 6.05, p = 
0.0139), 84 (H = 9.67, p = 0.0019), 85 (H = 10.86, p = 0.0010) representing O2. 
Differences over time in the control group 
P3 
A decrease in the β-1 activity was also observed in the ipsilateral parietal area of the 
control group compared to the baseline measurement in electrodes 48 (X2 = 13.2, p = 
0.05), 52 (X2 = 16.3, p = 0.05), 53 (X2 = 13.5, p = 0.05), 54 (X2 = 13.1, p = 0.05) and 61 
(X2 = 12.7, p = 0.05).  
Differences over time in the experimental group 
There were no changes in the experimental group over time. 
4.3.8.1.2 Thirty-six hours 
F3 and F4 
At 36 hours after the exercise protocol significant changes between the experimental 
and control group were more localized and mainly found in the ipsilateral (F3) 
electrodes 25 (H = 4.36, p = 0.0367) and 29 (H = 4.36, p = 0.0367) and over the 
contralateral pre-motor area (F4) in electrodes 113 (H = 4.56, p = 0.0327) and 119 (H = 
4.17, p = 0.0411). 
Cz and C3 
Significant differences were also found around the vertex 7 (H = 4.56, p = 0.0327) and 
81 (H = 4.17, p = 0.0411) and also in electrode 42 (H = 4.97, p = 0.0259) representing 
C3. 
P3 and Pz 
Differences between groups occurred in the ipsilateral parietal area (P3) at electrodes 
52 (H = 5.61 p = 0.0179), 53 (H = 5.39, p = 0.0203) and 61 (H = 5.61, p = 0.0179) as 
well as the central parietal area (Pz) at electrodes 54 (H = 6.28, p = 0.0122), 62 (H = 
6.52, p = 0.0107), 68 (H = 5.83, p = 0.0158), 73 (H = 5.83, p = 0.0158) and 80 (H = 
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6.52, p = 0.0107).  
 
P4 
In the contralateral parietal electrodes 78 (H = 3.99, p = 0.0459) and 79 (H = 5.83, p = 
0.0158), 87 (H = 5.39 p = 0.0203) and 92 (H = 6.76 p = 0.00093) showed significant 
differences between groups. 
 
O2 
Significant differences occurred in the occipital region in electrodes 77 (H = 4.76 p = 
0.0291), 84 (H = 4.36, p = 0.0367) and 85 (H = 5.61, p = 0.0179). 
 
Differences over time in the control group 
F4 
The control group also showed a significant decrease compared to baseline in the 
contralateral frontal area in electrodes 113 (X2 = 8.5, p = 0.05), 117 (X2 = 9.7, p = 0.05), 
119 (X2 = 11.8, p = 0.01) and 123 (X2 = 10, p = 0.05). 
 
C3 
Changes over time occurred in the ipsilateral central area of the control group in 
electrode 48 (X2 = 13.2, p = 0.05). 
 
Cz 
Electrodes 7 (X2 = 10.1, p = 0.05), 107 (X2 = 8.5, p = 0.05) and 129 (X2 = 9.3, p = 0.05) 
overlying the vertex area showed significant differences over time between the 
baseline value and 36 hours after the EIMD protocol.  
 
P3  
Decreases in activity in the control group were also recorded in electrodes overlying 
the ipsilateral parietal area. These were electrodes 51 (X2 = 7.9, p = 0.05), 52 (X2 = 
16.3, p = 0.001), 53 (X2 = 13.1, p = 0.05) and 61 (X2 = 12.7, p = 0.01).  
 
Pz 
Decreases in activity compared to baseline also occurred in electrodes 54 (X2 = 13.1, p 
= 0.05), 55 (X2 = 12.4, p = 0.01), 62 (X2 = 15, p = 0.001) and 80 (X2 = 9.3, p = 0.05), 






Decreases in activity in the control group spread into the contralateral parietal area and 
were detected in electrodes 77 (X2= 10.3, p = 0.05), 79 (X2 = 10.1, p = 0.05), 81(X2 = 
9.0, p = 0.05) and 87 (X2 = 7.9, p = 0.05).  
 
Differences over time in the experimental group 
There were no changes in the experimental group over time. 
 
4.3.8.1.3  One-hundred and thirty-two hours 
F4 
At 132 hours after the exercise protocol significant changes in β-1 between the 
experimental and control group were more localized and only found in two electrodes 
overlying the contralateral pre-motor cortex in electrodes 4 (H = 4.76, p = 0.0291) and 
119 (H = 3.99, p = 0.0459). 
 
P3 and Pz 
The parietal area shows significant differences between the groups at electrodes 
representing P3 and Pz. Changes in the P3 area were observed in electrodes 52 (H = 
5.18, p = 0.0229), 53 (H = 7.75, p = 0.0053) and electrodes 54 (H = 6.29, p = 0.0122), 
62 (H = 7.75, p = 0.0053) and 68 (H = 4.36, p = 0.0367) which represent changes in 
the Pz area.  
 
O2 
The occipital region also shows significant differences around the O2 area at 
electrodes 77 (H = 4.36, p = 0.0367) and 84 (H = 5.83, p = 0.0158). 
 
Differences over time in the control group 
C3, P3 and Pz 
A difference was also observed in the β-1 activity of the control group over time 
compared to the baseline measurement in electrodes representing the area around 
C3, P3 and Pz, these are electrodes 48 (X2 = 13.2, p = 0.05), 52 (X2 = 16.3, p = 0.01), 
53 (X2 = 13.5, p = 0.05) and 54 (X2 = 13.1, p = 0.05). 
 
O2 





Differences over time in the experimental group 
No differences occurred in the experimental group over time.  
 
4.3.8.2 Beta 2 
Differences between the control and experimental group in the β-2 activity at twelve 
hours were represented in slightly different areas than β-1 activity. The contralateral 
pre-motor area (F4) showed no differences between groups in the β-2 activity. 
Differences did occur between the two groups in the ipsilateral pre-motor (F3), 
supplementary motor (Fz), motor (C3, Cz, C4) and parietal areas (P3, Pz).  
 
While no differences in β activity occurred between the experimental and control group 
on the contralateral side, differences on the ipsilateral side are visible at twelve hours. 
 
At 36 hours differences are only seen in the ipsilateral central and parietal areas and at 
132 hours changes have attenuated (besides one significant difference in an ipsilateral 

















Figure 4.6 The global change (%) of β-2 activity measured with 129 electrodes over the scalp is 
shown in the control (a) and experimental (b) group. An outline of the electrodes showing 







4.3.8.2.1 Twelve hours 
At twelve hours after the EIMD protocol the differences between control and 
experimental group were widespread from the vertex to the occipital area of the head 
and to a smaller extend in the ipsilateral frontal area. 
 
Fz 
Significant differences between the experimental and control group occurred in the 
frontal area electrodes 11 (H = 5.61, p = 0.0179), 12 (H = 6.05, p = 0.0139), 13 (H = 
5.61, p = 0.0179), 20 (H = 5.39, p = 0.0203), 21 (H = 4.56, p = 0.0327), 25 (H = 4.36, p 
= 0.0367) and 118 (H = 3.99, p = 0.0459). 
 
 
Figure 4.7 Twelve different electrodes representative of the change (%) of β-2 activity in the frontal, 
central and parietal areas of the brain in the control () and experimental () group. Each graph is 
labeled with the corresponding electrode number. The vertical dotted line marks the time of the EIMD 
inducing protocol in the experimental subjects. 
---- 
(* indicates results of the Kruskal-Wallis nonparametric test, #, †, ‡ indicate results of the Friedman’s non parametric test) 
* p < 0.05 control group versus experimental group, ** p < 0.01 control versus experimental group, *** p < 0.001 control versus 
experimental group. # p < 0.0512 and 36 hours post versus pre in the control group, ## p < 0.01 at 12and 36 hours post versus 
pre in the control group.† p < 0.05 at 36 versus 12 hours post in the experimental group, ‡ p < 0.05 at 132 versus 12 hours post 





In the ipsilateral motor area electrodes 31 (H = 5.39, p = 0.0203), 32 (H = 5.39, p = 
0.0203), 42 (H = 7.50, p = 0.0062), 43 (H = 4.97, p = 0.0259) and 48 (H = 3.99, p = 
0.0459) differences occurred between the experimental and control groups at twelve 
hours after the induction of EIMD. 
 
Cz 
Over the vertex area of the head differences between the groups were seen in 




In the ipsilateral parietal area the electrodes 52 (H = 7.50, p = 0.0062), 53 (H = 7.50, p 




Differences occurred in electrodes 54 (H = 8.55, p = 0.0158), 55 (H = 8.83, p = 
0.0030), 62 (H = 11.17, p = 0.0008), 68 (H = 10.86, p = 0.0010), 73 (H = 9.39, p = 
0.0022) and 80 (H = 7.00, p = 0.0081) representing the parietal area.  
 
P4 
Electrodes 78 (H = 5.83, p = 0.0158), 79 (H = 9.11, p = 0.0025), 87 (H = 7.25, p = 
0.0071) and 92 (H = 4.76, p = 0.0291) were significantly different between the 
experimental and control group.  
 
O1 
Electrodes 66 (H = 5.61, p = 0.0179), 67 (H = 8.28, p = 0.040), 72 (H = 4.76, p = 




Significant differences also occurred in the contralateral occipital area in electrodes 77 






Differences over time in the control group 
Differences were observed in the β-2 activity of the control group over time compared 
to the baseline measurement at twelve hours post –EIMD induction. These mainly 
occurred in the areas of F3, Cz and Pz. 
F3 
Electrodes 20 (X2 = 11.8, p = 0.01) and 21 (X2 = 8.7, p = 0.05) overlying the pre-motor 
area showed significant decreases between the baseline and twelve hour post 
measurement in the control group. 
C3 
A significant decrease also occurred in electrode 42 (X2 = 11.5, p = 0.05) overlying the 
ipsilateral motor area. 
Cz 
Significant decreases occurred in electrodes 7 (X2 = 9.9, p = 0.05) and 81 (X2 = 8.7, p = 
0.05) representing the vertex of the head. 
Pz and P4 
Electrodes 62 (X2 = 13.5, p = 0.05), 68 (X2 = 12.2, p = 0.01), 73 (X2 = 13.3, p = 0.05), 
79 (X2 = 13.0, p = 0.01) located over the parietal area all recorded significant 
decreases compared to baseline in the control group.  
O2  
Electrode 77 (X2 = 11.5, p = 0.05) showed significant decreases in the control group. 
Differences over time in the experimental group 
No differences were seen in the experimental group over time. 
4.3.8.2.2 Thirty-six hours 
Fz 
At 36 hours after the EIMD protocol the only difference in activity between groups in 
the frontal area occurred in electrode 11 (H = 6.28, p = 0.0122) and 20 (H = 4.36, p = 
0.0367). 
C3 
Differences between the two groups were found in the ipsilateral motor area in 
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In the ipsilateral parietal area electrodes 53 (H = 5.83, p = 0.0158), 61 (H = 4.97, p = 
0.0259) and 67 (H = 4.76, p = 0.0291) displayed differences between the groups. 
 
Pz 
The area around Pz at electrodes 54 (H = 7.50, p = 0.0062), 68 (H = 4.17, p = 0.0411) 
and 73 (H = 4.76, p = 0.0291) showed significant differences between the control and 
experimental group at 36 hours after the induction of EIMD. 
 
O2 
Differences between groups occurred in electrodes 84 (H = 3.99, p = 0.0459) and 85 
(H = 3.99, p = 0.0459) overlying the occipital area. 
 
Differences over time in the control group 
Fz and F3 
Decreases were observed in the frontal β-2 activity of the control group compared to 
the baseline measurement in electrodes 5 (X2 = 8.7, p = 0.05), 11 (X2 = 10.8, p = 0.01) 
and 12 (X2 = 8.7, p = 0.05) all representing (Fz) as well as electrode 25 (X2 = 7.9, p = 
0.05) representing F3. 
 
C3 and P3 
The Ipsilateral central and parietal area each had one electrode in which a significant 
decrease occurred over time; these were electrodes 48 (C3) (X2 = 8.4, p = 0.05) and 52 
(P3) (X2 = 8.7, p = 0.05). 
  
Pz 
Decreases, compared to baseline, occurred in electrodes 54 (X2 = 10.1, p = 0.05), 55 
(X2 = 13.5, p = 0.01) and 68 (X2 = 12.2, p = 0.05) in the medial parietal area. 
 
Differences over time in the experimental group 
T3 
 A difference was observed in the β-2 activity of the EIMD group over time compared to 




4.3.8.2.3 One hundred and thirty-two hours 
Fz 
At 132 hours the only differences between groups was in the frontal electrode 12 (H = 
3.99, p = 0.0459). 
 
Differences over time in the control group 
Differences were observed in the control group over time compared to the baseline 
measurement in electrodes along an ipsilateral anterior- posterior axis. In electrodes 
35 (F3) (X2 = 9.0, p = 0.05), 42 (C3) (X2 = 11.5, p = 0.05), 53 (P3) (X2 = 11.8, p = 0.01) 
and 73 (Pz) (X2 = 13.3, p = 0.05). 
 
Differences over time in the experimental group 
Fz and F4 
In the frontal area of the experimental group decreases occurred in electrodes 6 (Fz) 
(X2 = 11.1, p = 0.01) and 117 (F4) (X2 = 10.13, p = 0.05). 
 
T3 and T5 
Difference were observed in the β-2 activity of the experimental group over time 
compared to the baseline measurement in electrodes running along an anterior-
posterior line in the ipsilateral temporal area 35 (F3) (X2 = 10.35, p = 0.05), 41 (T3) (X2 
= 15.23, p = 0.01), 51 (T5) (X2 = 12.15, p = 0.01), 59 (T5) (X2 = 9.25, p = 0.05). 
  
P3 
Differences in the EIMD group were also seen in electrode 52 between 12 and 132 
hours (X2 = 10.35, p = 0.05).  
 
As well as in electrode 60 between 12 and 36 hours (X2 = 15.23, p = 0.05) and 
between 12 and 132 hours (X2 = 15.23, p = 0.01). 
 
C4 
Differences occurred in electrode 104 (X2 = 10.28, p = 0.01637) in the experimental 









Typical symptoms of EIMD were experienced by the experimental group (Figure 4.3). 
These included the symptoms of pain as well as decreased neuromuscular function as 
measured by force output (Figure 4.3). 
 
 The study also showed a trend in increased submaximal EMG activity in the biceps 
brachii in the first twelve hours (p = 0.051) after the induction of EIMD (Figure 4.3f). 
This is in agreement with chapter 2 which found submaximal EMG increased twelve 
hours after the induction of EIMD with the same protocol and a smaller cohort (25 
participants of the 37). In the same chapter we could show that a submaximal flexion-
extension movement lead to increased EMG activity until 132 hours after the EIMD-
inducing protocol. 
 
It has been shown that EIMD, as well as muscular pain in the biceps brachii, not only 
leads to altered proprioception and motor-perception but also changes in 
neuromuscular function and motor recruitment 301. Several studies 62, 300, 339, 398 have 
previously shown that movement steadiness and force output, both associated with 
motion perception and proprioception, are difficult to maintain during low force 
contractions whilst experiencing symptoms of EIMD 339, as observed in this study. 
 
The novel finding of this study was the significant changes in cortical β activity which 
occurred for up to 132 hours whilst experiencing symptoms of EIMD. Due to the β 
frequency range (from 13.67 to 35.16 Hz) overlapping with the α-2 frequency in the 
lower range and γ frequency in the upper range, we divided β into two different 
frequency bands, β-1 (13.67 to 18.55 Hz) and β-2 (19.35 to 35.16 Hz) activity 
respectively, for analysis and discussion.  
 
4.4.1 Beta 1 
 
The most pertinent β-1 finding was that differences between the experimental and 
control groups peaked at twelve hours after the induction of EIMD, these were 
predominantly evident in the frontal and parietal areas of the cortex (Figures 4.4 and 
4.5). Interestingly β-1 activity peaked at twelve hours post-EIMD in the experimental 
group. This was evident in the ipsilateral frontal and temporal areas as well as the 
entire central area. These differences were only seen at 12 and 36 hours after the 
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induction of EIMD, and not at 132 hours post. However, in the contralateral frontal and 
the entire parietal area these changes were visible over the entire duration of the trial 
(132 hours post-EIMD) (Figure 4.4 and 4.5).  
 
The increase in β-1 activity in the cortical areas, together with the above-mentioned 
similar changes in EMG activation during the same time period, suggest a link between 
the EEG and EMG activity patterns. Changes in the frontal and parietal cortical areas 
are often associated with movement perception, proprioception and movement 
integration 5, 208, 249, 386. These concurrent changes in cortical and neuromuscular 
measurements indicate a top–down regulatory mechanism 119, 152, 175, 250, 256, 257, 285, 
where cortical β activity regulates neuromuscular recruitment whilst the symptoms of 
EIMD are experienced. 
 
This hypothesis is supported by previous studies which have shown that a coherent 
firing of the motor cortex and peripheral motor units in a 15 Hz activity range is evident, 
especially during steady state contractions 64, 83, 199. These studies suggest a regulating 
interaction between the motor cortex and the motor units innervated. However, further 
substantiation by means of a cortico-muscular coherence study, would help determine 
if this is indeed a predominantly top-down regulatory mechanism between β-1 activity 
and motor units during biceps brachii contractions.  
 
Interestingly, these changes in neuromuscular function, seen as changes in EMG 
activity and force output, could also act as a bottom up control mechanism which would 
lead to a compensatory increase in β-1 activity in the associated frontal and parietal 
areas seen in our study 5, 208, 249, 386. This hypothesis is supported by previous studies 
which have not only shown cortico-motor coherence in the β frequency range 13, 157, but 
also that β-1 activity measured in the frontal, somatosensory and parietal area is 
associated with bottom up sensory signalling from the peripheral motor system 22, 209, 
344 to the brain. As the β-1 activity links afferent sensory information to motor planning, 
it has been suggested that this networking aids the decision making process before the 
execution of movement 48, 107, 116, 209, 257, 344, 344, 394.  
 
These studies support the findings of our experimental group (EIMD) which had 
increased β-1 activity in the parietal and frontal areas. Therefore the findings of this 
study also lead us to suggest that increased β-1 activity is associated with a bottom up 
feedback of sensory information (proprioception, altered neuromuscular function, motor 
perception, movement unsteadiness and force output) to cortical areas associated with 
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motor planning and movement execution.  
 
Hence we propose that an increase in β-1 activity in the parietal area during brisk 
biceps brachii contractions is due to altered bottom-up input as a result of the disturbed 
neuromuscular function (increased submaximal EMG and decreased maximal EMG) 
and decreased force output associated with EIMD. This increased β-1 activity in the 
parietal area may be involved in the integration of neuromuscular information 
movement learning and planning in the frontal and prefrontal areas as well as an top-
down feed-forward mechanism to the periphery. 
Interestingly at 132 hours post-EIMD differences between the groups can still be seen 
in frontal and parietal β-1 activity as well as in force output and serum creatine kinase 
activity, while all others markers of EIMD have already returned to baseline values. 
This strongly suggests that neuromuscular function (bottom-up signal) and movement 
planning (top-down) are still altered between the control and experimental group at 132 
hours. Therefore we propose that there could be a modification in the upstream 
regulator integrating movement perception and proprioception 47, 300 whilst experiencing 
the symptoms of EIMD.  
 
4.4.2 Beta 2 
 
In contrast to β-1 activity, β-2 activity differences are marked between the groups at 12 
and 36 hours but not at 132 hours after the exercise protocol. This difference is mainly 
seen in the frontal and parietal area and is due to a concomitant increase in activity in 
the experimental group and decrease in activity in the control group.  
 
This is the first study to show decreases in β-2 activity in the control group during 
repeated trials over 132 hours. This decrease was most pronounced at 12 and 36 
hours after the exercise protocol and was seen globally except for the contralateral 
motor area (Figure 4.7; electrode 104).  
 
During testing session two (12 hours) the decrease in β-2 activity was most notable in 
the parietal area whilst the most prominent decrease during testing session three (36 
hours) was observed in the frontal area. This is unlikely to be explained by circadian 
rhythm as both groups responded differently at the same time points.  
 
It is known that an increased β activity is related to maintaining the status quo of a 
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movement whilst new information is being integrated 116. A decrease in β activity, as 
seen in the control group and the contralateral motor area of the experimental group 
(Figure 4.7; electrode 104), is possibly a learning or familiarization response to 
repeated tasks. In this study the testing protocol was repeated over several days and 
the participants became familiarized with the voluntary movements as the experiment 
progressed. This is further supported by the decrease in β-2 activity in the frontal and 
parietal areas; both are brain areas associated with motor learning, attention and 
anticipation 5, 208, 249, 386. 
In the experimental group it was found that β-2 activity did not decrease but rather 
increased within the first twelve hours, suggesting that familiarization may have been 
delayed while EIMD symptoms were peaking. Therefore it seems that the EIMD 
protocol lead to changes in either afferent signals influencing β-2 activity or in efferent 
β-2 activity signalling to the muscle 22, 208, 209, 217, 359. 
This increase in β-2 activity was most pronounced in the parietal and somatosensory 
area (Figure 4.6 and 4.7) as shown by Rougeul et al. 313. Previous animal models have 
shown this increased activity is due to increased synchrony in the neuronal firing 363, 
which is known to be augmented by focused attention as well as anticipation 12, 13, 68, 314,
363. Previous research has also shown that the inferior parietal area is activated during
the experience of muscle pain and is associated with the localization of the painful
stimulus 205, 367. Therefore β-2 activity in this current study appears to be due to
anticipation of movement or pain on the focused attention.
This is supported by studies by Chang et al. and Worthen et al., which showed that β-2 
activity is positively correlated to pain intensity, especially muscle pain 68, 411. Our study 
also noted an increased β-2 activity in the experimental group while they experienced 
muscular pain associated with EIMD. Therefore the increased β-2 activity in our study 
could be due to the recognition or anticipation of pain (Figure 4.6 and 4.7) induced by 
the EIMD protocol. This is supported by non-significant differences in β-2 activity 
between the groups at 132 hours where there were no differences in either pain, 
swelling or changes in elbow angle as these had returned to pre-EIMD values by 132 
hours. 
In summary we found that β-2 activity in the control group decreased over time due to 
familiarization of the testing protocol. In contrast, this familiarization appeared delayed 
in the experimental group reflected by an initial increase in β-2 activity. It may be 
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surmised from this that the β-2 activity increases due to the cognitive evaluation of, and 
attention to, both pain and neuromuscular changes caused by EIMD. This is supported 
by previous research that has shown that β-2 activity appears to be a common mode of 
long-range communication in cognitive networks 203, 204. Therefore we conclude that β-2 
activity may be associated with the anticipation of pain induced by movement and the 
neuromuscular changes associated with EIMD. 
 
4.4.3 Limitations 
This novel study, conducted over 132 hours, explored the relationship between pain 
induced by an EIMD protocol and β-1 and β-2 activity measured by EEG. Although our 
study investigated changes in induced β activity, rather than event related β activity, 
the aim was to investigate the influence of pain and neuromuscular changes induced 
EIMD on β activity over the entirety of a movement task. Also our data were not 
normalised to baseline but rather compared to pre-EIMD protocol values to identify 
percentage changes in β activity post- versus pre-EIMD. We also measured EMG and 
EEG during the same testing protocol but not at similar time points and therefore 
correlations and coherences can only be postulated and further research is needed to 
confirm our hypothesis. 
 
4.4.4 Conclusion 
In conclusion this novel study showed an increased β-1 activity in the parietal area, 
possibly due to a bottom-up and top-down interaction to integrate information about 
disturbed neuromuscular function, decreased force output, increased submaximal and 
decreased maximal EMG. These data suggest that there could be a change in activity 
in the upstream regulator integrating movement perception and proprioception 47, 300 
after a bout of exercise as a result of EIMD. Additionally our data suggest that an 
increased β-2 activity might be associated with the anticipation of pain induced by 
movement and the cognitive evaluation of neuromuscular changes associated with 
EIMD. 
 
Further motor-cortical coherence research is required to elucidate, firstly the 
association between β-1 activity and motor perception and proprioception, and 
secondly β-2 activity and the anticipation of pain and changes in neuromuscular 
functioning (loss of force, stiffness and changes in EMG activation) while experiencing 
the symptoms of EIMD. 
 
CHAPTER 5                                                              







Exercise–induced muscle damage is experienced by many athletes after periods of 
long inactivity or after strenuous unaccustomed exercise. It has been documented that 
EIMD leads to a disruption of peripheral homeostasis. The understanding thereof has 
been a topic of continuous research over the last few decades, including research on 
micro- and macroscopic tissue damage, the delayed pain response, clinical symptoms 
and gross recovery of the muscle. However, the dissociation of the clinical symptoms 
from the perception of pain and changes in neuromuscular function associated with 
EIMD has not been well reported. Further no convincing explanations for the 
association between the delayed, and over exaggerated pain response, and the 
structural damage of the muscle have been presented. Countless studies have 
reported cellular and sub-cellular changes due to EIMD, however there are a lack of 
data on the neuromuscular changes and altered cortical upstream regulation due to 
EIMD. This lack of information can, among other things, be attributed to the difficulty of 
measuring upstream regulation.  
 
Interestingly studies have investigated the cortical anticipation and regulation of 
evoked pain as well as the cortical involvement in voluntary movement control. 
However, this methodology has not been applied to study the regulation of EIMD and 
associated symptoms, pain response and neuromuscular changes.  
 
Therefore this thesis intended to document the changes in muscular and cortical 
activation for 132 hours following the induction of EIMD. A summary of the main 
findings of the studies follows: 
 
1. The experimental group, which underwent the EIMD inducing protocol, had 
increased serum creatine kinase activity, swelling of the M. biceps brachii, a decrease 
in elbow angle at rest, a loss of force during a maximal voluntary contraction and the 
sensation of pain, whereas the control group did not display symptoms of EIMD. 
 
2. There was a significant decrease in EMG activity during a maximal voluntary 
contraction at 132 hours after the EIMD inducing protocol, whilst during a submaximal 
isometric contraction EMG activity increased twelve hours after the EIMD protocol in 
the experimental group. Furthermore, EMG activity increased during a submaximal 
flexion-extension protocol in the experimental group from 12 until 132 hours whilst 
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experiencing EIMD. These dissociations in EMG activation in the experimental group 
suggest the possibility of an upstream regulator of neuromuscular function as a result 
of EIMD. 
 
3. An increase of α-1 activity in the motor, pre-motor and supplementary motor areas of 
the cortex was seen in the experimental group compared to the control group for the 
first 36 hours while experiencing EIMD. Together with the location and the previous 
findings of increased submaximal EMG twelve hours after inducing EIMD, this could 
imply the involvement of α-1 activity in the up-regulation of the neuromuscular function 
post EIMD. 
  
4. Alpha-2 activity increased, in the contralateral frontal area, twelve hours after 
inducing EIMD in the experimental compared to the control group. The location and 
frequency of the activity suggest an inhibition of the painful stimulus within the first 
twelve hours of experiencing EIMD.  
 
5. A decreased β-1 activity was observed in the control group for the duration of the 
study. This is associated with the familiarisation of the participants to the movement 
protocol over the days of the experiment, suggesting less anticipation and necessity of 
conscious control during the movement tasks.  
 
6. An increase in β -1 activity occurred in the frontal and parietal area at twelve hours 
post EIMD in the experimental group. The increase in β-1 activity especially in the 
parietal and posterior parietal area proposes a feedback link about EIMD induced 
peripheral changes in proprioception, force steadiness and neuromuscular function in 
the experimental participants.  
 
7. Significant differences were evident between the experimental and control groups 
and over time in the ipsilateral frontal, central and parietal areas at 12 and 36 hours 
post EIMD. In the experimental group there were significant increases in β-2 activity in 
the ipsilateral parietal area at 12 hours and a consistent decrease towards 132 hours. 
This change in activity, from an increase to a decrease, suggests that β-2 might be 
associated with the anticipation of movement and/or pain which explains its peaking at 
12 hours and its continuous decrease until the end of the study at 132 hours.  
 
A future research model, describing how to investigate further the central upstream 
regulation in response to the neuromuscular changes and delayed pain caused by the 
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disturbance of system homeostasis due to EIMD, has been proposed. This research 
model has been developed from the findings of the experiments described in the 
previous three chapters as well as previous research as discussed in chapter 1.  
The next section will explain how this model was developed based on the findings of 
this study. 
5.2 SUMMARY OF CHAPTER 2 
Chapter 2 shows that changes in neuromuscular recruitment and delayed pain are 
associated with the clinical symptoms of EIMD.  
Particularly interesting is the finding that neuromuscular changes during maximal 
isometric and submaximal isometric and flexion-extension contractions are dissociated. 
The decrease of EMG activity during a maximal contraction is caused by damage to 
the contractile machinery and the down regulation of neural drive to the muscle. The 
increased EMG activity during submaximal neuromuscular activity suggests that more 
muscle fibres are recruited to compensate for the disturbed motor perception and 
altered proprioception. Both the up and down regulation of EMG activity during 
contraction suggests that an upstream (central) regulator might be located within the 
central nervous system. 
It was also noted during this study that the pain response is delayed and dissociated 
from the neuromuscular responses. The neuromuscular changes are most pronounced 
twelve hours after the induction of EIMD while the pain response is delayed and the 
symptoms of pain peak only 48 hours after the induction of EIMD.  
This suggests that there is a central regulator overriding the pain within the first 12 to 
24 hours. This could be explained using evolutionary principles as the delayed onset of 
the symptoms made a “fight or flight” response possible, after which the damage to the 
tissue could heal. Therefore it may be argued that the delayed onset of pain is an 
evolved mechanism, acquired for survival, as it provided the human being time to 
escape from danger before severe pain forced them to rest to give the damaged tissue 
time to recover. 
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↓ EMG activity during MVC 
 
 ↑ EMG activity during submaximal isometric (12 hours) and flexion-
extension movements (132 hours) 
 
This dissociation suggests upstream regulation 
 
EIMD symptoms 
↑ Muscular pain 
↑ Arm circumference 
↑ Serum creatine kinase activity 





5.3 SUMMARY OF CHAPTER 3 
 
The second study was designed to determine the involvement of the cortex in 
neuromuscular control and pain perception following EIMD. The cortex was selected 
as the area of the brain for this research, rather than the lower lying brain areas as it is 
easier to measure changes with EEG and also due to the fact that the motor and 
somatosensory control areas are to a large extent based in the cortex.  
 
To determine whether the cortex was affected by EIMD the EEG was measured during 
a similar movement protocol in which the EMG was measured. EEG was measured 
during a movement sequence as the effect of movement was assumed to heighten the 
sensation of pain caused by EIMD.  
 
The study found increased α-1 activity in the electrodes overlying the motor and 
somatosensory area during a submaximal flexion–extension contraction within the first 
36 hours after the induction of EIMD. Previous research has shown that these areas 
are concerned with the integration of proprioceptive and motor perceptive feed back as 
well as the control of voluntary movement. 
 
As these areas are associated with sensory stimuli as well as motor control it was 
concluded that the increased α activity was associated with the changed 
neuromuscular function measured with EMG in chapter 2. This conclusion was based 
on the fact that α-1 activity was elevated during the same time period during which 
neuromuscular disturbances had been measured in chapter 2. Therefore it was 
proposed that the increased activity was due to increased movement planning, to 
maybe counteract the altered proprioceptive feedback reaching the brain.  
 
Alpha-2 activity, in contrast, increased in the pre-motor and motor cortex contralateral 
to the movement. These areas are to be part of the medial pain system and are 
associated with the perception and integration of a painful stimulus. Therefore it is 
proposed that an increased contralateral fronto-central α-2 activity acts as a cortical 
top-down regulator of the perception of pain twelve hours after the induction of EIMD 
which consequently leads to the delayed onset pain response associated with EIMD.  
 
As hardly any significant changes are seen in α-2 activity 36 and 132 hours after EIMD 
induction it is proposed that α-2 activity suppresses the sensation of pain at the cortical 
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level even if painful stimuli are received from the periphery. This suppression is 
attenuated at 36 hours and therefore allows the sensation of pain to develop. It might 
even be attenuated earlier, as the sensation of pain is often felt 24 hours after the 
induction of EIMD. However this was not tested in this study and follow up studies 
would need to be conducted to show this. It is suggested that this is the mechanism by 
which the delayed onset of pain, possibly necessary for survival as mentioned earlier, 
is provided. This hypothesis needs to be tested further. 
 




















Cortical alpha activity 
↑ alpha-1 activity in the motor area at 12 hours, decreasing at 36 hours and 
disappearing at 132 hours. 
 
Suggests that α-1 activity is associated with motor response and execution of 
movement. 
 
↑ alpha-2 activity in the contralateral frontal and pre-motor area at 12 hours post, no 
significant changes at 36 and 132 hours. 
 
Suggests that α-2 activity is associated with suppressing the sensation of pain.  
Chapter 5 
 129 
5.4 SUMMARY OF CHAPTER 4 
 
The findings of the experiment described in Chapter 3 lead to the question of how the 
information about the neuromuscular changes and the painful stimulus are sent and 
perceived by the cortex before the feed-forward response can be formed.  
 
The sensory information about the clinical changes due to EIMD (increased serum CK 
activity, oedema) and the proprioceptive information (shortened muscles, decreased 
force output, changes in neuromuscular function) are relayed to and integrated in the 
brain in the 14–35 Hz frequency. 
 
Recent research has shown that proprioceptive information is not only received and 
integrated in the cerebellum but also in the parietal area of the cortex. In this study β-1 
activity is increased particularly in the parietal and frontal areas of the cortex while 
experiencing EIMD. Therefore it is proposed that there is a link between the changed 
neuromuscular functioning, disturbed proprioception and the increased β-1 activity in 
the parietal area. This suggests that the increased β-1 activity in the parietal and frontal 
area is directly related to the feedback about proprioceptive changes and adaptations. 
 
Beta-2 on the other hand seems to decrease in both groups over the time course of the 
study (132 hours) and we therefore propose that an increased β-2 activity is related to 
anticipation either of the movement or pain felt during the movement.  
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Figure 5.3 Schematic overview of the main findings of chapter 4 
  
 
FEEDBACK and FEED-FORWARD 
 
Cortical beta activity 
↑ Beta-1 activity in the medial frontal, central and parietal area. Subsiding in frontal 
and central areas, but still different from control group in the parietal area at 132 
hours. 
 
Suggests that β-1 activity is linked to proprioception and motor perception. 
Bottom-up feedback from periphery to parietal area as well as top-down 
control from cortical areas to periphery 
 
↑ Beta-2 activity at 12 hours in the ipsilateral frontal, central and parietal areas, 
subsiding towards 36 hours and differences between the groups are mainly seen in 
ipsilateral parietal area at 36 hours. This is the only frequency in which changes are 
seen over time in the experimental group between 12 and 132 hours post.  
 
Suggests that β-2 could be associated with the anticipation of movement and 
pain, which could explain the over-compensatory increase in submaximal 





This novel study, conducted over 132 hours, explored the relationship between pain 
and neuromuscular changes induced by an EIMD protocol and cortical α-1 and α-2 
activity as well as β-1 and β-2 activity measured by EEG. Although the study 
investigated changes in induced cortical activity, rather than event related activity, the 
aim was to investigate the influence of pain and neuromuscular changes induced by 
EIMD on cortical activity as well as EEG over the entirety of a movement task. Also our 
data were not normalised to baseline but rather compared to pre-EIMD protocol values 
to identify percentage changes in cortical activity post- versus pre-EIMD. We also 
measured EMG and EEG during the same testing protocol but not at similar time 
points and therefore correlations and coherences can only be postulated and further 
research is needed to confirm our hypothesis. We acknowledge that other factors such 
as changes in pain pathways or inflammatory processes could have lead to the 
dissociated response of neuromuscular changes and the delayed pain response, but 
the interest of this study was how EIMD and its associated symptoms affected the 
cortical α  and β activity measured over the cortical areas. Further research is needed 
to integrate not only the pain and neuromuscular response with the EEG recordings 
but also possible inflammatory changes and adaptations in the pain pathways. Future 
studies should consider correlations between EMG and EEG, as well as look at a 
broader spectrum of EEG frequencies (including β, θ and γ). 
Further limitations are that the distribution of the data needs to be seen with caution as 
the recorded signal source localization data was corrupted and could therefore not be 
used for further analysis. Signal source localization would have been of integral help in 
confirming the brain areas involved in the response to pain and changes in 
neuromuscular function.  Also the additional recording of fMRI data would increase the 
interpretability of the data. 
There was also a large amount of intra and inter subject variability especially in the 
EEG recordings leading to large standard deviations and the use of the non-
conservative non-parametric statistical tests which might have lead to accepting false 
assumptions, although we tried to counteract this phenomenon by presenting data at 
p<0.05 but only discussing data at p<0.01 as calculated by an Bonferoni adjustment. 
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5.6 PROPOSED RESEARCH MODEL 
 
Based on these three findings described in the preceding chapters and previous 
research summarized in the review of the literature the following proposed research 
model integrating the information is put forward (Figure 5.4 and 5.5).  
 
This proposed model suggests that information supplied to the brain by the pain 
specific and proprioceptive pathways is received, integrated and processed in the 
cortical areas to generate an appropriate motor and somatosensory response to 
restore system homeostasis and neuromuscular function.  
 
The first proposed line of communication is the sensation of pain during movement 
tasks which is assessed and integrated in the somatosensory structures. The 
inflammatory response (guided partially by the brain as mentioned in chapter 1) in the 
areas affected by the pain caused by EIMD is integrated and a response can be 
formed.  
 




The second proposed communication pathway is the interaction between the periphery 
and the brain with information about the damaged muscle fibres being sent to the brain 
for assessment and processing. To be able to execute the identical submaximal 
movement task the brain is required to feed-forward this information to augment the 
contraction and recruitment patterns of the damaged muscle fibres to counteract the 
associated force loss.  
 
 The studies conducted for this thesis were the first studies to investigate the effect of 
EIMD on cortical activity. Therefore the approach was kept very broad and only 
general concomitant activity patterns in the muscle and cortical areas were 
investigated. Therefore in this last paragraph a model is suggested on which further 
research could be based to investigate the interaction between peripheral and cortical 
changes associated with EIMD in more detail.  
 
 In summary the proposed research model suggests that a feed-forward –feedback 
loop exists between the periphery and the cortical brain areas while the symptoms of 
EIMD are experienced. Information about pain and neuromuscular changes is 
transmitted to the brain via a feedback mechanism leading to increases in parietal β-1 
and β-2 activity. The parietal area is known to be involved in the integration of 
movement and proprioception; therefore it is an entry point of feedback information. 
From the parietal area β-1 and -2 activities propagate information to the frontal areas of 
the brain where movement planning takes place. The pre-motor area relays planning 
information to the motor cortex. Within the motor cortex increased α-1 activity acts as a 
feed-forward mechanism to co-ordinate submaximal neuromuscular function detected 
as submaximal EMG activation. Concomitantly α-2 activity is increased in the frontal 
and pre-motor area leading to a suppressed pain sensation. Further activity in this area 
may also act as an additional feedback to control neuromuscular function, as moving 












Figure 5.5 An abstract model of the communication pathways between the peripheral muscle 
and the cortical areas. Each colour represents a frequency. Blue = β-1, green = α-2, red = α-1 
and yellow = β-2. The solid lines connect areas in which activity was found during the 
mentioned studies, while the dotted lines represent suggest interactions. The direction of the 





5.7 FUTURE DIRECTIONS 
 
This thesis has provided the foundation for understanding the complex interactions 
between the periphery and the brain during EIMD and exercise-induced muscular pain. 
The feed-forward and feedback loops as well as the information transmitting pathways 
in the proposed model, which was developed based on the experimental findings of 
this thesis, needs to be researched extensively in future studies to prove their 
proposed existence. Future research will have to confirm this proposed model by 
measuring coherences in changes in frequency and time between EMG and EEG 
(cortico-muscular) as well as EEG changes between brain areas (cortico-cortical). 
Further the investigation of changes in θ and γ activity as a result of EIMD could reveal 
a greater understanding of cortico-muscular communication. 
 
This is the first study to document changes in cortical activity using EEG methodology 
over 132 hours (six days) after the induction of EIMD. This and other studies could 
further broaden the knowledge on the treatment of EIMD as well as the incurrence of 
the repeat bout effect. 
 
Future studies should also consider evoked potentials, temporal spectral 270 and 
wavelet analysis should be further used to elucidate the signal propagation velocity 
and location within the cortical networks (i.e.. if the signal travels front to back or back 
to front in the fronto-parietal network). This increase in the body of knowledge will lead 
to the further understanding of pain during movement tasks and perhaps the use of 
biofeedback with different brain frequencies to control acute and exercise-induced pain 
states.  
 
It would also be interesting in future to use fine-wire EMG electrodes as well as nerve 
stimulation or nerve conduction velocity measurements to gain more information about 
the neuromuscular changes within the muscle as well as to maybe determine in more 
detail if sensation of pain associated with EIMD is an emotional response to the 
nociceptive signal or an actual mechanical or physiological disturbance of the 
nociceptors or the nociceptive pathways. 
 
In conclusion, these are the first series of studies illustrating the involvement in the 
cortical areas and documenting the time course of central and peripheral interactions 
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which co-ordinate movement tasks while experiencing pain associated with EIMD. This 
is the first study to illustrate the involvement of the cortical areas and document the 
time course of central and peripheral changes in relation to EIMD. The model 
contributes to the understanding of the physiological changes as a result of EIMD and 
the understanding of pain associated with it. These findings could contribute to better 
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THE ASSESSMENT AND ANALYSIS OF HANDEDNESS  










Please indicate your preferences in the use of hands in the following activities by 
putting + in the appropriate column. Where the preference is so strong that you would 
never try to use the other hand unless absolutely forced to, put ++. If in any case you 
are really indifferent put + in both columns. Some of the activities require both hands. 
In these cases the part of the task, or object, for which hand-preference is wanted is 
indicated in brackets. Please try to answer all the questions, and only leave a blank if 











  R L 
1 Writing   
2 Drawing   
3 Throwing   
4 Scissors   
5 Comb   
6 Toothbrush   
7 Knife (without fork)   
8 Spoon   
9 Hammer   
10 Screwdriver   
11 Tennis Racket    
12 Knife (with fork)   
13 Cricket Bat (lower hand)   
14 Golf Club (lower hand)   
15 Broom (upper hand)   
16 Rake (upper hand)   
17 Striking match (match)   
18 Opening box (lid)   
19 Dealing cards (card being dealt with)   
20 
Threading needle (needle, thread according to which is 
moved) 
  
21 Which foot do you prefer to kick with?   






MODIFIED PHYSICAL ACRIVUTY READINESS QUESTIONNAIRE (PAR-Q)  
 
Name Date 
DOB Age Home Phone Work Phone 
Regular exercise associated with many health benefits, yet any change of activity may 
increase the risk of injury. Completion of this questionnaire is a first step when planning 
to increase the amount of physical activity in your life. Please read each question 




1) Has a physician ever said you have a heart condition and 
you should only do physical activity recommended by a 
physician? 
Yes No 2) When you do physical activity, do you feel pain in your chest? 
Yes No 3) When you were not doing physical activity, have you had chest pain in the past month? 
Yes No 4) Do you ever lose consciousness or do you lose your balance because of dizziness? 
Yes No 5) Do you have a joint or bone problem that may be made worse by a change in your physical activity? 
Yes No 6) Is a physician currently prescribing medications for your blood pressure or heart condition? 
Yes No 7) Do you have insulin dependent diabetes? 
Yes No 8) Are you 45 years of age or older? 
Yes No 9) Do you know of any other reason you should not exercise or increase your physical activity? 
If you answered yes to any of the above questions, talk with your doctor BEFORE you 
become more physically active. Tell your doctor your intent to exercise and to which 
questions you answer yes. 
If you honestly answered no to all questions, you can be reasonably positive that you 
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can safely increase your level of physical activity gradually. 
If your health changes so you then answer yes to any of the above questions, seek 











MEDICAL QUESTIONNAIRE  
 





Date of Birth:  
Age: 
 







































Are you able to visit the laboratory at the Sports Science Institute (Boundary Road, 
Newlands) for the eccentric exercise protocol, and again at 12, 36, 60, 84, 108 and 132 






















Please complete the following table. List any sport/activity in which you have regularly 





months/yr hrs/week level * HIT ** 
(yes/no) 
       
       
       
       
       
       
       
       
       
       
       
* competitive or social 
** interval or high-intensity training (HIT) included; yes or no 
 
Examples of sporting activities include: 
- jogging  - tennis  - aerobic dance/step 
- swimming  - badminton  - dancing 
- cycling  - volleyball  - skating 
- walking  - netball  - hiking 
- rugby   - squash  - rock climbing 
- football/soccer - canoeing  - martial arts 








INFORMED CONSENT FORM 
Dear Volunteer, 
 
The MRC/UCT Research Unit for Exercise Science and Sports Medicine will be conducting a 
trial on the effect of exercise-induced muscle stiffness on brain cortical encephalographic 
patterns. 
 
The clinical trial will involve the following tests: 
1.  Weight and height measurements  
2.  Anthropometric assessment of body composition  
3.  An eccentric exercise bout designed to induce muscle stiffness of the biceps muscle in 
the non-dominant arm. The magnitude of this induced muscle stiffness is of similar 
magnitude to that experienced after a bout of vigorous or unaccustomed exercise ( 
people in the control group are not required to do this exercise bout). 
4.  Repeated assessments of muscle function (peak isometric, concentric and eccentric 
force), using a Biodex isokinetic dynamometer. These measurements will occur before 
the muscle is exercised, and again at 12, 36, 60, 84, 108, and 132 hours after the 
exercise. 
5.  Resting biceps girth measurements and elbow joint angles will be measured before the 
bout of exercise, and again at 12, 36, 60, 84, 108, and 132 hours after the exercise.  
6.  Muscle soreness will be measured using a visual analogue scale, and subjectively 
according to a “rating of perceived pain” scale. Both procedures will be explained to you 
in detail. 
7.  Blood samples will be collected from an antecubital vein prior to each test of muscle 
function to determine plasma creatine kinase activity (This is a marker of muscle 
damage.). This is the only invasive technique used in this study and standard medical 
practice and sterile procedures will be strictly adhered to. 
8.  The measurement of electrical activity of the elbow flexor and extensor muscles using 
an electromyography (EMG). This involves the marking of the skin of the upper arm with 
a washable body marker and 7 hypo-allergic sticky disks will be placed on these 
markings on the skin. To improve the stickiness, the skin will be wiped with an alcoholic 
wipe and if necessary body hair will be shaved with a disposable razor. The EMG will be 
measured before and again 12, 36 and 132 h after the bout of exercise. 
9.  The measurement of electroencephalographic (EEG) activity. Before the EEG net is 
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fitted on the head, the hair will be washed with Johnson’s Baby Shampoo. This 
procedure will ensure optimal conduction of the EEG electrodes. The EEG 
measurements will be performed before and again 12, 36 and 132 h after the bout of 
exercise. During this test the subjects will perform several movements with the left arm 
either on command or self paced. 
10.  Immediately after the EEG testing, the position of EEG electrodes and anatomical 
landmarks will be scanned using a PolhemusTM 3D digitizer. This system uses a 
transmitter which generates a magnetic field for use as a reference frame. A stylus with 
an electromagnetic coil set is then used to tap on leads and reference points. A receiver 
then detects the position of the stylus in the reference frame and allows the leads and 
reference points to be marked in 3D.  
11.  During the trial, subjects will be required to refrain from alcohol consumption, strenuous 




There will be a small risks for the subjects associated with the drawing of blood from the 
antecubital vein. Risks associated with the drawing of blood include discomfort, infection 
(wound sepsis), muscle bruising (haematoma formation) and numbness (peripheral 
subcutaneous nerve injury). The risks will be minimized by cleaning the area around the 
antecubital vein with a disinfectant alcohol swap before the blood will be drawn. Immediately 
afterwards a protective plaster will be applied. 
 
The subjects will be instructed on the usage of the Biodex dynamometer. The risks 
associated with the Biodex are similar to the risks associated with training with weights. The 
bout of eccentric exercise on the Biodex dynamometer is designed to cause moderate 
muscle stiffness which disappears after about 3 days (Rec.Ref.075/99). The muscle stiffness 
might lead to a slight feeling of discomfort or pain which will disappear within 3 days after the 
exercise protocol and will not influence the subjects’ daily life in any way. 
The EEG and EMG will only be used for receiving electrical impulses from the brain and 
muscle respectively and as such will place no inherent risk on the subjects. Neither the EEG 
nor the EMG is being used as a diagnostic tool, but only as a research tool in this study. If 
any abnormalities show during either of the recordings the subjects will be referred to a 
qualified neurologist. 
 





The subjects will receive their results when the study has been completed. This feedback will 
contain their anthropometrical data including an estimate of their body fat percentage and 
the maximal power output of their biceps muscle. 
 
The study will contribute to the better understanding of the mechanisms associated with a 
decline in muscle function after a bout of exercise which causes muscle stiffness. 
 
This trial is undertaken for research purposes and is not designed to treat any medical 
condition. 
 
I confirm that the nature, purpose, testing procedures, and the likely duration of the clinical 
trial study have been fully explained to me. I understand that I may ask questions at any time 
during the testing procedures. I agree to comply with any instruction given during the study 
and to co-operate with the project co-ordinator. I realise that I am free to withdraw from the 
study without prejudice at any time, should I choose to do so. I have been informed that the 
personal information required by the researchers will be held in strict confidentiality. In 
addition, I know that the information derived from the testing procedures will remain 
confidential and will be revealed only as a number in statistical analyses. I understand that 
this study has been reviewed by the Ethics and Research Committee of the University of 
Cape Town Medical School. 
 
I have carefully read this form. I understand the nature, purpose and procedure of this study. 




Name (in full) of volunteer:  
 
Signature of volunteer:   
 
Name (in full) of witness:  
 
Signature of witness:   
 







UNIVERSITY OF CAPE TOWN 
30 Apr;1 2004 
REC REF' 090/2004 
Prof M Lambert 
Human B;0109Y 
Sports Science Institute 
Dear Prof Lambert 
Research Ethics Committee 
Faculty of Health Sciences 
OMS E46 Room 26, GSH 
Queries: Xolile Fula 
Tel: (021) 406-6492 Fax: 406-6411 
E-mail: Xfula@curie.uct.ac.za 
THE EFFECT OF EXERCISE INDUCED MVsa..E STIFFNESS ON BRAIN CORTICAL 
ENCEpHAL06AAPHICPATTERNS 
Thank you for submItting your study to the Research Ethics Committee for 
review. 
It is a pleasure to inform you that the Ethics Committee has formally approved 
the above-mentIoned study on the 29'h Aprd 2004. 
Your comments and revisions have been noted with thanks. 
Ple.ase quote. the. Reference. number in all correspondence. 
Yours Sincerely 
PROF T . v,sow )~ ~ 















1. Rate the average level of pain you have experienced in your left biceps brachii in 
the past 24 hours by making a mark on the line below. 
 
 




2. Rate the level of pain that you are experiencing currently in your left biceps brachii 
by making a mark on the line below. 
 
 




3. Rate the level of pain that you experienced while performing a single left biceps curl 
with a 3 kg weight by making a mark on the line below. 
 
 
No pain          Excessive 
Pain 
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